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ABSTRACT OF THE DISSERTATION 
Functional Roles of Nucleases in DNA Metabolism and Genome Stability 
by 
Justin Lee Sparks 
Doctor of Philosophy in Biology and Biomedical Sciences 
Molecular Cell Biology 
Washington University in St. Louis, 2014 
Professor Peter Burgers, Chair 
 The work outlined in this dissertation focuses on two distinct areas that are 
important for genome stability. Both areas focus on DNA repair pathways that require the 
action of nucleases, specifically Exonuclease 5 and Ribonuclease H2. First, I describe the 
biochemical and molecular characterization of the novel Exonuclease 5 family of 
enzymes from S. cerevisiae, S. pombe, and humans. The Exo5 family consists of bi-
directional single-strand DNA specific exonucleases that all contain an iron-sulfur cluster 
as a structural motif and all have various roles in DNA metabolism. In the 
Saccharomycetales order that includes the budding yeast, S. cerevisiae, Exo5 is a 
mitochondrial protein that is essential for mitochondrial genome maintenance. In an 
unrelated yeast species, Schizosaccharomyes pombe, Exo5 is important for both nuclear 
and mitochondrial DNA metabolism. The human ortholog is important for nuclear 
genome stability, and for DNA repair. The work outlined in Chapter II of this 
Dissertation establishes Exo5 as a protein that is important for DNA metabolism.   
 The second area of study outlined in Chapters III and IV is related to the 
phenomenon of ribonucleotide incorporation into the genome by replicative polymerases, 
iv
and these chapters focus on the enzymes that remove these noncanonical nucleotides. 
Ribonucleotides are incorporated into DNA by the replicative DNA polymerases at 
frequencies of about 2 per kb, which makes them by far the most abundant form of 
potential DNA damage in the cell. Their removal is essential for restoring a stable intact 
chromosome. In Chapter III, I present a complete biochemical reconstitution of the 
ribonucleotide excision repair (RER) pathway with enzymes purified from 
Saccharomyces cerevisiae. I highlight the requirement for RNase H2 in the process of 
RER and investigate the redundancies at different steps of repair. Also outlined in this 
dissertation is the dissection of the different functions of RNase H2 in RER and in the 
removal of RNA-loops in DNA, and implications for genome instability in human 
diseases that are affected for these activities. 
 Chapter IV of this dissertation discusses work on an alternative pathway for 
ribonucleotide removal from the genome by Topoisomerase I. In S. cerevisiae, deletion 
of rnh201, the catalytic subunit of RNase H2, results in the persistence of ribonucleotides 
remain in the genome, which leads to ~100-fold increase in the frequency of 2-5 bp 
deletions at di-nucleotide repeat sequences. These deletions are dependent on 
topoisomerase I (Top1) activity. Here we present an in vitro reconstitution of the 
mechanism of Top1-dependent deletions at di-nucleotide repeat sequences and a 
mechanism for Top1-initiated removal of ribonucleotides outside of the context of these 
repeat sequences in S. cerevisiae. Top1 attack at a ribonucleotide leads to the formation 
of a 2’, 3’ cyclic phosphate terminated ssDNA nick, followed by subsequent formation of 
a Top1-cleavage complex (Top1-cc) upstream of the 2’, 3’ cyclic phosphate. If the 
ribonucleotide is in the context of a di-nucleotide repeat, there can be realignment of the 
v
DNA allowing for religation and release of Top1, leading to a 2-nucleotide deletion. If 
the ribonucleotide resides outside a repeat sequence, the realignment is not possible and a 
different pathway must repair the Top1-cc. Tdp1-dependent repair of Top1-cc requires 
prior proteolytic processing of the Top1-cc before it can be removed leaving a 3’-
phosphate that can be removed by Tpp1, Apn1, or Apn2 forming a substrate suitable for 
repair by DNA polymerase δ, FEN1 and DNA ligase. 
vi
 CHAPTER I 
INTRODUCTION  
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  The vast majority of DNA metabolic pathways, including replication and repair, require 
specific regulated DNA cutting, trimming, and nucleotide removal. The first observation of the 
enzymatic degradation of nucleic acids was reported in 1903 (Araki 1903). DNA repair pathways 
are essential for maintaining the integrity of the genetic material of the cell through both repair of 
damaging events and also through DNA metabolic processes such as replication. DNA repair 
pathways require nucleases to remove aberrant structures and lesions from the damaged DNA, 
and also are critical for creating DNA structures that are substrates for downstream repair 
activities such as template extension or homologous recombination. Nucleases are critical 
components involved in a variety of functions in maintaining the integrity and fidelity of the 
genome.  
 The widely varying metabolic processes requiring DNA or RNA to be removed in some 
capacity has necessitated that cells utilize a toolbox of nucleases with different activities. First, 
nucleases can be divided into two groups based on their backbone sugar, either ribonucleases 
(RNA) or deoxyribonuclease (DNA). A second division of nucleases is the requirement of a free 
DNA/RNA end. Exonucleases require a free end of DNA/RNA to be able to load, allowing 
access to the active site whereas endonucleases bypass this requirement and are able to load 
internally on the molecule. Exonucleases can be subdivided further by the directionality of the 
enzyme’s activity. Directionality of the enzyme comes from the inherent polarity of DNA/RNA. 
DNA/RNA is a polar molecule that has two distinct ends, either a 5’-phosphate or a 3’-hydroxyl. 
Most nucleases degrade the nucleic acid in a 5’-3’ or 3’-5’ direction, although there are several 
exonuclease that are bi-directional. Exonuclease 5, discussed in Chapter II is one example of a 
bidirectional exonuclease. Nucleases can also have a structural specificity. Examples of structure 
specific nucleases include Flap endonuclease 1 (FEN1) and Mus81-mms4 endonuclease (Kao, 
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 Henricksen et al. 2002; Bastin-Shanower, Fricke et al. 2003).  Nucleases are an integral part of 
maintaining the genome and their necessity can be appreciated from the degree of redundancy 
that is inherent in DNA repair pathways. Many pathways can utilize several different nucleases 
to accomplish the same function, making a clear, genetic delineation of the role of a specific 
nuclease difficult. Much work has been carried out to determine how nucleases function in DNA 
metabolism and a short overview will be presented here.  
Replication 
 Nucleases are intimately involved in DNA metabolism during replication of the genome. 
Nucleases actively function on the lagging strand of DNA. Lagging strand synthesis is carried out in a 
discontinuous manner: Polymerase α primase (Pol α) lays down a RNA primer (Okazaki fragment) 
followed by a complex of polymerase δ (Pol δ) with the processivity clamp PCNA (proliferating cell 
nuclear antigen), and clamp loader RFC performs the extension of the RNA primer leading to Okazaki 
fragments around 200 nt in length in eukaryotes (Ogawa and Okazaki 1980). A graphic representation of 
a replication fork is outlined in Figure 1. When Pol δ encounters the 5’-terminus of the adjacent Okazaki 
fragment it initiates strand displacement synthesis to 
form RNA/DNA flaps that are removed by two 
partially redundant pathways (Figure 2C). The 
predominant pathway is called the short flap pathway 
utilizing Flap endonuclease 1 (scFEN1, spRad2, 
hFen1), a structure specific 5’-3’ exonuclease that 
cleaves short RNA or DNA flaps (Figure 2C) 
(Bambara, Murante et al. 1997). FEN1 also has a 
PCNA 
Figure 1.  The eukaryotic replication fork (Nick 
McElhinny, Watts et al. 2010) 
3
   
Figure 2. Stages of lagging strand replication. (A) Lagging strand replication Polα lays down an 
RNA primer and is then handed off to PCNA and Polδ along with FEN1. (B) Polδ extends the 
RNA primer until it reaches the 5’-end of adjacent Okazaki fragment. (C) Maturation of Okazaki 
fragments is carried out by at least two pathways either short flap pathway requiring FEN1 or if 
flaps grow longer than ~20 nt and are bound by RPA the long flap pathway requiring both Dna2 
and FEN1 (Garg and Burgers 2005). 
 
interacting motif that allows for recruitment and coordination of the activities of enzymes of Okazaki 
fragment processing (Li, Li et al. 1995; Kao and Bambara 2003). In the short flap pathway Pol δ 
displaces a short flap less than ten nucleotides that is cleaved by FEN1, and this process is iterative until 
the RNA primer has been removed and the DNA is finally ligated by DNA ligase 1 (Bambara, Murante 
et al. 1997; Ayyagari, Gomes et al. 2003). The alternative pathway arises when Pol δ displaces a flap 
longer than ~22 nucleotides that becomes a substrate for the stable binding of the single strand binding 
protein RPA, subsequently blocking the ability of FEN1 to remove the flap (Rossi and Bambara 2006); 
the alternative pathway is therefore called the long flap pathway of Okazaki fragment processing (Figure 
2C). The long flap pathway utilizes a nuclease/helicase containing protein called Dna2 to degrade the 
long flap to 5-6 nucleotides, thereby removing the bound RPA and allowing for FEN1 and the short flap 
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 pathway to finish the processing. Dna2 is a bi-directional exonuclease with weak 5’-3’ helicase activity 
(Kang, Lee et al. 2010). In S. cerevisiae DNA2 is an essential gene, and it has been shown to have many 
functions including Okazaki fragment processing (Budd, Tong et al. 2005), 5’-3 resection during 
homologous recombination (Zhu, Chung et al. 2008), and checkpoint activation (Kumar and Burgers 
2013) among others. It has been proposed that the long flap pathway is necessary because of the action 
of a helicase Pif1, at least in S. cerevisiae where Pif1 augments the strand displacement synthesis 
activity of Polδ leading to increased frequency of long flaps. Deletion of PIF1 in S. cerevisiae 
suppresses the lethality of a dna2∆, supporting a model where deletion of Pif1 removes the requirement 
of Dna2 to perform long flap Okazaki processing (Budd, Reis et al. 2006). Proper maturation of Okazaki 
fragments is essential for faithful DNA replication and genome maintenance. Replication fork stalling 
and collapse is another aspect of replication that requires coordinated activities of several nucleases. 
Fork stability and collapse will be discussed later in the context of homologous recombination. How 
cells stabilize and restart stalled replication forks is a very intense area of research, and is essential to 
understanding how cells deal with the task of replicating their genomes.  
Base Excision Repair (BER) 
 Base excision repair is important for repair of damaged bases that occur from endogenous 
damage resulting in AP-site formation. AP-sites are thought to be one of the most abundant 
forms of DNA damage with estimates of ~10,000 sites per mammalian cell per day (Lindahl and 
Andersson 1972; Friedberg, Walker et al. 2006). 
 Base excision repair pathway, particularly in yeast, shares many features with Okazaki 
fragment maturation. BER is utilized for the repair of a wide variety of damaged DNA bases that 
maintain the DNA structure with little distortion including 8-oxoguainine (oxidation of guanine),  
5
  Figure 3. Base excision repair. AP sites can either be cleaved by AP endonucleases or a 
class of AP lyases leading to different forms of base excision repair (Boiteux and Guillet 
2004). 
 
uracil (deamination of thymine), and many others. These lesions are thought to occur by both 
endogenous and exogenous sources. These bases are first recognized by DNA glycosylases that 
cleave the glycosidic bond between the DNA base and the deoxyribose sugar backbone leaving 
an abasic site (AP-site). There are many DNA glycosylases that have various damaged base 
substrates. Once, an AP-site has been formed it is subsequently cleaved by an AP-endonuclease, 
in yeast Apn1 and Apn2 (Figure 3). These enzymes cleave the phosphate backbone at AP-sites 
leaving a free 3’-hydroxyl that is a substrate for extension by a DNA polymerase. Also, in yeast 
several DNA glycosylases can cleave AP-sites including Ntg1, Ntg2, and Ogg1 (Figure 3) 
(Girard and Boiteux 1997). These DNA glycosylases leave a 3’-phosphate that must be removed 
by Apn1, Apn2, or Tpp1 before extension by a polymerase (Vance and Wilson 2001). There are 
6
 two main pathways that can be utilized to fill in the ssDNA gap (Figure 3). First is the short 
patch mechanism where Pol β insert a single nucleotide and the nick is ligated by DNA ligase 
III. Alternatively, the long patch mechanism results from Pol δ carrying out strand displacement 
synthesis leading to the formation of a 5’-flap that is cleaved by FEN1 similar to short-flap 
Okazaki fragment maturation. The latter pathway is the only one operating in yeast. 
 Another specialized form of base excision repair has recently been characterized in S. 
cerevisiae: Ribonucleotide Excision Repair (RER). Replicative DNA polymerases have a strong 
preference for the incorporation of deoxynucleotide (dNMPs) over ribonucleotides (rNMP) into 
DNA, but in cells the concentration of 
rNTPs are in 10-100-fold excess of 
dNTPs leading to significant number of 
rNMPs incorporated into the genome 
(Nick McElhinny, Kumar et al. 2010; 
Nick McElhinny, Watts et al. 2010). 
These incorporated rNMPs are the most 
abundant non-canonical nucleotides 
incorporated into the genome (Nick 
McElhinny, Watts et al. 2010).  In vitro 
experiments using a template with a single 
ribonucleotide causes Pol δ and Polε to 
pause leading to slower replication (Watt, Johansson et al. 2011). RER is responsible for removal 
of these incorporated rNMPs from the genome and is important for maintaining genome stability. 
RER is initiated by RNase H2, a heterotrimeric RNase H protein complex that cleaves on the 5’-
Figure 4. Aicardi Goutières Syndrome is an 
autoimmune disorder. Mutations in several 
nucleases have been shown to cause this 
syndrome including Rnase H2 (Lee-Kirsch, 
Wolf et al. 2013). 
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 side of a ribonucleotide in a RNA/DNA hybrid. RNase H2 can cleave at sites of a single rNMP 
or at a long stretch in a RNA/DNA hybrid (Eder and Walder 1991; Rychlik, Chon et al. 2010). In 
yeast, RNase H2 is not an essential gene, but in mice RNase H2 is essential for growth after 
gastrulation and its deletion causes rNMPs to remain in the genome (Reijns, Rabe et al. 2012). 
Bi-allelic hypomorphic mutations in RNase H2 and several other nucleic acid metabolism 
proteins including a 3’-exonuclease Trex1 and a protein of unknown function, SamHD1, have 
been shown to be the cause of the human disease Aicardi-Goutières syndrome (Figure 4) (Crow, 
Leitch et al. 2006). RNase H2 cleaves on the 5’-side of the rNMP leaving a 5’-phosphate and a 
3’-hydroxyl that is a substrate for extension. The rNMP is removed by the concerted work of 
either Polδ or ε performing strand displacement synthesis and forming short flaps that are 
cleaved by FEN1, in an analogous fashion to Okazaki fragment maturation mentioned earlier 
(Sparks, Chon et al. 2012).  
 In S. cerevisiae deletion of RNase H2 leads to a small increase in the mutation rate but 
leads to a significant increase in short 2-5 bp deletions, specifically at sites of di-nucleotide 
repeats that are dependent on Topoisomerase 1 (Top1) (Nick McElhinny, Kumar et al. 2010; 
Kim, Huang et al. 2011; Williams, Smith et al. 2013). Both human and vaccinia viral Top1 
homologs were shown to possess endoribonuclease activity on rNMPs in a RNA/DNA hybrid 
(Sekiguchi and Shuman 1997; Kim, Huang et al. 2011). A model has been proposed for the Top1 
induced mutagenesis based on these studies in which Top1 first cleaves the incorporated rNMP 
leaving a 2’, 3’-cyclic phosphate terminated nick within or near a di-nucleotide repeat sequence. 
Subsequently, a second Top1 cleavage occurs within six nucleotides to the 5’-side of the nick, 
allowing the diffusion of the short intervening oligonucleotide, including the rNMP, and leading 
to the formation of a Top1-DNA covalent complex (Top1-cc) (Cho, Kim et al. 2013). Resolution 
8
 of this Top1-cc would result from realignment in the non-cleaved DNA strand allowing 
proximity of the 5’-hydroxyl to the 3’-phosphate permitting religation of the DNA and release of 
the Top1 protein (Cho, Kim et al. 2013). The mismatch repair or the subsequent round of 
replication would lead to the 2-5 bp deletion in one of the daughter cells. No direct biochemical 
studies have been undertaken to test this model in vitro. Chapter IV of this dissertation is the first 
direct biochemical reconstitution rNMP removal and di-nucleotide repeat deletions caused by 
Top1. 
 Resolution of Top1-cc has been an intense focus of study for some time because several 
classes of therapeutic cancer drugs target Top1 and stabilize the cleavage complex leading to 
DNA damage. Several pathways have been shown to resolve Top1-cc in cells. One pathway that 
has been extensively studied is the TDP1 (tyrosyl-DNA phosphodiesterase 1) pathway. 
Biochemical studies support a model in which Top1-cc must be partially unfolded and/or 
partially proteolyzed before Tdp1 is able to remove Top1. Cell biological studies support a role 
of the proteasome in the Top1 proteolysis (Lin, Ban et al. 2008). The partially proteolyzed Top1-
peptide can be removed by Tdp1 (Debethune, Kohlhagen et al. 2002). Tdp1 activity leaves a 3’-
phosphate that must then be removed by one of several redundant pathways. These pathways 
include protein phosphatases Tpp1, Apn1, and Apn2 (Vance and Wilson 2001). Tpp1 (Three 
prime phosphatase 1) is a 3’-phosphatase that is distantly related to the T4 polynucleotide kinase, 
but it does not have the kinase domain. Apn1 and Apn2 are apurinic/apyrimidinic endonucleases 
that have endonuclease, 3’-diester, and 3’-5’ exonuclease activity. Genetic evidence supports a 
redundant role for these proteins in removal of the 3’-phosphate after Tdp1 removal of the Top1-
peptide (Vance and Wilson 2001). There have been several genetic studies that have implicated 
other pathways for resolving the Top1-cc including roles for the Rad1-Rad10 endonuclease as 
9
 well as the homologous recombination machinery (Liu, Pouliot et al. 2002). In the absence of 
RNase H2 in S. cerevisiae, a Top1-dependent pathway is able to remove a small portion of the 
incorporated rNMPs from the genome (Williams, Smith et al. 2013). Further studies will be 
needed to resolve the mechanistic details of these other pathways. 
Mismatch Repair 
 Mis-incorporations of nucleotide bases during replication that are not removed by the 
3’to 5’ proofreading domain of the replicative polymerases, are another form of damage that 
must be repaired for sequence fidelity to be maintained. The repair pathway mostly responsible 
for the repair of these mismatches is the mismatch repair pathway (MMR). Much of our 
understanding of mismatch repair system comes from studies of the E. coli MutHLS system. In 
this prokaryotic system the strand discrimination is mediated by MutH endonuclease that cleaves 
hemimethylated dam sites on the unmethylated daughter strand. In eukaryotes there are multiple 
MutL and MutS homologs, but no MutH homologs (Culligan and Hays 2000). Strand 
discrimination signals in eukaryotic systems still remain to be established. In vitro studies of 
eukaryotic systems demonstrated that a ssDNA nick can signal strand discrimination (Thomas, 
Roberts et al. 1991) (Holmes, Clark et al. 1990). DNA nicks are abundant in the lagging strand 
during DNA synthesis, and some evidence supports this model for discrimination on the lagging 
strand (Pavlov, Newlon et al. 2002; Nick McElhinny, Kissling et al. 2010). The leading strand of 
DNA replication is thought to be fairly continuous and it was unknown how strand 
discrimination was achieved. Recently, two studies have provided evidence that the cleavage by 
RNase H2 of rNMPs mis-incorporated into the leading strand during replication may in part 
serve as a strand discrimination signal for the leading strand (Figure 4) (Lujan, Williams et al. ; 
Ghodgaonkar, Lazzaro et al. 2013). Deletion of RNase H2 in S. cerevisiae leads to a minor 
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 reduction in the efficiency of MMR (Ghodgaonkar, Lazzaro et al. 2013; Lujan, Williams et al. 
2013). In S. cerevisiae the mismatch is recognized by either a 
complex of Msh2-Msh6 (MutSα) or Msh2-Msh3 (MutSβ), 
along with the major MutL complex of Mlh1-Pms1 (Prolla, 
Christie et al. 1994). Pms1 has been reported to have 
endonuclease activity that may allow entry of the down stream 
exonuclease Exo1. Both Msh3 and Msh6 have PCNA 
interacting motifs that are important for mismatch recognition 
of the MutS complexes (Flores-Rozas, Clark et al. 2000). DNA 
single-strand nicks either at Okazaki fragment junctions 
(lagging strand) or RNase H2 cleavage at incorporated rNMPs 
(leading strand), and by additional mechanism(s) to be 
determined, allow loading of PCNA and allow loading of 
Exonuclease 1 (Exo1), which is a 5’ to 3’ exonuclease 
activity. Exo1 is responsible for degradation of the mismatch 
strand, leaving a gap that is filled by polymerase δ and finally 
ligated to leave the repaired site. Mismatch repair is 
important for maintaining the fidelity of genome from 
prokaryotes to eukaryotes.  
Nucleotide Excision Repair (NER) 
 Nucleotide excision repair (NER) is the main pathway of repair DNA damage events 
such as UV radiation induced damage and other bulky DNA lesions. NER was first discovred in 
1964 and early studies were important for this pathway and human disease, specifically the 
Figure 5. Eukaryotic rNMP 
repair directed MMR. 
MutSα binds mismatch and 
MutLα loads. Incision by 
RNase H2 at incorporated 
rNMPs is the signal for 
strand discrimination in 
eukaryotic system (Williams 
and Kunkel 2014).  
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 genetic disorder xeroderma pigmentosum (XP) (Boyce and Howard-Flanders 1964; Pettijohn and 
Hanawalt 1964; Rasmussen and Painter 1964; Setlow and Carrier 1964; DiGiovanna and 
Kraemer 2012). XP is characterized by patients having high degree of sensitivity to sunlight and 
a significant increased disposition to acquiring skin cancer (DiGiovanna and Kraemer 2012). 
Study of XP patient cells facilitated the determination of proteins that are essential for NER and 
delineation of the pathway. Further studies in several model systems finally led to the 
reconstitution of the NER 
pathway from purified 
components (Wood, 
Aboussekhra et al. 1993; 
Aboussekhra, Biggerstaff et al. 
1995). The NER pathway is a 
series of sequential steps that is 
initiated by detection 
distortions to the B-form DNA 
helix. The DNA helical 
distortions are detected by a 
protein XPC, Rad4 in S. 
cerevisiae, and bind to non-
damaged bases that thermodynamically destabilize, allowing them to flip out of the helix and 
recognize a wide variety of lesions (Sugasawa, Okamoto et al. 2001). Next the TFIIH complex, 
which has roles in both transcription and NER, is recruited with two ATPase/helicases XPB and 
XPD (Evans, Fellows et al. 1997). XPB is thought to open the DNA and allow for loading of 
Figure 6. Proposed model for NER. XPC binds damaged 
nucleotide. Followed by binding TFIIH, XPD, XPB 
leading to DNA unwinding recruiting XPF-ERCC1 and 
XPG leading to incisions and followed by replication and 
ligation (Scharer 2014). 
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 XPD. Then XPD is responsible for opening up the DNA duplex around the lesion and 
translocates along the DNA, being stalled at the lesion (Winkler, Araujo et al. 2000). Following 
the opening of a DNA bubble and XPD stalling at the lesion, XPA is able to bind and recruit 
structure specific endonuclease XPF-ERCC1 (scRad1-Rad10, spRad16-swi10) while TFIIH 
recruits XPG (scRad2, spRad13); these nucleases are responsible for cleavage of the damaged 
strand. XPF-ERCC1 is responsible for cleavage on the 5’-side of the bubble and XPG on the 3’-
side. The removed DNA patch is then filled by DNA polymerase δ and repair is finished by 
strand displacement synthesis and subsequent ligation, allowing for repair of the damage site. 
Double-Strand Break Repair  
 DNA double-strand breaks (DSBs) are one of the most detrimental forms of DNA 
damage because of the possibility of loss or translocation of large portions of chromosomes. As a 
result, repairing double-strand DNA breaks is imperative for cell survival. Eukaryotes have 
evolved two major pathways for the repair of these lesions—Non-Homologous End Joining 
(NHEJ) and Homologous Recombination (HR). There are also alternative end joining pathways, 
one of which is called Microhomology-Mediated End Joining. The choice of repair pathway 
depends on many factors including the phase of the cell cycle and the structure of the double 
strand break that must be repaired.  
Non-Homologous End Joining 
 Classical non-homologous end joining is the major pathway of repair when there is no 
sister chromatid present as a template, but there are also alternative end joining mechanisms that 
are also important for DSB repair. Classical NHEJ involves processing of the ends of the broken 
DNA to allow for religation of the broken ends of DNA, which has the potential to be a 
mutagenic process leading to the loss of genetic information or to genomic rearrangements. 
13
 DSBs are first bound by the MRX complex in yeast (Mre11-Rad50-Xrs2) or MRN in humans 
(Mre11-Rad50-Nbs1), and by the heterdimeric Ku complex (Yku70-Yku80) (Walker, Corpina et 
al. 2001; Lisby, Barlow et al. 2004). The Ku complex DNA binding protects the DNA ends from 
degradation and allows time for religation and facilitates recruitment of other NHEJ proteins 
(Aylon, Liefshitz et al. 2004; Clerici, Mantiero et al. 2008).  Ku interacts with Dnl4, whereas 
Xrs2 interacts with Lif1, allowing for recruitment of the DNA ligase IV (Teo and Jackson 2000). 
Lif1 has specific interactions with Xrs2 and ku80 with Mre11 (Chen, Trujillo et al. 2001; Daley, 
Palmbos et al. 2005). The MRX complex is able to stimulate the ligase activity of Dnl4-Lif1 in 
vitro indicating that the MRX complex plays a role in NHEJ (Chen, Trujillo et al. 2001). Once 
the DNA ligase IV is in place the DNA ends must be aligned and paired to allow for ligation to 
occur, possibly one strand at a time (Pascal, O'Brien et al. 2004). If the ends are not suitable for 
religation there can be recruitment of DNA processing enzymes, such as FEN1, that are able to 
remove ssDNA flaps; however, the kinetics parameters of this process are unknown. Also, the 
kinetics for switching to the Homologous Recombination pathway are also unknown; the 
pathway choice for how a DSB is made will be discussed later. 
 Recently, there have been several alternative end joining pathways described in yeast 
including single-strand annealing (SSA) and microhomology mediated end joining (MMEJ) that 
can be used to repair DSBs, although these mechanisms require resection of the 5’-end of the 
DNA ends. The SSA mechanism requires 5’-resection that exposes short regions of homology 
that are able to anneal, and end processing by an endonuclease Rad1-Rad10 that allows for the 
removal of non-homologous DNA ends; the DNA is then religated (Ivanov and Haber 1995). 
SSA results in the loss of genetic information in the search for homology (Daley, Laan et al. 
2005).  
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  MMEJ is a pathway similar to SSA that is characterized by microhomology at the break 
junction and is associated with deletion of genetic material (Boulton and Jackson 1996). MMEJ 
does not require the canonical NHEJ protein Ku but does require the activity of the MRX 
complex (Ma, Kim et al. 2003). The mechanism is similar to SSA in which the break must be 
resected to allow for the homology search and the intervening DNA between the microhomology 
is processed out, leading to deletions. These alternative-NHEJ pathways are mutagenic 
mechanisms for the repair of DSB that may cause genomic instability.  
Homologous Recombination 
 Homologous Recombination is considered a non-mutagenic pathway of repair because it 
requires the use of a homologous sister chromatid as a template. Much of our understanding of 
homologous recombination has come from studies in S. cerevisiae in which several nucleases are 
important, including: Exo1, Dna2/Sgs1, Mre11, and Sae2 (Mimitou and Symington 2008; Zhu, 
Chung et al. 2008). After a DSB, the cell must make the choice how to repair the break, either 
using NHEJ or HR. The switch that initiates HR is the 5’-end resection that eliminates NHEJ 
repair and allows for the formation of long 3’-ssDNA tails that can be used for Rad51 dependent 
homology search. In S. cerevisiae, a two-step resection model has been proposed. First, resection 
is initiated by the MRX complex along with the endonuclease activity of Sae2 removing a short 
oligonucleotide from the 5’-strand leading to limited processing (Mimitou and Symington 2008; 
Zhu, Chung et al. 2008). MRX and Sae2 are only required when the DNA ends are modified 
either chemically or protein-DNA crosslinks. At DSBs with clean ends MRX and Sae2 are not 
essential. Many studies of DSB repair in S. cerevisiae take advantage of rare-cutting 
endonucleases such as the HO-endonuclease or I-SceI that allow site specific formation of a DSB 
that can be analyzed directly. MRX and Sae2 initiate slow processing up to around 100 
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 nucleotides away from the break (Mimitou and Symington 2008; Zhu, Chung et al. 2008). This 
initial processing is then handed off to two different long-range resection pathways. It is not 
known how this exchange from MRX-Sae2 is accomplished, but the pathways depend on Exo1 
and Dna2/STR (Sgs1-Top3-Rmi1), respectively, and they play redundant roles in the 5’ to 3’ 
resection away from the break (Mimitou and Symington 2008; Zhu, Chung et al. 2008). Exo1 is 
a 5’-3’ dsDNA exonuclease that is stimulated by MRX and Sae2 in vitro (Nicolette, Lee et al. 
2010; Nimonkar, Genschel 
et al. 2011). Dna2 is a bi-
directional exonuclease that 
also has weak helicase 
activity and interacts with 
the STR complex (Zhu, 
Chung et al. 2008). It was 
shown in vitro that in the 
presence of RPA, Dna2 
becomes restricted to being 
a 5’-3’ exonuclease (Niu, 
Chung et al. ; Cejka, 
Cannavo et al. 2010; Niu, Chung et al. 2010). Sgs1 is a 3’-5’ RecQ family DNA helicase that 
interacts with two other proteins Top3 and Rmi1 and this STR complex plays an important role 
in maintaining the genome (Bernstein, Gangloff et al. 2010). The human STR complex (BLM-
Top3α-RMI1-RMI2) suppresses mitotic crossovers and in vitro is able to dissolve double holiday 
junctions using the topoisomerase activity of Top3α (Bernstein, Gangloff et al. 2010). Top3-
Figure 8. Two-step mechanism of 5’-resectioning. The first 
step is short-range resection mediated by MRX and Sae2. 
Free DNA ends do not require MRX, but chemically 
modified ends require the activity of MRX and Sae2. The 
second step is mediated either by Dna2 or Exo1 pathway 
(Symington and Gautier 2011). 
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 Rmi1 complex is not essential to the resection activity of the STR-Dna2 pathway but they do 
stimulate the resection activity (Cejka, Cannavo et al. 2010; Niu, Chung et al. 2010). Long range 
resection is not essential for HR and in cells defective for Sgs1-DNA and Exo1, MRX is able to 
form short 3’-ssDNA tails ~100-700 nucleotides in length that still allow for limited 
recombination (Gravel, Chapman et al. 2008; Mimitou and Symington 2008; Zhu, Chung et al. 
2008). One function of long-range resection carried out by the Exo1 and Sgs1-Dna2 pathways is 
to create long stretches of RPA coated ssDNA that can activate the DNA damage checkpoint 
(Mimitou and Symington 2008; Zhu, Chung et al. 2008; Chung, Zhu et al. 2010). Another reason 
for long-range resection is to expose longer stretches of ssDNA to increase the possible sequence 
for homology search. There is a high level of functional redundancy of nucleases in the cells, 
which is expected because of the importance of maintaining the fidelity of the genome (Mimitou 
and Symington 2009). The pathway of homologous recombination intimately requires the work 
of nucleases for proper resection and ultimately for the repair of double-strand breaks. Following 
resection, the 3’-ssDNA tail must have the RPA replaced by Rad51, a homolog of the RecA 
protein in E. coli. Rad51 requires the function of mediator proteins to displace RPA from the 
ssDNA, and these mediators assist in the formation of Rad51 nucleofilaments by several 
mechanisms including assisting in loading, stabilizing, and protecting these nucleofilaments 
during HR. These mediator proteins include Rad52 and the Rad51 paralogues, Rad55, and 
Rad57. The Rad51 filament is able to form synapsis with the DNA substrate and form a D-loop 
that is essential for the homology search. Once homology is established the invading 3’-tail can 
be extended by a polymerase and several mechanisms can be used to resolve the DNA. First, the 
invading 3’-tail can be religated to the 5’-end of the broken DNA (second end capture) leading to 
the formation of a double holiday junction that can be resolve in two ways; either by resolution, 
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 using structure specific endonucleases or by dissolution, by the use of the Sgs1-Top3-Rmi1 
complex to untangle the DNA strands (Szostak, Orr-Weaver et al. 1983). The second pathway 
for resolution of the D-loop is by synthesis-dependent strand-anneling (SDSA), where the D-
loop is dissolved before the “second end capture” by a helicase, either Srs2 or Mph1 (Nassif, 
Penney et al. 1994; Allers and Lichten 2001), and the single-strand DNA overhangs anneal and 
are able to be ligated together. Finally, the D-loop can be converted into a replication fork that 
can be extended to the end of the chromosome, a pathway known as break-induced replication 
BIR (Malkova, Ivanov et al. 1996). This choice of pathway for resolution of the Rad51 D-loops 
is determined by several factors, including the structure of the DSB, and by the many Rad51 
regulators that must be coordinated to lead to repair.  
DSB Repair Pathway Choice 
 NHEJ is thought of as a more mutagenic form of repair where the two ends of the double-
strand break are made compatible with religation and are then ligated back together, possibly 
leading to loss of genetic material. 
Homologous recombination, on the 
other hand, is thought of as a high 
fidelity repair pathway that is non-
mutagenic, and requires the sister 
chromatid to be used as a template to 
refill the break. In a process termed 5’-
resection, the HR pathway requires 
several nucleases to produce long 3’ 
DNA tails used to invade the sister 
Figure 9. Model for DSB repair choice. 5’-
resection is the major determinate controlling the 
pathway choice (Chiruvella, Liang et al. 2014).  
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 chromatid template and as primers for replicating across the break. Homologous recombination 
is essential during S phase where collapsed replication forks form single ended double strand 
breaks that have no partner to religate and must be repaired via a HR pathway. The critical step 
for determining the pathway that is utilized to repair a double strand break is the initiation of the 
5’-resection that commits the cell to repair by homologous recombination or MMEJ (Ira, 
Pellicioli et al. 2004; Zhang, Shim et al. 2009). The NHEJ DNA end binding complex Ku blocks 
the DNA ends from being processed and Ku must be removed before 5’-resection and HR can 
take place. In cells lacking a functional Ku complex HR is up-regulated, but cells lacking HR do 
not have increased NHEJ activity, implying that cells first attempt to repair the break using a Ku 
dependent NHEJ and subsequently allow resection (Allen, Kurimasa et al. 2002; Frank-Vaillant 
and Marcand 2002; Zhang, Shim et al. 2009). How the cell determines the efficiency of resection 
initiation is cell cycle dependent and is strictly controlled.  
 The cell has evolved mechanisms for regulating 5’-resection on a cell cycle basis, 
decreasing 5’-resection capacity in G1 when there is no sister chromatid to be used as a template 
for HR, and increasing resection efficiency in S and G2 phases of the cell cycle to stimulate HR 
activity (Aylon, Liefshitz et al. 2004; Jazayeri, Falck et al. 2006; Barlow, Lisby et al. 2008; 
Zhang, Shim et al. 2009). CDK (Cdc28) is the cyclin-dependent protein kinase that regulates the 
cell cycle, and also plays a key role in DSB repair pathway choice by stimulating resection and 
driving the repair into the HR pathway. CDK activity is low in the G1 phase of the cell cycle, 
and the activity of NHEJ Ku complex leads to reduced 5’-resection and therefore less HR repair 
(Aylon, Liefshitz et al. 2004; Clerici, Mantiero et al. 2008; Zhang, Shim et al. 2009). In S and G2 
phases of the cell cycle 5’-resection is stimulated by the activity of CDK, and several proteins in 
the HR pathway are targets for phosphorylation. The CDK target that seems to control the switch 
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 required to turn on resection is Sae2 in S. cerevisiae (CtIP human). It is phosphorylated at Ser 
267, and mutation of S267A leads to a phenotype that is similar to a sae2 deletion, which is 
defective in HR (Huertas, Cortes-Ledesma et al. 2008). Sae2 has endonuclease activity in vitro, 
and HR defects of a sae2-deletion are suppressed by concurrent deletion of the Ku complex, 
suggesting that Sae2 may remove Ku from DNA ends and facilitate resection initiation (Mimitou 
and Symington 2010). Sae2 activity may lead to a substrate that allows for recruitment of the 
long-range resection machinery and flip the switch from a substrate suitable for NHEJ to one that 
facilitates homology directed mechanisms. 
Interstrand Cross link (ICL) Repair  
DNA Interstrand cross-links (ICLs) are genotoxic lesions that covalently link the single-strands 
of the DNA duplex stably together. The ability to destabilize and separate DNA strands is an 
essential step in the processes of DNA replication and transcription. ICLs form potent 
obstructions of these fundamental processes leading to potent genotoxicity that must be 
efficiently repaired for cell viability. Importantly, ICLs can arise from exogenous agents such as 
mitomycin C but also from endogenous sources in the form of by-products of metabolic 
processes (Minko, Harbut et al. 2008). Repair of an ICL lesion is complicated by the inclusion of 
both strands of DNA in the lesion; thus, precluding the removal of the lesion and use of the 
opposite strand as an error-free template.  
 It has been previously appreciated that proteins from several classical DNA repair 
pathways must be coordinated to efficiently repair ICLs; including proteins involved in 
nucleotide excision repair (NER), translesion synthesis (TLS), homologous recombination (HR), 
and in many higher eukaryotes the proteins of the Fanconi Anemia (FA) pathway  
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 Figure 10. Models for replication-coupled repair of ICLs from studies in Xenopus laevis  
and mammalian systems (Zhang and Walter 2014). 
 
(McCabe, Olson et al. 2009; Moldovan and D'Andrea 2009). Fanconi Anemia is a human 
inherited cancer predisposition disorder, and patients show hypersensitivity to interstrand cross-
linking agents (Wang 2007). The FA pathway is utilized during the S-phase of the cell cycle and 
is believed to be involved in the resolution of DNA lesions including DSBs brought on through 
replication stress and ICL (Diffley, 2000). The pathway consists of a core complex of proteins 
FANCA, B, C, D, E, F, G, L, M, and also several associated proteins that create a scaffold for the 
ubiqitin ligase FANCL (Ciccia, Ling et al. 2007; Collis, Ciccia et al. 2008). The core complex 
then leads to the monoubiquitination of a heterodimeric complex of FANCD2 and FANCI (ID-
complex) (Garcia-Higuera, Taniguchi et al. 2001; Taniguchi, Garcia-Higuera et al. 2002). 
Recently, the monoubiquitinated ID-complex has been shown to recruit the nuclease FAN1 to 
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 sites of ICL lesions through its monoubiquitin-binding domain (MacKay, Declais et al. 2011). 
Schizosaccharomyces pombe has a Fan1 homolog and it recently has been shown to work in a 
pathway with the FANCM homolog in S. pombe Fml1 (Fontebasso, Etheridge et al. 2013). The 
role of FAN1 in the repair of ICLs is still not clear, but it has been shown that the unhooking of 
ICLs requires monoubiquitinated FANCD2 (Knipscheer, Raschle et al. 2009). 
 The clearest mechanistic studies of ICL repair have been carried out in the Xenopus 
laevis egg extract system in which a site specific ICL is made in a plasmid that can be replicated 
in the extract (Raschle, Knipscheer et al. 2008). These detailed biochemical studies are now 
unraveling the mechanistic details of ICL repair. The model that has come from these studies  
begins with the convergence and stalling of two replication forks at the ICL with the leading 
strands of both forks stalling ~30 nucleotides and the lagging strands stalling ~50 nucleotides 
from the ICL (Fu, Yardimci et al. 2011). The stalling leads to the unloading of one of the MCM 
helicases from the DNA allowing for the approach of the partner leading strand polymerases to 
within one nucleotide of the ICL (Knipscheer, Raschle et al. 2009). The repair begins by 
inducing incisions of the opposing single strand on either side of the ICL termed “unhooking,” 
carried out by structure specific endonucleases: XPF-ERCC1 along with its scaffolding protein  
SLX4 (Klein Douwel, Boonen et al. 2014). Following the unhooking of the lesion, the uncleaved  
strand is first extended by one nucleotide by a yet to be identified translesion polymerase, and is 
subsequently extended by polymerase ζ (Raschle, Knipscheer et al. 2008; Knipscheer, Raschle et 
al. 2009). The unhooking process also creates a double-strand breaks (DSBs) that are repaired by 
the HR-mediate pathway. The resolution of the HR-mediated repair requires the SLX4 complex 
to resolve the DNA-intermediates of the pathways. The SLX4 complex sets up a scaffold for 
several nucleases including SLX1, MUS81-EME1, and XPF-ERCC1(Garner and Smogorzewska 
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 2011). There are also other nucleases that have been shown to be involved in repair of ICLs, but 
their specific role in the repair process remains elusive. First, through genetic studies in both S. 
cerevisiae and S. pombe, the deletion of the nuclease PSO2/pso2+ leads to hypersensitivity to 
interstrand cross-linking agents. In S. cerevisiae it has been shown that ∆pso2 strains have 
normal incision (unhooking) of the ICLs, but fail to fully resolve the double-strand breaks 
(Magana-Schwencke, Henriques et al. 1982; Li, Hejna et al. 2005). The specific mechanism of 
repair is still not well characterized because of the complexity of the repair pathways, and 
biochemical techniques for studying the system have only recently been developed.  
 ICL repair predominately occurs during DNA replication, initiated by one or dual 
collision of a replication fork(s) at site of ICLs (Raschle, Knipscheer et al. 2008).  There is still 
much discussion about which of the two models is more relevant in vivo (MacKay, Declais et al. 
; Raschle, Knipscheer et al. 2008; Kratz, Schopf et al. 2010; MacKay, Declais et al. 2011). One 
of the main questions of the single-collision model is that in metazoan cells there is no known 
mechanism for reloading the MCM helicase during S phase, as seen for other treatments that 
collapse replication forks and require converging forks for rescue (Petermann, Orta et al. 2010). 
There is no conclusive in vitro evidence that a single replication fork collision can initiate 
productive repair of and ICL. The critics of the dual-collision is that in metazoan cells the 
replication origins are spaced roughly 100 kb apart and a single-fork stalled at an ICL will have 
to wait a long time before a second replication fork converges (Duderstadt, Reyes-Lamothe et al. 
2014). These factors seem to point to the possibility that both of these models may take place in 
cells, and there may be different mechanisms of repair based on the convergence of the forks. 
Recently, a third model has been proposed, based on observations using DNA combing and 
fluorescently labeled ICLs where ~60% of ICLs had been bypassed by a single replication fork 
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 without unhooking the ICL (Huang, Liu et al. 2013). This model has been called the “transverse 
model”, and was shown to require the Fanconi Anemia helicase FANCM, but the mechanism of 
repair of the ICL is still not understood (Huang, Liu et al. 2013). The repair of ICLs has only 
recently been explored and there is the possibility of many new discoveries about how all of 
these processes are integrated and regulated during repair.  
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 CHAPTER II 
Characterization of Exonuclease 5 family of novel single-strand specific bi-directional 
exonucleases 
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 PREFACE TO THE CHAPTER 
 This chapter describes the biochemical and molecular characterization of the novel 
Exonuclease 5 family of enzymes from S. cerevisiae, S. pombe, and humans. Section IIA is 
focused on the biochemical and in vivo function of the S. cerevisiae EXO5 homolog. In S. 
cerevisiae Exo5 is essential for mitochondrial genome maintenance, but there is no apparent 
nuclear function. The biochemical characterization demonstrated that scExo5 is a 5’ to3’ 
exonuclease leaving di-nucleotides as its major product. Peter Burgers performed the majority of 
the biochemical work, while I performed the remaining experiments. Bonita Yoder and Carrie 
Stith carried out the strain construction and in vivo experiments as well as protein purification. 
 Section IIB outlines the work that characterized the human Exo5 protein in vitro and in 
vivo. Biochemical analysis of the human homolog demonstrates that the human protein has a 
different in vitro and in vivo activities compared with the S. cerevisiae homolog. Human Exo5 is 
a bi-directional, single-strand, DNA-specific exonuclease that has a propensity to slide along 
ssDNA prior to cleavage, and has a direct interaction with human single-strand binding protein 
complex RPA that enforces a 5’-3’ directionality onto Exo5 in vitro. Also, in this study using a 
new oligonucleotide system, we are able to show that the S. cerevisiae homolog is also a bi-
directional exonuclease. The in vivo experiments demonstrate that human Exo5 is localized to 
the nucleus and cytoplasm and knockdown of Exo5 in human cells leads to a significant increase 
in sensitivity to a variety of DNA damaging agents, particularly interstrand crosslinking agents. I 
carried out all of the biochemical assays for this work and most of the protein purification, with 
early purifications carried out by Carrie Stith. Our collaborators in Tej Pandita’s lab, Rakesh 
Kumar and Mayank Singh, carried out the in vivo experiments. Also, wild type and several 
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 human RPA mutants were provided by Marc Wold’s lab, while Tim Lohman provided several 
oligonucleotides used in this section. 
 Section IIC describes the genetic and biochemical characterization of the S. pombe Exo5 
homolog. S. pombe Exo5 works in an identical fashion to the human protein, but it is ~100-fold 
higher in activity. Our genetic characterization reveals the knockout of Exo5 in S. pombe 
recapitulates the sensitivity to DNA damaging agents as seen by knockdown in human cells. The 
exo5∆ S. pombe strains are sensitive to UV-irradiation, methyl methanesulfonate (MMS), and, in 
particular, ICL forming drugs. Epistasis experiments demonstrate that exo5∆ rad2∆ (FEN1) is 
synergistically more sensitive to MMS and cis-platin, an ICL forming drug, than either of the 
single mutants; this is consistent with a model where Exo5 and Rad2 are in different pathways 
that compete for the same lesion. Also, we see a negative genetic interaction where exo5∆ rad2∆ 
cells are slow growing and cells are elongated, indicating checkpoint activation. Exogenous 
overexpression of Exo5 is lethal to the cell, and cell elongation indicating strong checkpoint 
activation. The observed lethality is not caused by the nuclease activity of the protein. Exo5 
physically interacts with RPA, and PCNA and our hypothesis is that overexpression of Exo5 
titrates away these proteins from an essential function in replication leading to checkpoint 
activation and lethality. I conducted all of the strain and plasmid construction for this study and 
did most of the biochemical and cell biological assays. Anna Ballard assisted with several of the 
biochemical and DNA damage sensitivity assays. We received many S. pombe strains from a 
variety of labs and their generosity allowed this work to be performed.   
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Yeast Exonuclease 5 is essential for mitochondrial genome maintenance 
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Yeast exonuclease 5 is encoded by the YBR163w (DEM1) gene, and this gene has been renamed EXO5. It is
distantly related to the Escherichia coli RecB exonuclease class. Exo5 is localized to the mitochondria, and
EXO5 deletions or nuclease-defective EXO5 mutants invariably yield petites, amplifying either the ori3 or ori5
region of the mitochondrial genome. These petites remain unstable and undergo continuous rearrangement.
The mitochondrial phenotype of exo5 strains suggests an essential role for the enzyme in DNA replication and
recombination. No nuclear phenotype associated with EXO5 deletions has been detected. Exo5 is a monomeric
5 exonuclease that releases dinucleotides as products. It is specific for single-stranded DNA and does not
hydrolyze RNA. However, Exo5 has the capacity to slide across 5 double-stranded DNA or 5 RNA sequences
and resumes cutting two nucleotides downstream of the double-stranded-to-single-stranded junction or RNA-
to-DNA junction, respectively.
Endonucleases and exonucleases are intimately involved in
all aspects of DNA metabolism in the cell. In mitochondria,
several constitutive nucleases have been identified that con-
tribute to the proper maintenance of the mitochondrial ge-
nome through replication and recombination pathways. In ad-
dition, nucleases can localize to mitochondria in response to
DNA stress in order to mediate appropriate DNA repair.
Among the constitutive mitochondrial nucleases in Saccharo-
myces cerevisiae are the Nuc1 nuclease that contributes to
DNA recombination efficiency and functions in apoptosis (4,
38) and the Cce1 endonuclease that resolves recombination
intermediates (29). The Din7 endonuclease is a mitochondri-
ally located 5 flap endonuclease related to FEN1 (20). While
deletion of the gene for either of these enzymes produced
marginal mitochondrial phenotypes, more severe phenotypes
were observed when combined deletions of these nuclease
genes were studied or when they were combined with deletions
of other genes involved in DNA recombination or repair, such
as MHR1 or MSH1 (20, 22, 27). Recently, human Dna2 was
shown to localize to both the nuclear and mitochondrial com-
partments and to participate in mitochondrial DNA replica-
tion and base excision repair (11, 39). Its function in yeast
mitochondrial DNA maintenance has not been studied in de-
tail. Finally, the 5 flap endonuclease FEN1, which normally
functions in primer RNA degradation during Okazaki frag-
ment maturation in the nucleus, also localizes to the mitochon-
drion in response to DNA damage, participating in long-patch
base excision repair (19, 23).
Since mitochondrial function is not essential to yeast sur-
vival, dysfunction caused by mutations of the mitochondrial
genome can be readily detected as a loss of respiration func-
tion, which is scored as the inability to grow on nonfermentable
carbon sources. A defect in the mitochondrial DNA polymer-
ase MIP1 results in complete loss of the mitochondrial DNA,
and the mutant fails to grow on glycerol-containing media
lacking glucose (14). Such cells are designated 0. Genome
maintenance defects can also result in the generation of petite
mutants that still contain mitochondrial DNA. Generally, most
of the mitochondrial genome has been deleted, and a small
origin-containing region has been amplified (). S. cerevisiae
contains eight such origin regions that are highly similar in
sequence and are distributed over the 86-kb mitochondrial
genome (8, 9, 15). Petites that have amplified the ori5 region
have been studied more extensively (16, 22).
While the nucleases listed above participate in the proper
maintenance of the mitochondrial genome through their rep-
lication and/or recombination functions, none appears to be
essential for the integrity of the mitochondrial genome. One
reasonable explanation for these observations is functional re-
dundancy. Indeed, functional nuclease redundancy is quite
common; it has been observed in the process of DNA degra-
dation during mismatch repair in Escherichia coli, during Oka-
zaki fragment maturation in yeast, and during the resection of
double-stranded breaks in yeast (7, 25, 33). However, the pos-
sibility remains that an additional nuclease(s) is active in the
mitochondrion. The present paper describes an essential mi-
tochondrial exonuclease that is distantly related to the nucle-
ase domain of RecB, a subunit of the bacterial RecBCD re-
combinase. This nuclease was discovered over 2 decades ago
during a biochemical chromatographic survey of yeast exo-
nucleases and was called exonuclease 5 (3). Initial studies with
a partially purified enzyme preparation showed it to be a 5
exonuclease specific for single-stranded DNA (ssDNA). Here
we report the identification of the EXO5 gene and describe
comprehensive biochemical and genetic studies that show a
critical role for EXO5 in mitochondrial DNA maintenance,
presumably through the processing of replication intermedi-
ates. Upon deletion of EXO5 or inactivation of its nuclease
activity, only  mutants could be recovered. EXO5 has pre-
viously been characterized as DEM1 (defects in morphology)
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because the deletion mutant shows defects in growth and in
mitochondrial morphology (10, 12). No nuclear defect associ-
ated with an EXO5 deletion has been detected.
MATERIALS AND METHODS
Plasmids and oligonucleotides. Plasmid pBL253 contains the YBR163w
(EXO5) open reading frame (ORF) together with 249 nucleotides (nt) of 5
untranslated sequence and 300 nt of 3 untranslated sequence cloned into cen-
tromere vector yCp50 (ARS1 CEN4 URA3). Plasmid pBL256 contains the same
EXO5 region cloned into centromere vector yCplac22 (ARS1 CEN4 TRP1).
Plasmids pBL256-270 and -320, with active-site mutations exo5-D270A and exo5-
D320A, respectively, were made by site-directed mutagenesis, and the correct
sequences were confirmed by sequencing of the entire gene. Plasmid pBL254
(bluescript 2m ori HIS3 M13 ori GAL1-10 GST-EXO5) contains the Schisto-
soma japonicum glutathione S-transferase (GST) gene fused to the N terminus of
the EXO5 gene in vector pRS424-GALGST (5). The GST tag is separated from
the EXO5 gene by a recognition sequence for the human rhinoviral 3C protease
(LEVLFQ/GP). After cleavage by the protease, the N-terminal sequence of the
Exo5 polypeptide is extended with the GPEF sequence. Plasmids pBL254-270
and -320 have active-site mutations as in pBL256. Plasmids and sequences are
available upon request.
Oligonucleotides were purchased from IDT (Coralville, IA) and purified by
high-performance liquid chromatography or urea-polyacrylamide gel electro-
phoresis (PAGE): v31, GCCCATCAACGTTCCAGACC; c41, GGTCTGGAA
CGTTGATGGGC; cT41, TGGTCTGGAACGTTGATGGGC; c42, GGTCTG
GAACGTTGATGGG; c43, GGTCTGGAACGTTGATGG; c44, GGTCTGGA
ACGTTGAT; c45, GGTCTGGAACGTTGATGGGCT10; c48, GGTCTGGAA
CGTTGAT10; c49, GAACGTTGATGGGC; c50, GGTCTGGAACGTTG;
cT50, TGGTCTGGAACGTTG; v71, TCGAATTGGTCTTTTTTTTCC; vR73,
UCGAAUUGGUCTTTTTTTTCC (RNA underlined); Bio-vR74, TBioCGAAU
UGGUCTTTTTTTTCC; c72 GGAAAAAAAAGACCAATTCGA; v81, TTGC
CGATGAACTTTTTTTTTTGATCGAGACCTT. The 5 32P label was intro-
duced on oligonucleotides v31, v71, vR73, Bio-vR74, and v81 with [-32P]ATP
and T4 polynucleotide kinase, while for the addition of a 3 32P label, oligonu-
cleotide v31 (containing an unlabeled 5 phosphate) was incubated at a 10-fold
molar excess over carrier-free [-32P]dATP with terminal deoxynucleotidyltrans-
ferase under the manufacturer’s conditions, with an additional 150 mM KCl. The
addition of salt limited processive addition by the enzyme, thereby ensuring
mainly the addition of a single [32P]dAMP residue. The labeled v oligonucleo-
tides were hybridized with a twofold molar excess of the relevant c oligonucle-
otides. Labeled v81 was circularized by hybridization to equimolar oligonucleo-
tide circ-81 (ATCGGCAAAAGGTCTC), which anneals to both 5 and 3 ends.
After ligation with T4 ligase, the circular oligonucleotide was further purified on
a urea–12% polyacrylamide gel.
Yeast strains. Deletions of RAD27, EXO1, MUS81, and MRE11 were obtained
as gene replacements with KanMX4 in BY4741 (MATa his3-1 leu2-0
met15-0 ura3-0). Strain PY207 (MATa/ his31/his31 leu20/leu20
ura30/ura30 met150/ lys2/ exo5::HIS3/ [rho]) was obtained by
transformation of diploid BY4743 with exo5::HIS3. PY209 (MAT his3-1
leu2-0 trp1-0 ura3-0 exo5::HIS3  pBL253 [rho]) was obtained from
sporulation of PY207 after transformation with pBL253. Strain W303/mip1-01
(MAT ura3 his3 ade2 leu2 trp1 mip1-01::URA3 [rho0]), from Francoise Foury,
was made exo5::HIS3 by transformation to give PY215. This strain was mated
with the BY4741 series of nuclease deletion strains to give [rho] heterozygous
diploids. This series of diploids was sporulated, and appropriate haploids were
selected, mip1 as Ura, exo5 as His, and rad27 (or other nuclease dele-
tions) as G418 resistance. Genotypes were confirmed by diagnostic PCR analysis.
These sets of strains were used in the analysis in Fig. 7.
Exo5 overproduction and purification. Overexpression was in S. cerevisiae
strain PY116 (MATa his3-11,15 ura3-52 trp1- leu2-3,112 prb1-1122 prc1-407
pep4-3 nuc1-LEU2) transformed with pBL254. Growth, induction, and extract
preparation were essentially as described elsewhere (5). Briefly, cells (60 g of
packed cells resuspended in 12 ml of water) frozen previously in liquid nitrogen
in the form of popcorn were blended in dry ice powder with 30 ml of buffer 3 	
A (buffer A is 30 mM HEPES-NaOH [pH 7.8], 10% glycerol, 2 mM EDTA, 1
mM EGTA, 0.02% Nonidet P-40, 2 mM dithiothreitol [DTT], 10 mM sodium
bisulfite, 10 M pepstatin A, 10 M leupeptin). All further operations were
carried out at 0 to 4°C. After thawing of the lysate, 0.5 mM phenylmethylsulfonyl
fluoride (from a 100 mM stock in ethanol) and 150 mM ammonium sulfate (from
a 4 M stock) were stirred in, followed by 0.45% polymin P (from a 10% stock at
pH 7.3). After being stirred for 15 min, the lysate was cleared at 40,000 	 g for
30 min and the supernatant was precipitated with 0.31 g/ml solid ammonium
sulfate. The precipitate was collected by centrifugation at 40,000 	 g for 20 min
and redissolved in 
50 ml of buffer A until the conductivity equaled that of
buffer A300 (the subscript denotes the NaCl concentration). Batch binding to 1
ml of glutathione-Sepharose 4B beads (GE Healthcare), equilibrated previously
in buffer A300, was done by gentle rotation in the cold room for 2 h. The beads
were collected at 1,000 rpm in a swinging-bucket rotor, batch washed by resus-
pension and spinning with 2 	 20 ml of buffer A300, transferred to a 10-ml
column, and washed at 1 ml/min with 100 ml of buffer A300. Bound chaperones,
particularly Ssa1, were removed by washing with 50 ml of buffer A300 containing
1 mM ATP and 5 mM Mg-acetate. After another wash with 10 ml of buffer A150
to remove residual nucleotide and decrease the salt concentration, the beads
were resuspended in 1 ml of buffer A150 containing 20 mM glutathione (pH
adjusted to 8.0). The capped column was incubated on ice for 10 min, and the
eluant was collected. This procedure was repeated four times. Most of the
protein eluted in fractions 1 to 4. These fractions were incubated overnight at 4°C
with 30 U of rhinoviral 3C protease and, after dilution with buffer A0 to equal
buffer A100, loaded onto a 1-ml heparin-Superose column. Protein was eluted
with a linear gradient of buffer A100 to buffer A1000. Pure Exo5 eluted at 250 to
300 mM NaCl. Mutant forms of Exo5 were purified similarly through the GST-
Sepharose step.
Enrichment of Exo5 from yeast extracts. Yeast single-ORF deletion deriva-
tives of BY4741 were grown in 1 liter of YPD (2% peptone, 1% yeast extract, 2%
glucose) to mid-log phase. The cells were harvested, and extracts were prepared
by beating with glass beads, polymin P precipitation, and ammonium sulfate
precipitation as described previously (3). Protein (1 mg) in buffer A50 was gently
agitated for 2 h with 200 l of DEAE-Sephacel plus 200 l of SP-Sepharose in
a total volume of 1.5 ml. Under these buffer conditions, Exo5 does not bind to
either matrix. Beads were spun down, and the supernatant was used for nuclease
assays with 5-32P-labeled dT12 substrate.
Exonuclease assays. The standard 20-l assay mixture contained 20 mM
HEPES-NaOH (pH 7.6), 20 g/ml bovine serum albumin, 1 mM DTT, 5 mM
Mg-acetate, 50 mM NaCl, 100 fmol of 32P-labeled oligonucleotide substrate, and
enzyme. Incubations were at 30°C for the indicated times. Variations from the
standard assay are indicated in the legends to the figures. Reactions were
stopped with 10 mM (final concentration) EDTA plus 0.2% SDS and analyzed by
thin-layer chromatography (TLC) on polyethyleneimine-cellulose in 0.7 M LiCl
or stopped with 10 mM (final concentration) EDTA plus 40% formamide and
analyzed by 20% PAGE–7 M urea electrophoresis. After the TLC plate or gel
was dried, it was subjected to PhosphorImager analysis.
PCR and Southern analysis. Total cellular chromosomal DNA preparations
were made from 5-ml cultures grown overnight in selective media (17). These
were subjected to 20 cycles of PCR in a 50-l reaction mixture with 100 ng of
chromosomal DNA and 50 pmol each of primers ori-in (GGGGGTCCCAATT
ATTATTTTC and TAGGGGGAGGGGGTGGGT), ori-out (primers comple-
mentary to ori-in: GAAAATAATAATTGGGACCCCC and ACCCACCCCCT
CCCCCTA), COX2 (GCATGTTATTTTCAGGATTCAGCAACACC and GA
ACCTTCAGCTTCAATAAAACCTAAAATTC), and AI1 (GATACTCAATA
TGGAAAGCCGTATGATG and CGGACAATCCCGTATTTCTTAATTTT
CC). Analysis was on a 2.5% metaphor agarose gel.
To label the ori sequences, the isolated ori3 or ori5 PCR fragment was ream-
plified by PCR with ori-in primers but with 10 M [-32P]dATP and the other
three deoxynucleoside triphosphates at 200 M. The labeled ori3 and ori5 frag-
ments were mixed and used as a probe of EcoRV-cut total cellular DNA. EcoRV
cuts either origin near the end of the fragment (see Fig. 6).
RESULTS
Identification of the S. cerevisiae EXO5 gene. Previously, we
had partially purified Exo5 from yeast and established some of
the properties of the enzyme (3). Specifically, we noted that the
enzyme preferentially degraded ssDNA and produced dinucle-
otides as the main products of digestion. In order to further
studies of this unique enzyme and gain an understanding of its
physiological role in the cell, we first identified the gene for
Exo5.
The enzyme was partially purified from yeast as described
before, through four chromatographic steps (3). This prepara-
tion was further fractionated on a MonoQ column. Unfortu-
nately, sodium dodecyl sulfate (SDS)-PAGE analysis still did
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not allow positive identification of a protein band that comi-
grated with exonuclease activity. Therefore, the fraction with
the highest exonuclease activity and a neighboring fraction
with much reduced enzyme activity but with a similar protein
banding pattern were fractionated by SDS-PAGE and each of
the two lanes was cut into 15 slices and subjected to liquid
chromatography-tandem mass spectrometry analysis. Six yeast
proteins (Ade3, Tos9, Ngl1, Rfx1, Dem1, and Gon3) that were
present in greater abundance in the active lane than in the lane
without activity were identified. In order to determine which
one corresponded to Exo5, we obtained deletion strains for
each one of these genes (none of the genes identified was
essential for growth). Extracts were prepared, partially en-
riched for Exo5, and assayed for activity. Only the extract of
the dem1 mutant strain lacked a dinucleotide-producing
activity (Fig. 1A). This analysis suggests that the DEM1 gene
is required for Exo5 activity, and the simplest explanation is
that it actually encodes Exo5.
An analysis of yeast protein databases revealed some infor-
mation about YBR163w  EXO5  DEM1. The deletion mu-
tant is respiration deficient and shows morphological defects of
the mitochondrion, hence the original gene designation DEM1
(defects in morphology) (12). Consistent with a mitochondrial
function for EXO5/DEM1, the localization of the protein is
mitochondrial (18). In support of this observed localization,
the protein sequence contains a strong mitochondrial localiza-
tion signal, using several prediction programs (MitoProt, Pre-
dotar), predicting cleavage at Ser26/Leu27 during mitochon-
drial import.
Overproduction and purification of Exo5 and Exo5 mutants.
Exo5/Dem1 was overproduced in yeast from a multicopy plas-
mid with the EXO5/DEM1 gene placed under the control of
the galactose-inducible GAL1-10 promoter. A cleavable GST
tag was added to aid in purification (see Materials and
Methods). Following glutathione affinity column chroma-
tography, the GST tag was proteolytically cleaved and Exo5/
Dem1 was further purified by heparin-agarose chromatog-
raphy to more than 98% purity (Fig. 1B). Upon SDS-PAGE
analysis, the protein migrated as a 64-kDa protein, in agree-
ment with the size calculated from the ORF sequence (67
kDa). A gel filtration analysis showed that Exo5 migrated as a
58-kDa protein, indicating that Exo5 is a compact monomeric
enzyme (Fig. 1C).
An analysis of the gel filtration fractions, using a 5-la-
beled oligonucleotide as the substrate, showed potent exo-
nuclease activity that comigrated with the protein peak
(data not shown). In agreement with previous studies of the
partially purified enzyme, dinucleotides were the main prod-
ucts of digestion (Fig. 2C and 3). Since these studies strongly
suggest that the DEM1 gene actually encodes exonuclease 5,
we will from now on refer to this gene as EXO5.
We subjected EXO5 to a PSI-BLAST analysis, followed by
a protein threading analysis (http://toolkit.tuebingen.mpg
.de/hhpred) (32). The PSI-BLAST analysis identified EXO5 as
the member of a poorly conserved protein family. Interestingly,
the threading analysis that was carried out with the consensus
sequence obtained from the PSI-BLAST analysis yielded bac-
terial RecB-type nucleases as top-scoring structural homologs
of EXO5 (Fig. 2A). Among the putative homologs in other
model eukaryotic organisms are ORFC185.02 in Schizosaccha-
romyces pombe and C1orf176 in humans, both uncharacterized
ORFs. While the conservation with E. coli RecB was restricted
to just three small motifs in the C-terminal nuclease domain of
RecB (Fig. 2A), the members of the eukaryotic Exo5 family
showed conservation of a large number of small motifs over a
core domain of 
250 amino acids (alignment not shown).
Remarkably, a set of conserved cysteine residues in the C-
terminal domain of the Exo5 members was conserved with the
AddB nuclease domain of the Bacillus subtilis AddAB recom-
binase (36). In AddB, these cysteines coordinate an iron-sulfur
cluster, suggesting that the Exo5 class may also possess this
structural domain.
The first and second motifs conserved with the E. coli RecB
nuclease are in two  strands that contain the two aspartates
that chelate the divalent metal ion in the active site of the
nuclease (31). The third conserved motif is in an  helix that
overlies the active-site aspartates (Fig. 2B). Although the func-
tion of this  helix is not known, the proximity of the invariant
glutamine and tyrosine to the active site is remarkable. Previ-
ous studies of RecB had shown that mutation of D1080, one of
FIG. 1. Cloning of EXO5 and overproduction of Exo5 nuclease. (A) Extracts from the indicated deletion mutants of strain BY4741 were
subjected to partial purification. Standard assay mixtures contained 2 l of the fraction that flowed through the mixed-bed ion exchanger (see
Materials and Methods). Controls were no extract () or partially purified Exo5. Migration positions of phosphate (Pi) and mono- and
dinucleotide (1 and 2, respectively) are indicated. (B) Overexpression and purification of Exo5. Lane 1, GST-Exo5 after glutathione column
chromatography; lane 2, after cutting with 3C protease and heparin-Sepharose chromatography; lanes 3 and 4, the same for the Exo5-D270A
mutant; lanes 5 and 6, the same for the Exo5-D320A mutant. Each lane contained 
2 g of protein. wt, wild type. The values on the left are
molecular sizes in kilodaltons. (C) Superose 12 gel filtration analysis of Exo5 in buffer A200. Marker proteins are bovine serum albumin dimer and
monomer, ovalbumin, and carbonic anhydrase.
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the aspartates that ligate the divalent metal ion, abolishes the
exonuclease activity of RecB (37). Therefore, we mutated ei-
ther putative active-site residue Asp270 or Asp320 to alanine,
overproduced and purified the mutant proteins analogously to
the wild type (Fig. 1B), and determined the resulting exonu-
clease activity. No exonuclease activity was detectable in Exo5-
D270A, while that of Exo5-D320A was less than 104 times
that of the wild type (Fig. 2C). This analysis not only confirms
that EXO5 actually encodes the exonuclease but also lends
strength to the threading analysis indicating that Exo5 belongs
to the RecB family of nucleases.
Exo5 is a single-strand-specific 5 exonuclease. Previous en-
zymatic studies with a partially purified preparation of Exo5
showed that the enzyme is specific for ssDNA and releases
primarily dinucleotides as products. (3). We carried out a more
thorough investigation of the enzymatic properties of the pure
enzyme. First, we tested whether Exo5 has endonuclease ac-
tivity. A 34-mer linear oligonucleotide was circularized, and
activity on the circular substrate was compared with that of the
linear substrate. No activity was detected on the circular oli-
gonucleotide (Fig. 3A). We repeated this experiment with a
3-kb-long ssDNA circular plasmid. Again, no degradation by
Exo5 was detected unless the circle was first linearized with a
restriction endonuclease (Fig. 3B). From these experiments,
we conclude that any possible endonuclease activity by Exo5
should be at least 105-fold lower, on a nucleotide basis, than
the exonuclease activity.
Next, we labeled a 20-mer oligonucleotide either at the 5
end with T4 polynucleotide kinase or at the 3 end by extension
with terminal transferase of a single [32P]dAMP residue (see
Materials and Methods). Exo5 was incubated with a 10-fold
molar excess of DNA substrate, and digestion was followed
over time. Digestion of the 5-32P-labeled oligonucleotide with
Exo5 yielded mainly the dinucleotide as a product, while
longer products, 4 to 7 nt in length, made up a total of 
5% of
the digestion products (Fig. 4A, lanes 3 to 6). These longer
products disappeared at longer incubation times. On the other
hand, incubation of the 3-32P-labeled oligonucleotide under
the exact same conditions generated a ladder of intermediates
of odd lengths, consistent with a model in which the enzyme
sequentially releases dinucleotides from the 5 terminus of the
21-mer oligonucleotide (Fig. 4B, lanes 4 to 7). The starting
21-mer oligonucleotide was contaminated with 
10% 22-mer
due to the addition of two dAMP residues during labeling (Fig.
4B, lane 3). This contamination likely accounted for the pres-
ence of small amounts of even-sized oligonucleotides in the
digest. These data strongly indicate that Exo5 is a 5 exonu-
clease and releases dinucleotides as main products of catalysis.
Exo5 showed no detectable nuclease activity when the 5 32P
oligonucleotide was completely double stranded (Fig. 4A, lane
12). Activity at the 5-32P-labeled end was not affected when
just the 3 end was made double stranded by hybridization of
a 14-mer, leaving 6 nt single stranded at the 5 end (Fig. 4A,
lanes 7 to 10). However, no dinucleotide was produced when
only the 5 end was made double stranded (Fig. 4A, lane 11).
Interestingly, a 16-mer product was made at an 
50-fold-
reduced rate compared to the single-stranded control. This
16-mer could not have resulted from endonucleolytic activity
since Exo5 has none (Fig. 3). However, generation of the
16-mer product could have resulted from 3 loading of Exo5
with low efficiency, followed by cutting 4 nt in from the termi-
nus or, alternatively, Exo5 could have loaded at the double-
stranded end at a reduced rate and, after sliding across the
double-stranded DNA (dsDNA) region, cut 2 nt downstream
from the dsDNA-ssDNA junction. Based upon studies with the
FIG. 2. Mutational analysis of EXO5. (A) Threading analysis of Exo5. Motifs conserved with E. coli RecB nuclease are shown. Sc, S. cerevisiae;
Sp, S. pombe; Hs, Homo sapiens. (B) Active site of the RecB nuclease domain from the crystal structure of E. coli RecBCD (31). The active-site
divalent metal ion (black) is coordinated by Asp1067 and Asp1080 (dark gray), which are part of the two gray beta strands, 1057 to 1072 and 1078
to 1082, respectively. The active site is closed off by the  helix at 1107 to 1125 (light gray) with the conserved Gln1110 and Tyr1114 residues (dark
gray). (C) Standard nuclease assay mixtures contained the indicated concentrations of wild-type (wt) or mutant Exo5 for 10 min. Analysis was by
TLC. (D) Strain PY209 (exo5::HIS3 but [rho] because it contains pBL253 [EXO5 URA3]) was transformed with the empty vector (vector) or
pBL256 (EXO5), pBL256-270 (exo5-D270A), or pBL256-320 (exo5-D320A). Transformants were streaked onto FOA plates to select for loss of
plasmid pBL253, with either glucose or glycerol as the carbon source. Plates were photographed after 2 days (glucose plates) or 4 days (glycerol
plates) of growth at 30°C.
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3-labeled substrate discussed below, we conclude that the
latter model is most likely.
Next, we assayed enzymatic activity on 3-end-labeled sub-
strates. No nuclease activity was detected on the fully double-
stranded substrate (Fig. 4B, lane 13). When only the 3 end was
made double stranded, the primary product was 17 nt in length
and was followed by a 15-mer at a reduced rate. This again
indicates that Exo5 digests from the 5 end but cuts with lim-
ited efficiency at the dsDNA-ssDNA junction (Fig. 4B, lanes 8
to 11). When just the 5 end was made double stranded, di- and
trinucleotides were produced, similar to the results observed
with the single-stranded oligonucleotide, but they were pro-
duced at an 
50-fold reduced rate (Fig. 4B, lane 12). Together
with the data from the 5-labeled substrate, these data are most
consistent with the ability of Exo5 to load at dsDNA ends with
low efficiency and slide across dsDNA, followed by initiation of
degradation at a position 2 nt down from the dsDNA-ssDNA
junction.
To determine Exo5 activity at or close to junctions, we car-
ried out a comprehensive analysis with different partially dou-
ble-stranded substrates (summarized in Table 1). A partially
dsDNA substrate with a 4-nt 5 overhang is cut as efficiently as
ssDNA (compare entry 5 with entry 1); however, a 2-nt 5
overhang shows only 2.8% activity and a single-nucleotide
overhang is inactive (entries 4 and 3). Exo5 also cuts pseudo-
forks with a similar substrate preference, showing full activity
as long as 4 nt of the 5 strand are single stranded (entry 7). As
expected from the substrate specificity displayed by the en-
zyme, model Holiday junctions were not cut by Exo5 (data not
shown).
Exo5 slides across RNA regions to engage downstream
DNA. Incubation of Exo5 with labeled RNA yielded little or no
digestion products, indicating that the enzyme shows sugar
specificity (data not shown). However, how does the enzyme
react with chimeric RNA-DNA molecules such as those that
might arise as a result of RNA-primed DNA synthesis? Exo5
was incubated with oligonucleotides with increasing-length
sections of 5 RNA (Fig. 5A). Remarkably, while incubation
with pT12 released the dinucleotide pTpT, incubation with
pUT11, pU2T10, and pU3T9, yielded tri-, tetra-, and penta-
nucleotides, respectively, indicating that the enzyme cuts se-
lectively 2 nt downstream of the RNA-DNA junction. Since we
know from the analyses described above that Exo5 shows nei-
ther endonuclease activity nor 3 exonuclease activity, we con-
clude that Exo5 binds to 5 RNA termini and, after sliding
across the RNA substrate, cuts the DNA 2 nt from the RNA-
DNA junction. The rates of hydrolysis do not decrease signif-
icantly with the addition of increasing 5 RNA sections, indi-
cating that loading of Exo5 at the 5 terminus and sliding
across RNA do not constitute a rate-limiting step in the reac-
tion. This type of analysis was repeated with a chimeric oligo-
nucleotide containing 10 ribonucleotides, followed by 11 de-
oxyribonucleotides, and in addition a 5 biotin label that allows
blocking of the 5 end by streptavidin binding (Fig. 5B). With
the unblocked RNA10DNA11 oligonucleotide, the major cut
site was at position 12, 2 nt downstream of the RNA-DNA
junction, and the rate of cutting was reduced to about 50% of
that of the comparable DNA oligonucleotide (compare lanes 8
and 9 with lanes 2 and 3). However, when the 5 end was
blocked with a biotin-streptavidin moiety, only residual nucle-
ase activity was observed, indicating that Exo5 has to load at
the 5 RNA end and slide across the RNA prior to cutting
downstream DNA (lanes 14 and 15). As demonstrated above,
converting the oligonucleotides to a double-stranded state ab-
rogated all nuclease activity (lanes 4 and 5, lanes 10 and 11, and
lanes 16 and 17). This specificity suggests that if Exo5 were
involved in the processing of RNA-primed DNA replication
intermediates, it would require prior strand displacement syn-
thesis by the DNA polymerase or the participation of a 3-5
helicase, e.g., Hmi1, in order to generate the appropriate sub-
strate for digestion (30).
Mitochondrial defects of EXO5 mutants. The large-scale
gene deletion project already indicated that EXO5 (DEM1)
deletions are respiration deficient (12). To confirm this mito-
chondrial phenotype, we made a his3/his3 diploid strain
heterozygous for EXO5/exo5::HIS3. After sporulation, tet-
FIG. 3. Exo5 lacks endonuclease activity. (A) Standard nuclease
assay mixtures contained either 10 nM linear or circular 34-mer oli-
gonucleotide 32P-c81 (see Materials and Methods) and 1 nM, 10 nM,
or 100 nM Exo5. Analysis was on a 7 M urea–20% polyacrylamide gel.
Note that the circular (circ.) oligonucleotide migrates slower than the
linear form and is contaminated with 5% linear form (asterisk). This
contaminating linear form is converted into the dinucleotide by Exo5.
PDE, snake venom phosphodiesterase ladder. (B) Standard assay mix-
tures contained 5 nM circular or linear bluescript SK2 ssDNA (linear-
ized by hybridizing a 12-mer oligonucleotide across the EcoRV site,
followed by cutting with EcoRV and heating to restore complete single
strandedness) and 200 nM Exo5. Aliquots taken after the indicated
times were analyzed on a 1.2% agarose gel. Note that under these
conditions the linear form migrates slightly slower that the circular
form.
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rads were dissected onto YPD plates. A 2:2 segregation was
observed for histidine prototrophy, and all His colonies failed
to grow on YPG plates, i.e., containing 5% glycerol as a non-
fermentable carbon source, while all His colonies did grow on
YPG (data not shown). The tetrad analysis was repeated, but
this time spores were directly germinated onto YPG plates.
Each of the 14 tetrads dissected yielded a maximum of two
colonies that were all His. Therefore, even under selective
conditions, cells lacking EXO5 are respiration deficient.
In order to determine whether the nuclease activity of Exo5
was required to maintain respiration proficiency, we first made
strain PY209, which is exo5::HIS3 but is wild type ([rho])
because of the presence of a complementing EXO5 plasmid
with a URA3 selectable marker. We then transformed this
strain with a TRP1 plasmid with wild-type EXO5, exo5-D270A,
exo5-D320A, or the empty vector and asked whether the URA3
plasmid could be evicted by growth on 5-fluoroorotic acid
(FOA) media, either on plates containing glucose or on plates
containing glycerol. While all four strains produced colonies on
FOA-glucose plates, only the strain with wild-type EXO5 pro-
duced colonies on FOA-glycerol plates (Fig. 2D). This analysis
shows that the nuclease activity of Exo5 is essential for respi-
ration proficiency and therefore indicates an essential role for
Exo5 exonuclease activity in the maintenance of the mitochon-
drial genome.
FIG. 4. Substrate specificity of Exo5. (A) 5-labeled substrates. 5-32P-labeled v31 was either single stranded (a) or hybridized to a twofold
excess of oligonucleotide c50 (b), oligonucleotide c49 (c), or oligonucleotide c41 (d). (B) 3-labeled substrates. 3-P-v31-32P-dA was either single
stranded (a) or hybridized to a twofold excess of oligonucleotide cT50 (b), oligonucleotide c49 (c), or oligonucleotide cT41 (d). An asterisk
indicates the position of the label. All of the assay mixtures contained 10 nM labeled substrate, 200 mM NaCl, and 10 nM Exo5 for the indicated
times at 30°C. Assay mixtures were analyzed on 7 M urea–20% polyacrylamide gels. PDE, partial digestion with snake venom phosphodiesterase,
a 3 exonuclease; RecJ, partial digestion with E. coli RecJ, a 5 exonuclease. A dotted guide line is added in panel B. The values on the left of each
panel are oligomer sizes.
TABLE 1. DNA substrate specificity for Exo5a
Expt DNA Sequence % Activity
1 v31 5-GCCCAT---- 100
2 c41 3-CGGGTA---- 0.01
v31 5-GCCCAT----
3 c42 3-GGGTA---- 0.05
v31 5-GCCCAT----
4 c43 3-GGTA---- 2.6
v31 5-GCCCAT----
5 c44 3-TA---- 78
v31 5-GCCCAT----
6 c45 3-T10CGGGTA---- 0.01
v31 5-GCCCAT----
7 c48 3-T10TA---- 113
v31 5-GCCCAT----
a Standard assay mixtures contained 100 fmol single-stranded 5-labeled oli-
gonucleotide v31 (experiment 1) or 100 fmol 5-labeled oligonucleotide v31
hybridized to 200 fmol of the indicated oligonucleotide and either 10, 100, or
1,000 fmol of Exo5 for 1, 3, or 10 min (see Materials and Methods). One hundred
percent activity corresponds to 0.14 dinucleotide released per second per Exo5
molecule.
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Analysis of petite phenotypes in exo5 yeast. Yeast strains
can become petite because of rearrangement or partial dele-
tions of the mitochondrial genome ([rho]) or because of the
deletion of all mitochondrial DNA ([rho0]). The latter pheno-
type is, for example, observed in mip1 mutant strains defec-
tive for the mitochondrial DNA polymerase. In petites that
arise from gross deletions in the genome ([rho]), the DNA
region retained is rapidly amplified, resulting in a total mito-
chondrial DNA content similar to that of the wild type (re-
viewed in reference 1). Many [rho] mutants retain a short,
tandemly repeated conserved segment of 
250 bp called the
ORI sequence. The wild-type genome contains eight ORI se-
quences that are located throughout the genome. They show a
high degree of sequence identity (
80%), and the A/T-rich
cores of all ORI sequences are bordered by identical G/C-rich
sequences. ORI sequences are found as amplified repeats in
[rho] strains of yeast (15, 22).
We generated petites by eviction of a complementing EXO5
plasmid from an exo5 mutant strain. The colonies arising
from 11 independent events were picked and grown on YPD
for 30 generations by serial dilution. Total DNA was prepared,
and the mitochondrial genome was examined by PCR with sets
of primers that map to different regions of the mitochondrial
genome. Control strains were wild type ([rho]) and mip1
mutant ([rho0]). The primer sets map to the AI1 gene (coor-
dinates 16.3 to 17.4 kb on the 86-kb circular mitochondrial
genome) or to the COX2 gene (coordinates 73.8 to 75.2 kb).
We also used a primer set (ori-in) that amplifies the various
mitochondrial ORI sequences because of their identical G/C-
rich border sequences (30). In the wild-type strain, PCR prod-
ucts were observed with all three primer sets while PCR of
total DNA isolated from the mip1 mutant strain showed no
detectable PCR product with any of the primer sets. Ten out of
11 petite isolates yielded an abundant PCR product with the
ori-in primer set, compared to the wild type. However, none
gave a PCR product with the AI1 primer set or the COX2
primer set (data not shown). We conclude that loss of Exo5
nuclease leads to deletion of major genomic regions and am-
plification of the ORI region(s). The petite isolates were grown
further for a cumulative 90 generations, and the total DNA was
analyzed again. Two out of the 11 isolates now failed to pro-
duce a PCR product with the ori-in primers, suggesting a
complete loss of mitochondrial DNA in these two isolates (Fig.
6B). Sequence analysis of the 
250-nt PCR products of the
nine remaining clones showed that each isolate contained one
single ORI sequence, either ori3 (coordinates 54.6 to 54.8 kb;
three isolates) or ori5 (coordinates 82.3 to 82.6 kb; six isolates).
Amplification of a particular ORI sequence in petites generally
produces head-to-tail repeats of the ORI sequence with variable
neighboring DNA. These neighboring sequences should be iden-
tifiable by PCR analysis with a primer set complementary to
the ori-in primers (ori-out, Fig. 6A). Indeed, PCR with the
ori-out primers showed prominent products for each isolate,
confirming that the generation of petites had occurred through
head-to-tail amplification of an ORI sequence-containing re-
gion. Remarkably, the ori-out PCR consistently identified
products with a very distributive size distribution (Fig. 6B).
This diffuse distribution could result either from a variability in
the repeat lengths generated during establishment of the petite
genome or from a general genomic instability in the exo5
petite cells during continued growth (Fig. 6B). A Southern blot
analysis was carried out with total mitochondrial DNA isolated
from these clones and digested with restriction endonuclease
EcoRV by using ori3 and ori5 DNAs as hybridization probes.
This analysis confirmed the pattern of strong mitochondrial
repeat length variability (Fig. 6C). Some isolates also showed a
FIG. 5. Exo5 slides across 5 RNA sequences. (A) Standard assay mixtures contained the indicated 5-labeled DNA or RNA-DNA chimera at
10 nM/either 1 or 30 nM Exo5 for 5 min at 30°C. Assay mixtures were analyzed on a 7 M urea–20% polyacrylamide gel. (B) Standard assay mixtures
contained the indicated 5-labeled DNA or RNA-DNA chimera at 10 nM (in order from the left) v71, v71/c72, vR73, vR73/c72, Bio-vR74 plus
streptavidin, or Bio-vR74/c72, plus streptavidin. Assay mixtures contained either 0.5 or 10 nM Exo5 for 5 min at 30°C and were analyzed on 7 M
urea–20% polyacrylamide gels. Klen., sequence ladder generated by partial degradation with the DNA polymerase I Klenow fragment. The values
beside the lanes are oligomer sizes.
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reduction in hybridization strength, particularly isolates 2 and
11, which is presumably due to partial loss of the mitochondrial
genome in subpopulations of cells. Furthermore, as expected,
isolates 4 and 7, which were [rho0], showed no hybridization
signal.
We reasoned that in the absence of Exo5, each mitochon-
drial replication cycle might be associated with a high proba-
bility of genome rearrangements and duplications, leading to a
dynamic variability in the sizes of the amp icons by PCR and by
Southern analysis. We sequenced the ori-out PCR products
from the nine clones shown in Fig. 6B (right panel). Overlap-
ping sequences were identified in all of the clones, prohibiting
accurate sequence assignment. However, for several isolates, a
specific sequence predominated and could be mapped to re-
gions directly to the left and right of either ori3 or ori5. Im-
portantly, this analysis showed that the sequences flanking ori3
or ori5 contained additional internal repeat sequences between
50 and 200 nt in length, suggesting that recombination fre-
quently occurred in the exo5 clones (Fig. 6D). We confirmed
the high-instability phenotype of exo5mutants by carrying out
an experiment in which two independently isolated exo5 clones,
one with ori3 amplified and one with ori5 amplified, were serially
propagated and expanded through successive growth cycles, and
individual clones were analyzed by PCR. The two clones pro-
duced after loss of EXO5 persistently altered their ori-out PCR
patterns upon serial propagation (Fig. 6E).
We next tested whether the reintroduction of EXO5 into the
petite clones would cause stabilization of the petite genomes.
FIG. 6. Analysis of mitochondrial DNA in exo5 petite mutants. (A) Head-to-tail arrangement of amplified ORI regions. A unique EcoRV
restriction site localized asymmetrically in both ori3 and ori5 is shown. The ori-in and ori-out primers were used for PCR analysis of either the ORI
sequences or the inter-ORI sequence regions, respectively. (B) PCR analysis of DNA from 11 individual exo5 clones after 90 generations of
growth. (C) Southern analysis of total yeast DNA from the clones in panel B, digested with EcoRV, and probed with a mixture of ori3 and ori5
probes. The probes were generated by PCR labeling of mitochondrial DNA obtained from ori3- and ori5-containing petites. Analysis of DNA from
the wild type (lane 1) shows the expected sizes for the wild-type (wt) ori3 and ori5 EcoRV fragments, marked with arrows. (D) The ori-out PCR
products shown in panel B were sequenced in both directions. The presence of different overlapping sequence runs allowed only approximate
sequence determination. For one representative clone, a matrix analysis of the ori-out sequence with that of the mitochondrial genome is shown
(coordinates 54168 to 55167), identifying a 23-nt identity per 25-nt sliding window. Regions directly to the left and right of ori3 were identified;
two internal repeats are apparent. (E) Instability of [rho] genomes during serial propagation. Two independent clones (clone A with ori3 amplified
and clone B with ori5 amplified) were obtained by eviction of EXO5 from PY209 and grown for 30 generations (gen.) by serial dilution. They were
plated on YPD, and two colonies were picked (A1 and A2 for the experiment with clone A) and grown for another 30 generations. Again, two
colonies were picked per culture, yielding clones A11, A12, A21, and A22, and grown. The scheme for clone A is shown; the clone B scheme was
the same. DNA from each isolate was prepared and subjected to PCR analysis with ori-in primers (top) and ori-out primers (bottom). (F) Clones
1, 2, 3, 5, 6, and 8 (as shown in panel B) were transformed with pBL253 (URA3 EXO5), and DNA from one transformant of each clone was
subjected to PCR analysis.
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An EXO5-complementing plasmid was transformed back into
randomly selected petite isolates, and the transformants were
analyzed by PCR analysis with the ori-in and ori-out primers
(Fig. 6F). Remarkably, the ori-out PCR product distribution
had narrowed drastically, indicating that a stable repeat pat-
tern had been established in the Exo5-containing transfor-
mants. Sequence analysis of the repeat unit identified unique
wild-type sequences that border ori3 or ori5 on the left and
right. The junction between the upstream and downstream
ORI sequences varied from clone to clone. However, invari-
ably, this junction was formed by a sequence 7 to 13 nt in
length that was present in both the upstream and downstream
mitochondrial genomic sequences. This observation strongly
suggests that junction formation had occurred through recom-
bination between these small identical sequence motifs.
Petite mutants can exhibit zygotic suppressiveness, a phe-
nomenon in which, upon mating with a wild-type [rho] strain,
the wild-type mitochondrial genome is excluded from diploids;
i.e., the diploids are also [rho] (13). Hypersuppressiveness is
a consequence of the large number of ORI sequence repeats in
the [rho] strain. Both RNA-primed replication and recombi-
nation mechanisms contribute to hypersuppressivity (22, 24).
The exo5 clones lacking mitochondrial DNA (clones 4 and 7
in Fig. 6B) showed no hypersuppressiveness upon mating with
a [rho] strain; i.e., all diploids were wild type [rho]. In con-
trast, the other clones showed high degrees of hypersuppres-
siveness, from 80% to 100%; i.e., up to 100% of the diploids
were [rho], in agreement with similar findings by others
(22, 24).
EXO5 deletion shows no nuclear phenotypes. We explored
the possibility that Exo5 may also reside in the yeast nucleus at
low levels, even though it was only detected in the mitochon-
dria (18). However, our genetic analysis identifying a potential
nuclear function for Exo5 was uniformly negative. To eliminate
phenotypes due to mitochondrial dysfunction, we carried out
all of our studies in a [rho0] mip1 mutant background. We
compared the growth and DNA damage survival of exo5
mip1 double mutants with mip1 mutants as a control. In
addition, we combined these mutants with deletions of the
additional nuclease genes RAD27, EXO1, MUS81, and MRE11.
The damage sensitivities of the triple mutants were compared
with those of the relevant double mutants (Fig. 7). FEN1,
encoded by RAD27, is primarily involved in Okazaki fragment
maturation and base excision repair, Exo1 is involved in mis-
match repair and double-strand break repair, Mus81 is in-
volved in the processing of stalled replication forks, and Mre11
is involved in double-strand break repair (reviewed in refer-
ences 2, 6, and 34). Serial dilutions were plated on YPD plates
containing hydroxyurea or camptothecin, or plates were UV
irradiated. No significant differences in damage sensitivity were
observed between a given mip1 nuclease double mutant and
the exo5 mip1 nuclease triple mutant. Therefore, we con-
clude that either EXO5 is not involved in nuclear DNA main-
tenance or a very efficient redundancy with other nucleases
exists in the DNA damage repair pathways tested.
DISCUSSION
Exo5 has the remarkable ability to slide over RNA and less
efficiently over dsDNA to initiate cutting at a position 2 nt
downstream of the RNA-DNA or dsDNA-ssDNA junction.
The ability to differentiate between RNA and DNA but cut
ssDNA flaps efficiently through sliding may be important for
the maturation of intermediates during mitochondrial DNA
replication. Since Exo5 does not degrade dsDNA or dsRNA-
DNA, the generation of such single-stranded flaps would have
to be accomplished either through strand displacement synthe-
sis by the mitochondrial DNA polymerase  or through the
participation of a 3-5 helicase. The first is an important Oka-
zaki maturation mechanism in the nucleus, where substrates
for cutting by FEN1 and by Dna2 are generated through strand
displacement synthesis by polymerase  (reviewed in reference
2). Alternatively, the single-stranded flap could be generated
through helicase action. The Hmi1 helicase has the correct
directionality (3-5) to generate substrates for Exo5, and it is
also essential for maintenance of the wild-type mitochondrial
genome but not for that of [rho] petites (21, 26). Unfortu-
nately, very little is known about the mechanism of replication
of the yeast mitochondrial genome. Replication may occur
through several mechanisms, including initiation by RNA poly-
merase and by double-strand break-induced recombinational
mechanisms that can mature into rolling-circle replication (22,
28, 35). Sufficient replicative ability must remain in an exo5
mutant strain to allow replication of the ORI repeat se-
quences, since these cells are [rho] and not [rho0]. However,
the observations that 2 out of the 11 petite isolates studied lost
their mitochondrial DNA and 2 more were severely depleted
for mitochondrial DNA indicate that even maintenance of the
[rho] genome is severely compromised (Fig. 6B and C).
An alternative function for Exo5 could be in recombination.
We think this is unlikely because of the extreme repeat vari-
ability displayed in the exo5 mutant strains that can only be a
consequence of very active recombination. All of the [rho]
clones that we generated by eviction of EXO5 had amplified
either ori3 or ori5, together with variable-length sequences
surrounding either ORI sequence. These regions showed
high variability during propagation, indicative of very active
FIG. 7. exo5 mutant strains are not damage sensitive. All strains
were mip1 ([rho0]) and, in addition, had the indicated genotype.
Serial 10-fold dilutions of late-log-phase cells, from 105 to 10 cells per
spot, were spotted onto YPD plates or YPD plates containing the
indicated concentrations of hydroxyurea (HU, mM) or camptothecin
(CPT, g/ml). Some YPD plates were irradiated with the indicated
fluency of UV254. Plates were grown for 3 days at 30°C and photo-
graphed. WT, wild type.
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recombination (Fig. 6B, C, and E). In addition, sequences
inside the repeat unit were subject to additional partial
duplication events, suggesting a hyperrecombination pheno-
type in the mutants (Fig. 6D).
The generation of conditional mutations in EXO5 should
be of invaluable help in delineating its contribution to mi-
tochondrial genome maintenance. As Exo5 is conserved in
other organisms, including humans (Fig. 2A), resolving the
mechanism of yeast EXO5 may have important implications
for understanding genome stability in higher organisms.
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Human Exonuclease 5 Is a Novel Sliding Exonuclease
Required for Genome Stability*
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Background: Deoxyribonucleases are key DNA metabolic enzymes, but their functions remain ill defined.
Results:Human EXO5 is a novel bidirectional single strand-specific sliding exonuclease; however, RPA enforces a 5-direction-
ality of nuclease activity.
Conclusion: hEXO5 functions in nuclear genome maintenance and interstrand cross-link repair.
Significance: Nucleases are important in directing pathway choices at DNA damage and replication blocks.
Previously, we characterized Saccharomyces cerevisiae exo-
nuclease 5 (EXO5), which is required formitochondrial genome
maintenance. Here, we identify the human homolog (C1orf176;
EXO5) that functions in the repair of nuclear DNA damage.
Human EXO5 (hEXO5) contains an iron-sulfur cluster. It is a
single-stranded DNA (ssDNA)-specific bidirectional exonu-
clease with a strong preference for 5-ends. After loading at an
ssDNA end, hEXO5 slides extensively along the ssDNA prior to
cutting, hence the designation sliding exonuclease. However,
the single-stranded binding protein human replication protein
A (hRPA) restricts sliding and enforces a unique, species-spe-
cific 5-directionality onto hEXO5. This specificity is lost with a
mutant form of hRPA (hRPA-t11) that fails to interact with
hEXO5. hEXO5 localizes to nuclear repair foci in response to
DNA damage, and its depletion in human cells leads to an
increased sensitivity to DNA-damaging agents, in particular
interstrand cross-linking-inducing agents. Depletion of hEXO5
also results in an increase in spontaneous and damage-induced
chromosome abnormalities including the frequency of triradial
chromosomes, suggesting an additional defect in the resolution
of stalled DNA replication forks in hEXO5-depleted cells.
Exonucleases are versatile processors of metabolic interme-
diates during DNA metabolism involving replication and
recombination and the various pathways that function during
the response to DNA damage in the cell (1). By definition, exo-
nucleases need a DNA end for activity, and the vast majority
generates mononucleotides as the products of nuclease action.
However, some exonucleaseswith specialized functions can cut
internally of the DNA end that they initially engage. An exam-
ple is the flap exonuclease Fen1 that cuts precisely at the base of
a 5-flap after having loaded at the 5 terminus during the proc-
ess of Okazaki fragment maturation (2, 3). The novel exonu-
clease described in this study, human EXO5 (hEXO5),3 loads at
ssDNA ends and then slides along the ssDNA prior to cutting
(sliding exonuclease). Our studies suggest that hEXO5 func-
tions in the repair of DNA damage, in particular ultraviolet
(UV) irradiation and interstrand cross-link (ICL) damage.
Interstrand cross-links are genotoxic lesions that covalently
link the two strands of the DNA duplex together. DNA strand
separation is an essential step in the processes of DNA metab-
olism including transcription, replication, and recombinational
repair. Interstrand cross-links create complete obstructions of
these fundamental DNAmetabolic processes, leading to potent
genotoxicity. Importantly, ICLs can arise from exogenous
agents such as the anticancer drugs cisplatin and mitomycin C
(MMC) and endogenous sources in the form of by-products of
metabolic processes (4). In general, these agents also form
intrastrand cross-links (5). However, the interstrand cross-
links are generally considered to be much more genotoxic. ICL
repair predominantly occurs during S phase while DNA repli-
cation takes place and is initiated by the convergence of repli-
cation forks at sites of ICLs (6).
Here, we describe the biochemical properties and biological
function of a novel human bidirectional exonuclease, which is a
sequence homolog of Saccharomyces cerevisiae Exo5 that we
characterized previously as an exonuclease essential for mito-
chondrial genome maintenance (7). However, through a fasci-
nating turn of evolutionary events, it appears that the distinct
mitochondrial function of Exo5 prevails only in the Saccharo-
mycetales order of fungi because they possess a strong mito-
chondrial localization signal. Other fungi and organisms
including mammals lack such a localization signal and may
have dedicated Exo5 to the task ofmaintaining nuclear genome
stability (see Fig. 1A). All members of the Exo5 family share
some common characteristics beyond that of primary amino
acid sequence. They possess an iron-sulfur cluster that is struc-
turally important in linking theN terminus to theC terminus of* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealth
Grants GM032431 and GM083970 (to P. M. B.); CA123232, CA129537,
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the enzyme, thereby likely creating a cavity that may encircle
the ssDNA. A similar structural motif was previously identified
in the Bacillus subtilis recombinase AddAB (8). However, our
study shows that the detailed biochemical properties of hEXO5
are quite different from those of the budding yeast enzyme, and
this may reflect their distinct functions in the nucleus versus
mitochondrion, respectively. Depletion of hEXO5 in human
293 cells leads to hypersensitivity to genotoxic agents including
UV irradiation and particularly to ICL-inducing agents. How-
ever, sensitivity to ionizing radiation exposure was not
observed in hEXO5-depleted cells. Depletion of hEXO5 also
leads to the accumulation of a higher percentage of chromo-
some aberrations either spontaneously or after treatment with
cross-linking agents. In particular, an accumulation of triradial
chromosomes was observed at metaphase that is indicative of
unresolved and collapsed replication forks (9). These biochem-
ical and genetic results suggest that hEXO5 plays a role in
genome stability in general.
EXPERIMENTAL PROCEDURES
Plasmids and Oligonucleotides—Plasmid pBL277 contains
the Schistosoma japonicum glutathione S-transferase (GST)
gene fused to the N terminus of the human EXO5 (C1orf176)
gene in vector pRS424-GALGST (10). TheGST tag is separated
from the N terminus of hEXO5 by a recognition sequence for
the human rhinoviral 3C protease (LEVLFQ2GP). Following
cleavage by the protease, the N-terminal sequence of hEXO5 is
extended with the GPEF sequence. All variants and mutants
were made in pBL277. Plasmid pBL276 contains the GST tag
fused to the N-terminal 220-amino acid domain of the Esche-
richia coli GyrB gene (11) followed by a six-amino acid linker
fused to theN terminus of hEXO5. Plasmid pBL272 is a plasmid
formammalian expressionwith aC-terminalGFP-hEXO5con-
struct. Plasmids and sequences are available upon request.
The following oligonucleotides were purchased from Inte-
grated DNA Technologies, Inc. (Coralville, IA) and purified by
urea-polyacrylamide gel electrophoresis (PAGE): c81, TTGC-
CGATGAACTTTTTTTTTTGATCGAGACCTT; v81, AAG-
GTCTCCATCAAAAAAAAAAGTTCATCGGCAA. The po-
larity switch oligonucleotides were a gift from Dr. Timothy
Lohman. The 5-32P label was introduced on oligonucleotides
using [-32P]ATP and T4 polynucleotide kinase, whereas the
3-32P label was introduced by incubation with [-32P]dATP
and terminal deoxynucleotidyltransferase under the manufac-
turers’ recommended conditions. Labeled oligonucleotides
were hybridized with a 3-fold excess of the relevant compli-
mentary oligonucleotide. Labeled c81 was circularized first by
hybridization with equimolar bridging oligonucleotide circ81
(ATCGGCAAAAGGTCTC) followed by ligationwithT4DNA
ligase and urea-PAGE purification.
EXO5Overproduction and Purification—EXO5 overproduc-
tion was carried out in S. cerevisiae strain FM113 (MATa ura-
3-52 trp1-289 leu2-3112 prb1-1122 prc1-407 pep4-3) trans-
formed with plasmid pBL277 (hEXO5) or pBL282 (mouse
EXO5 (mEXO5)). Growth, induction, extract preparation, and
ammonium sulfate precipitation (0.3 g/ml) were similar to the
procedures described previously (12). The precipitate was dis-
solved in buffer A0 (buffer A, 60 mM HEPES-NaOH (pH 7.8),
10% glycerol, 1mMdithiothreitol (DTT), 0.1mMEDTA, 0.005%
polyoxyethylene (10) lauryl ether, 5 mM sodium bisulfite, 5 M
pepstatin A, and 5 M leupeptin; subscript number indicates
the mM sodium acetate concentration) until the lysate conduc-
tivity was equal to that of buffer A400. The lysate was then used
for batch binding to 1 ml of glutathione-Sepharose 4B beads
(GE Healthcare), equilibrated with buffer A400, and gently
rotated at 4 °C for 2 h. The beads were collected at 1,000 rpm in
a swinging bucket rotor followed by batch washes (3 20ml of
buffer A400). The beads were transferred to a 10-ml column and
washed at 2.5 ml/min with 100 ml of buffer A400. The second
washwaswith 50ml of bufferA400 containing 5mMmagnesium
acetate and 1 mM ATP, and the third wash used 50 ml of buffer
A400 and 30 ml of buffer A200. Elution was carried out at a flow
rate of 0.2 ml/min with buffer A200 containing 20 mM glutathi-
one (pH adjusted to 8.0). Fractions containing EXO5were com-
bined and diluted with buffer A0 to equal buffer A100 and then
loaded onto a 1-ml Mono Q column. Protein was eluted with a
linear gradient of buffer A100 to A1200. The fractions containing
pure protein were incubated overnight at 4 °C with 30 units of
rhinoviral 3C protease, diluted with A0 to equal A100, and
loaded onto a 1-ml Mono Q column. Pure EXO5 protein was
eluted at 300–400 mM sodium acetate. mEXO5 and hEXO5
variants and mutants were overexpressed and purified
similarly.
Analytical Ultracentrifugation—Purified protein was dia-
lyzed against a buffer of 30mMHEPES (pH7.4), 100mM sodium
acetate, 5% glycerol, and 5mM -mercaptoethanol overnight at
0 °C. We used a Beckman Optima XL-A analytical ultracentri-
fuge and ran a velocity experiment at 40,000 rpm for 6 h with 5
MhEXO5. The traces were analyzed using the Sedfit program.
Exonuclease Assays—The standard 10-l assay mixture con-
tained 100 mM Tris-HCl (pH 7.8), 500 g/ml bovine serum
albumin, 5 mM DTT, 5 mM magnesium acetate, 50 mM NaCl,
50–100 fmol of 32P-end-labeled oligonucleotide substrate, and
enzyme. Incubations were carried out at 30 °C for the indicated
time periods. Deviations from the standard assay conditions are
indicated in the legends of the figures. Reactions were stopped
with 10 mM final concentration of EDTA in addition to 40%
formamide and analyzed by 7 M urea-18% PAGE. Dried gels
were subjected to phosphorimaging analysis.
Forced Dimerization Assay—The standard 10-l assay mix-
ture was the same as for the standard exonuclease assay; how-
ever, all assays were carried out under initial linear rate condi-
tions in which 30% of the substrate was hydrolyzed.
Coumermycin (Sigma-Aldrich) was dissolved in DMSO and
further diluted in H2O, and novobiocin (Sigma-Aldrich) was
dissolved in H2O. Reactions were stopped as described above.
The reactions were analyzed by 7 M urea-18% PAGE. Dried gels
were analyzed by phosphorimaging.
Electrophoretic Mobility Shift Assay (EMSA)—The standard
20-l EMSA assay mixture contained 100 mM Tris-HCl (pH
7.8), 500 g/ml bovine serum albumin, 5 mM DTT, 1 mM
EDTA, 50 mM NaCl, 20% glycerol, 50 fmol of 32P-end-labeled
oligonucleotide substrate or unlabeled oligonucleotide, and
enzyme. Incubations were carried out at 25 °C for the indicated
periods. Reactions were loaded on 5% non-denaturing poly-
acrylamide gels prerun for 2 h at 4 °C. Either gels were dried and
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subjected to phosphorimaging analysis, or the proteins were
transferred to nitrocellulose for Western analysis with rabbit
antibodies to hEXO5. Deviations from the standard assay con-
ditions are indicated in the legends to the figures.
Human Cell Growth and Transfection—Human 293 and
GM5849 cells were maintained by previously published proce-
dures (13). Full-length FLAG-tagged hEXO5 cDNA cloned in
pcDNA3.1 was transfected into cells. hEXO5 small interfering
RNA (siRNA) and control luciferase siRNAwere obtained from
Integrated DNA Technologies, Inc. or Dharmacon Research
(Lafayette, CO). The hEXO5 siRNAs were as follows:
ORF176-1, ACUCAGAACUGGUGUGAACUU  GUUCA-
CACCAGUUCUGAGUUU; ORF176-2, CUGUGAAGUC-
UUUGGGUGAUU  UCACCCAAAGACUUCACAGUU.
RNA interference (RNAi) treatment of 293 cells was performed
as described previously (14). Cells were used 72 h after trans-
fection for all experimental purposes.
HumanDamage Sensitivity Assays—Clonogenic survival was
determined using human 293 cells. Cells after 72 h of transfec-
tion with control or hEXO5 siRNA were seeded at known den-
sities onto 60-mm dishes in 5.0 ml of medium, incubated for
16 h, and washed with 1 phosphate-buffered saline (PBS)
prior to UV or ionizing radiation or exposure to the indicated
doses of mitomycin C for 24 h or cisplatin for 1 h. Cells were
washed and incubated in fresh medium for12 days and then
fixed in methanol-acetic acid (3:1) prior to staining with crystal
violet. Only colonies containing 50 cells were counted. Each
experimentwas repeated three to four times. The S.E. is given in
the figures. Chromosome aberrations were analyzed at meta-
phases, which were prepared by standard procedures (15, 16).
Cells were treated with cisplatin or mitomycin C, and meta-
phases were collected after different time points of drug
treatment.
Immunostaining—Cells grown in chamber slides were
exposed to irradiation (10 J/m2) and incubated at 37 °C prior to
fixation. Cells were fixed in 2% paraformaldehyde for 15 min,
washed in 1 PBS, permeabilized for 5 min on ice in 0.2% Tri-
ton X-100, and blocked in PBS with 1% bovine serum albumin.
The procedure used for immunostaining is the same as that
described previously (17–19).
RESULTS
hEXO5 Contains a Conserved Iron-Sulfur Cluster—The cat-
alytic domain of eukaryotic Exo5 is distantly related to the
E. coli RecB nuclease domain of the bacterial RecBCD recom-
binases (Fig. 1, B andC) (8).We recently reported that S. cerevi-
siae EXO5 is essential for mitochondrial genome maintenance
(7). However, a phylogenetic and cellular localization predic-
tion analysis of 95 eukaryotic Exo5 proteins indicates that
strong mitochondrial localization prevails only in the Saccha-
romycetales order of fungi (Fig. 1A). This phylogenetic analysis
along with our biochemical and functional cellular studies sug-
gests that in other fungi and in metazoans Exo5 has a role in
maintaining nuclear genome stability. Therefore, we carried
out a biochemical and genetic analysis of hEXO5. The cDNA
for human C1orf176 was cloned, and the gene was designated
EXO5. hEXO5 with an N-terminal GST tag was overexpressed
in a yeast overexpression system, and the recombinant protein
was purified to apparent homogeneity by a combination of
affinity and ion exchange chromatography (see “Experimental
Procedures”). An analysis of hEXO5 by analytical ultracentrif-
ugation showed that the protein exists in a monomeric form
(Fig. 1D). The homolog from Mus musculus (RP23-182D20.4,
Exo-5) was also cloned, and the enzyme was purified analo-
gously (data not shown).
Upon purification of hEXO5, we noticed that it was yellow-
brown in color, suggesting the presence of an iron-sulfur clus-
ter. Indeed, the UV-visible spectrum of hEXO5 showed a peak
at 410 nm, indicative of the presence of an iron-sulfur cluster,
most likely of the [4Fe-4S] form (Fig. 1E). From aligning several
Exo5 homologs, we noticed a set of four conserved cysteine
residues, one N-terminal with respect to the catalytic core and
three C-terminal of the catalytic core. This is a unique arrange-
ment for coordination of the Fe-S cluster that was previously
identified in theB. subtilisAddB helicase-nuclease (Fig. 1C) (8).
This arrangement is conserved in mEXO5, which also purifies
as a yellow protein with a UV-visible peak at 410 nm. To test
whether the conserved cysteines are responsible for coordina-
tion of the iron-sulfur cluster, we purified a hEXO5 form with
cysteines at 343 and 346 mutated to alanines (hEXO5-CCAA),
and the mutant hEXO5 protein was colorless and lacked
absorption at 410 nm (Fig. 1E). Lack of the iron-sulfur cluster
also led to an 80–90% loss of catalytic activity of hEXO5, indi-
cating that this structural motif is important but not essential
for enzymatic function (Fig. 1G).
Both human and mouse EXO5 degraded ssDNA; however,
their activities were both quite low with turnover numbers in
the order of min1 (Fig. 1F).Whenmammalian Exo5 was over-
expressed in E. coli, the persistent presence of contaminating
E. coli nucleases made a reliable characterization problematic
(data not shown). Therefore, we exploited the yeast overexpres-
sion system (described under “Experimental Procedures”),
which dramatically reduced the level of contaminating nuclease
activities. Considering the very low catalytic activity of hEXO5,
it was important to establish that the observed activity was not
caused by a contaminating yeast nuclease. Based upon the
alignment with the RecB nuclease domain (20), we predicted
that Asp-182 and Glu-196 bind the divalent metal ion that is
essential for catalysis (Fig. 1, B and C). The E196A form of
hEXO5 was purified and shown to display negligible nuclease
activity (1% of wild type), indicating that the observed wild-
type activity albeit low is valid (Fig. 1G). We also purified two
naturally occurring variants of hEXO5, either with a D115N or
V172G change, and these variants had activity similar to that of
the reference hEXO5 (Asp-115 and Val-172), which we desig-
nate as wild type (Fig. 1G). Below we explore the basis for the
low enzymatic activity of mammalian Exo5.
The Exo5 Orthologs Are Sliding Bidirectional Exonucleases—
A variety of oligonucleotide structures were analyzed as
substrates for hEXO5. The enzyme is specific for DNA as sin-
gle-stranded RNA was not degraded (data not shown). DNA
structures such asHolliday junctions, replication forklike struc-
tures, and DNA flap substrates showed no activity unless these
structures contained a free ssDNA tail, and none of these struc-
tures showed a higher activity than a simple ssDNA substrate
did (Fig. 2, A and C, and data not shown). Thus, hEXO5 is a
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single strand-specific deoxyribonuclease, and fully double-
stranded DNAs (dsDNAs) are resistant to degradation (Fig. 2A,
lanes 5–7 versus 11–13). The enzyme also requires a free DNA
end for activity as the circularized form of the single-stranded
oligonucleotide was not cleaved (lanes 8–10).
To determine whether hEXO5 is a 5- or 3-exonuclease, we
utilized an ssDNA substrate hybridized with a 12-nucleotide
complementary oligonucleotide to form a dsDNA block at
either the 5-end or the 3-end. Although the 5-blocked sub-
strate showed a large decrease in activity (Fig. 2A, lanes 14–16),
the 3-blocked substrate showed only marginal inhibition
(lanes 17–19), suggesting that hEXO5 is primarily a 5-exonu-
clease, but itmay also have 3-exonuclease activity (Fig. 2B).We
designed two partially double-stranded oligonucleotides with
either a 5- or 3-ss-(dT)25 flap (Fig. 2C). Both the 5- and 3-flap
substrates were degraded by hEXO5 with the 5-flap substrate
being the preferred substrate. These data suggest that hEXO5 is
a bidirectional single strand-specific exonuclease with a prefer-
ence for 5-ends. However, an alternative explanation that the
enzyme slides onto the dsDNA ends of the flap substrates prior
to cutting into the ssDNAregion could not be excluded by these
experiments.
To test the exonuclease polarity problem in an unambiguous
manner, we used a set of oligo(dT) substrates inwhich the chain
polarity is switched in the middle of the oligonucleotide by
either a 3-3- or 5-5-dinucleotide linkage so that the resulting
oligo(dT) has either two 5- or two 3-ends, respectively (Fig.
2D). The use of homopolymeric oligo(dT) substrates also elim-
inates potential problems in activity relating to sequence con-
text (Fig. 2A) or secondary structure formation. Control studies
showed that the proofreading 3-exonuclease activity of DNA
polymerase  degraded the substrate with only 3-ends but not
the substrate with only 5-ends (Fig. 2D). Conversely, -exonu-
clease, a 5-nuclease, degraded the substrate with only 5-ends
FIGURE 1. Catalytic activity of hEXO5. A, phylogenetic analysis. Using PSI-BLAST, 108 eukaryotic Exo5 sequences were identified in GenBank. This set was
culled by imposing the following requirements: (i) an N-terminal methionine and (ii) the diagnosticWCE and CX2CX5Cmotifs N-terminal and C-terminal of the
catalytic domain that constitute the iron-sulfur cluster coordinating cysteines. The remaining 95 sequences were subjected to PREDOTAR to identify classical
N-terminal mitochondrial localization sequences and to Phylogeny.fr for phylogenetic analysis using MUSCLE multiple alignment and PhyML phylogeny
analysis. All 15 Saccharomycetales Exo5 proteins showed amedium to strongmitochondrial localization probability (0.2–0.92). Themitochondrial localization
probability of all 80 other Exo5 proteins was 0–0.02with the exception of Zeamays (0.25) and Strongylocentrotus purpuratus (0.28). A tree of 18 representative
model organisms is shown. B, schematic representation of the domain architecture of hEXO5with conserved active site residues and iron-sulfur coordinating
cysteine residues indicated.C, sequence alignment of critical residues in the Exo5 family. Active site Asp/Glu are shown in red, Gln and Tyr of a highly conserved
helix are shown ingreen, and four conservedCys residues that coordinate the Fe-S cluster are shown in brown.Hsap,Homo sapiens;Mmus,M.musculus; Spom,
S. pombe; Scer, S. cerevisiae; RecB, nuclease domain of E. coli RecBCD recombinase; AddB, nuclease domain of B. subtilis AddAB recombinase.D, purified hEXO5
(5M) inbuffer containing100mMsodiumacetatewas run in aBeckmanOptimaXL-Aanalytical ultracentrifugeasdescribedunder “Experimental Procedures.”
Sedim. coeff., sedimentation coefficient. E, UV spectrum of hEXO5 and the C143A,C146A (CCAA) mutant. Traces were set to 1.0 at 279 nm. F, activity of hEXO5
variants andmutants. Standard assaymixtures used 10 nM5-labeled 34-nucleotideDNA substrate. The concentrations of the hEXO5 from left to right are 5, 15,
50, and 150 nM. The reactions were carried out at 30 °C for 4 min. The results were analyzed on a 7 M urea-18% polyacrylamide gel. G, the indicated hEXO5
mutant proteinswerepurified as described for thewild type, and standardnuclease assayswith increasing concentrations of proteinwere carriedout for 4min
at 30 °C.
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but not the substrate with only 3-ends (data not shown).
hEXO5 degraded both polarity switch oligonucleotides, indi-
cating that its activity is bidirectional in agreement with the
studies of the flap substrates (Fig. 2C).
Using these diagnostic substrates, we reinvestigated the
polarity preference of S. cerevisiae Exo5, which we previously
had designated to be a 5-exonuclease (7). Surprisingly, this
enzyme also showed bidirectionality but still with a preference
for 5-ends. However, in contrast to hEXO5, which generates
larger oligonucleotide products, yeast Exo5 predominantly
generates dinucleotide products from the 5-end and tri- and
tetranucleotides from the 3-end (Fig. 2D). We conclude that
our previous inability to detect a 3-directionality with yeast
Exo5 may have been caused by the sequence context of the
oligonucleotides used in that study.
Remarkably, hEXO5 releases oligonucleotides rather than
mononucleotides as products of exonuclease action. The
results from a single hit kinetic analysis of hEXO5 on (dT)60 are
consistent with a model in which hEXO5 loads at a DNA end
and then stochastically translocates along the ssDNA prior to
random cutting (Fig. 2E). In a single hit kinetic analysis, each
DNA molecule undergoes one cleavage event upon binding by
hEXO5. Under our experimental conditions, hydrolysis at early
time points was 10%. Importantly, the ratio of the different
length products formed between 2 and 4 min of reaction
remained constant. The ratio of 2–10-nucleotide products
FIGURE 2. hEXO5 is a single-stranded DNA-specific bidirectional exonuclease. A, standard assays containing a 10 nM concentration of the indicated
5-labeledDNAwere incubatedwith3, 10, or 21nMhEXO5 for 8min.PDE, ladder frompartial digestionwith snakevenomphosphodiesterase, a 3-exonuclease.
B, quantification of activity of hEXO5 on ssDNA, dsDNA, and 5- and 3-dsDNA substrates from A. C, standard assays containing a 10 nM concentration of the
indicated 5- or 3-labeled DNA substrate were incubated with 5, 15, 50, or 150 nM hEXO5 for 8 min at 30 °C. hydrol., hydrolysis. D, standard assays containing
a 10 nM concentration of 5-labeled (dT)65 or double 5-ended (dT)70, or 3-labeled double 3-ended (dT)70 were incubatedwith 5, 15, 50, 150, or 300 nM hEXO5
for 4 min or with 0.05, 0.15, or 5 nM S. cerevisiae (S. cer) Exo5 for 30 s at 30 °C. Controls contained DNA polymerase (Pol) where indicated with an arrow under
the gels. E, standard assays contained 10 nM 5-labeled (dT)60 and 5 nM hEXO5 for the indicated times. All samples were analyzed on 7 M urea-18% polyacryl-
amide gels and quantified by phosphorimaging. The asterisks indicate the position of the 32P label.
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made after 4 min compared with 2 min of reaction time was
1.89 0.2. In comparison, the ratio of 11–20-nucleotide prod-
ucts was 1.95 0.2. Multiple cleavage events would have led to
an accumulation of shorter products with increasing time. This
was not observed until the 15-min time point, indicating that at
the initial times single hit kinetics prevailed.
The sliding model predicts an equal probability of cutting
along the length of the DNA across which sliding occurs as
indeed was observed for the (dT)60 substrate with some prefer-
ence for cutting near the 5-end, which is the preferable loading
site. mEXO5 also exhibited this behavior of a sliding exonu-
clease (data not shown). However, S. cerevisiae Exo5, which
functions in mitochondria, predominantly released dinucle-
otides as products from the 5-end (Fig. 2D and Ref. 7). There-
fore, the biochemistry of mammalian Exo5 is quite different
from that of budding yeast Exo5.
hEXO5 Activity Is Greatly Increased by Forced Dimerization—
The extremely low mammalian Exo5 catalytic activity suggests
that its activity may be regulated. Interestingly, we noted that
under standard assay conditions with 10 nM substrate DNA the
activity of hEXO5 carrying the GST purification tag was
approximately 30-fold higher than that of the protein after pro-
teolytic removal of the GST tag (data not shown). However, the
product distribution remained very similar (data not shown).
We surmised that the increased activity of GST-hEXO5 was
caused by the tendency of GST domains to form homodimers
(10), thereby effectively dimerizing the exonuclease domain. A
likely explanation for the increased activity of the dimeric
enzyme would be an increased binding affinity for DNA. A full
kinetic analysis of the two forms of hEXO5 showed that the
native enzyme bound ssDNA over 100-fold more poorly than
did GST-hEXO5 (Fig. 3A). At saturating ssDNA concentra-
tions, the catalytic activities of both species differed less than
2-fold. In agreement with this conclusion, we observed no
detectable binding of hEXO5 to ssDNA in an EMSA, whereas
GST-hEXO5 did form a detectable complex (Fig. 3B). The GST
domain itself showed no DNA binding (data not shown).
To determine whether the increased exonuclease activity
was due to protein dimerization or a consequence of the pres-
ence of an N-terminal fusion, we reinvestigated this problem
using a system of forced chemical dimerization. The N-termi-
nal domain of the E. coli gyrase B subunit binds the drugs novo-
biocin and coumermycin with high affinity (21). Although
novobiocin binds the GyrB domain in a 1:1 complex, coumer-
mycin, which has two GyrB binding sites, forms a 1:2 complex
withGyrB.We fused theGyrB domain to hEXO5 andmeasured
its activity at 10 nM ssDNA concentrations with or without
drugs (Fig. 3C). In the absence of antibiotic, the GyrB-hEXO5
fusion protein had very low catalytic activity similar to that of
monomeric hEXO5 alone. Next, we titrated either novobio-
cin or coumermycin into a nuclease assay that contained a
constant concentration of GyrB-hEXO5 (215 nM). The addi-
tion of increasing concentrations of novobiocin had no effect
on the nuclease activity of GyrB-hEXO5. However, increas-
ing concentrations of coumermycin led to a maximal10-fold
increase in nuclease activity at 100 nM drug, an 1:2 ratio of
coumermycin to GyrB-hEXO5, followed by a gradual decrease
in activity at higher concentrations of coumermycin (Fig. 3C).
The latter observation is consistent with a 1:2 equilibrium of
coumermycinGyrB-hEXO5 complexes that is driven to 1:1
complexes at higher coumermycin concentrations. Therefore,
we conclude that high affinity DNA binding activity of hEXO5
requires that it be in the form of a dimer.
Human Replication Protein A (hRPA) Enforces a 5-Direc-
tionality onto hEXO5—RPA is a highly conserved heterotrim-
eric complex that is essential for DNA replication and repair. It
FIGURE 3. hEXO5 possesses weak binding affinity that increases upon
forced dimerization. A, dependence of hEXO5 molar activity on DNA con-
centration. Data were fit to a Michaelis-Mentenmodel. For GST-hEXO5, Km	
27 4 nM and Vmax	 1.3 0.05min
1; for hEXO5, Km	 3,200 800 nM and
Vmax 	 0.7  0.1 min
1. B, EMSA assays as described under “Experimental
Procedures” using 10 nM 5-labeled 34-mer and the indicated concentrations
of hEXO5 or GST-hEXO5 (as monomer) were incubated at 20 °C for 10min, and
sampleswere analyzedona5%non-denaturingpolyacrylamidegel. FreeDNA is
shown. No binding was observed by GST alone (not shown). C, chemically
enforced dimerization of hEXO5. The standard assay with 215 nM GyrB-hEXO5
was carried out with the indicated concentrations of either coumermycin or
novobiocin.Novobiocin isanantibiotic thatbindsasingleGyrBdomain.Coumer-
mycin is a dimeric antibiotic that can bind twoGyrB domains as indicated.
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acts as a hub protein that recruits repair proteins to sites of
DNA replication stress and DNA damage (22). To determine
whether hRPA shows a functional interaction with hEXO5, we
performed an activity titration experimentwith increasing con-
centrations of either hRPA, S. cerevisiae RPA, or E. coli single-
stranded DNA-binding protein on oligo(dT)65 in the presence
of a constant hEXO5 concentration. Increased coating of the
ssDNA with either S. cerevisiae RPA or E. coli single-stranded
DNA-binding protein progressively inhibited hEXO5 activity,
whereas hRPA stimulated hEXO5 activity (Fig. 4, A and B).
Therefore, hEXO5 showed notable species specificity for inter-
action with its cognate RPA. Remarkably, the bound RPA also
curtailed the sliding ability of hEXO5.Whereas onnaked (dT)65
the probability of cutting was nearly constant over the length of
the DNA, coating of the DNA with RPA shifted the cutting
probability strongly toward the 5-end (Fig. 4C, right panel and
traces). This observation is most consistent with two simulta-
neous activities of hRPA. (i) It inhibits sliding of hEXO5 and
stimulates cutting near the site of 5-loading, and (ii) it inhibits
3-loading of hEXO5.
To test this model, we used the set of oligo(dT) polarity
switch oligonucleotides described in Fig. 2D. Coating of the
5-double-ended substrate with hRPA enhanced activity and
shifted cleavage to smaller products similarly to what was
observed with the natural (dT)65. In contrast, cutting of the
3-double-ended substratewas strongly inhibited by hRPA (Fig.
4C). Thus, RPA inhibits 3-activity of hEXO5 and thereby
enforces a 5-directionality onto the enzyme.
FIGURE 4. hEXO5 is an RPA-directed 5-exonuclease. A, standard assaymixtures using 10 nM 5-labeled (dT)65. The concentration of the hEXO5 is 50 nM. The
concentrations of WT hRPA, hRPA-t11, S. cerevisiae RPA (scRPA), and E. coli single-stranded DNA-binding protein (SSB) from left to right are 0, 5, 10, 20, and 40
nM. The reactions were carried out at 30 °C for 4 min. The results were analyzed on a 7 M urea-18% polyacrylamide gel. B, quantification of the gel from
A. C, standard assaymixtures using 10 nM 5-labeled (dT)65 or (dT)70 containing either a 3-3 or 5-5-dinucleotide linkage ssDNA substrate labeled at the 5- or
3-ends respectively. The concentration of the hEXO5 is 50 nM. The concentrations of human RPA from left to right are 0, 2.5, 5, 10, 20, and 40 nM. The reactions
were carriedout at 30 °C for 4min. The resultswere analyzedona7Murea-18%polyacrylamidegel. Graphs to the right show thedistributionof hEXO5cleavage
products without hRPA or with 40 nM hRPA. The asterisks indicate the position of the 32P label.
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To further examine the specificity of the hEXO5-hRPA
interaction, we took advantage of a previously characterized
mutation in the N-terminal domain of the RPA70 subunit,
RPA70-K45E or RPA-t11. This allele was first identified in S.
cerevisiae as a mutant (rfa1-t11) that caused sensitivity to DNA
damage (23), and the human mutant exhibits recombination
defects (24). Mutant hRPA-t11 failed to stimulate hEXO5. In
fact, it inhibited hEXO5 activity to a degree similar to that of S.
cerevisiae RPA, suggesting that the mutation abrogated stimu-
latory interactions with hEXO5 (Fig. 4A).
We used EMSA to assess interactions among hEXO5, hRPA,
and ssDNA (Fig. 5). In these studies, DNA was detected by
phosphorimaging of the 5-32P label and hEXO5 by Western
analysis. The (dT)40 oligonucleotide used in this study can bind
either one or twohRPAsdepending on the concentration (com-
plex 1 in lane 9 and complex 2 in lanes 10 and 11). A complex
between hEXO5 and hRPA was readily detectable by Western
analysis (lane 2). Under these conditions, no complex between
hEXO5 and ssDNA was detectable (lane 4; see also Fig. 3B).
However, addition of increasing hRPA shifted hEXO5 into
hRPADNA complex 1 (lane 5) or complex 2 (lanes 6 and 7).
These data suggest that hEXO5 is recruited to ssDNA through
binding to DNA-bound hRPA. Given the lack of stimulation of
hEXO5 activity exhibited by mutant hRPA-t11 (Fig. 4A), we
also determined interactions of the mutant protein with
hEXO5. Indeed, hRPA-t11 did not form a complexwith hEXO5
in the absence of DNA (compare lanes 12 and 4), and although
hRPA-t11 alone showed robust binding to ssDNA (lane 13), it
did not recruit hEXO5 into the RPAssDNA complex (compare
lanes 14 and 7). Therefore, hRPA-t11 is defective for binding
hEXO5 on or off the DNA. These data together indicate that
hEXO5 physically interacts with hRPA as a mechanism to
increase the affinity for ssDNA. Also, hRPA enforces 5-direc-
tionality onto hEXO5.
hEXO5 Functions in UV Irradiation and Interstrand Cross-
link Repair—Budding yeast Exo5 has a consensus mitochon-
drial localization signal, and the exo5
 mutant shows cata-
strophic mitochondrial defects but no detectable nuclear
defects (7). However, most other EXO5 genes including the
mammalian gene lack a mitochondrial localization signal, sug-
gesting that their primary function may be nuclear (Fig. 1A).
We tested the localization of a C-terminal GFP fusion to
hEXO5 in transfected HEK 293 human cells. GFP fluorescence
was distributed over both the cytosol and the nucleus (Fig. 6A).
However, approximately 4 h after exposure of cells to UV irra-
diation, we observed distinct nuclear GFP foci, suggesting that
hEXO5 is recruited to sites of DNA damage.
To determine the effect of hEXO5 on cell survival, cells with
or without depletion by hEXO5-specific siRNAs were exposed
to various genotoxic agents. RT-PCRwas used to determine the
level of hEXO5 mRNA knockdown to80% (data not shown).
Unfortunately, several independently raised antisera against
purified hEXO5 failed to recognize the protein in human cell
extracts. Therefore, to test the level of protein knockdown elic-
ited by siRNAs, a FLAG-tagged hEXO5 construct containing
the same RNA sequence that is targeted by the siRNAs was
expressed. Extracts of hEXO5 siRNA-transfected cells were
analyzed for FLAG-hEXO5 by Western analysis with anti-
FLAG antibodies. From these studies, an80% knockdown of
FLAG-tagged hEXO5was consistently achieved (Fig. 6B). From
these studies, we conclude that levels of native hEXO5 are sim-
ilarly decreased by the siRNAs.
Treatment of hEXO5-depleted cells with DNA-damaging
agents caused an increased sensitivity to various DNA-damag-
ing agents but not to -irradiation as determined by clonogenic
survival assays. We consider off-target effects of the siRNAs
unlikelybecauseneither siRNA1norsiRNA2causedan increase in
sensitivity to-irradiation (Fig. 6C), but both siRNA1 and siRNA2
showed strong and similar sensitivity to treatment of cells with
cisplatin (Fig. 7A). hEXO5 depletion in 293 cells also caused an
increased sensitivity to cell killing after UV irradiation and to the
alkylating agent methylmethane sulfonate (Fig. 6, D and E). An
analysis of the rate of appearance and disappearance of -H2AX
foci associated with UV damage showed a delay in their disap-
pearance, suggesting that the rate of UV damage repair is
slowed down in hEXO5-depleted cells (Fig. 6F).
Interestingly, hEXO5-depleted cells are very sensitive to
either interstrand cross-linking agent cisplatin or MMC as
determined by clonogenic survival assays (Fig. 7, A and B).
Defects in ICL repair such as in Fanconi anemia patients are
associated with an increase in metaphases with chromosomal
aberrations. In particular, there is an increased occurrence of
triradial chromosomes that is attributed to a failure in the res-
olution of stalled DNA replication forks (25). Indeed, we
observed that chromosome abnormalities were significantly
increased in hEXO5-depleted cells even in the absence of exter-
nal damage-inducing agents (Fig. 7, C, panel b, D, and E). Fur-
thermore, treatmentwith either interstrand cross-linking agent
cisplatin (Fig. 7D) or mitomycin C (Fig. 7E) led to a large
increase in the frequency of metaphases with chromosomal
aberrations in hEXO5-depleted cells compared with controls.
Interestingly, these included a higher frequency of triradial
chromosomes (Fig. 7C, panel d). Therefore, hEXO5 depletion
results in an increase in genomic instability and an increased
sensitivity to various DNA-damaging agents as determined by
clonogenic survival, metaphase aberrations, and appearance
and disappearance of repair foci.
FIGURE 5. Physical and functional interaction of hRPAwith hEXO5. EMSA
assayswereperformedasdetailedunder “Experimental Procedures” using50
nM 5-labeled ssDNA, varying concentrations of hRPA or hRPA-t11 mutant,
and 50 nM hEXO5 as indicated. The top panel visualizes the 5-32P-labeled
oligonucleotidebyphosphorimaging, and thebottompanel visualizeshEXO5
by a Western analysis with antibodies against hEXO5.
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DISCUSSION
The EXO5 gene is widely conserved in archaeal and eukary-
otic organisms includingmammals, fungi, plants, and protozoa;
however, surprisingly, it appears to be absent from insects and
worms. A phylogenetic analysis of all 95 eukaryotic complete
EXO5 genes deposited in GenBankTM shows that the proteins
from organisms that fall in the Saccharomycetales order are
more distantly removed from those in other orders and phyla,
and they show a strong mitochondrial localization signal (Fig.
1A). This phylogenetic and bioinformatics analysis is supported
by our experimental studies, which show severe mitochondrial
but no nuclear defects for S. cerevisiae exo5
 (7). In contrast,
other fungi and the mammalian forms generally lack a mito-
chondrial localization signal, and hEXO5-depleted human cells
show strong defects in nuclear genome stability.
The basic structure of Exo5 inwhich theN terminus is linked
to its C terminus via an iron-sulfur cluster is derived from the
AddB nuclease domain of the B. subtilis AddAB recombinase,
which in turn is related to the better known E. coli RecBCD
recombinase (8, 26). The linkage of the N terminus to the C
terminus of the protein through an Fe-S cluster could provide a
cavity through which the ssDNA threads. This model would
explain our observation that circular ssDNA is inactive for
hEXO5 (Fig. 2A). The Okazaki fragment-processing exonu-
clease Fen1 also contains a hole throughwhich the 5-end of the
ssDNA threads, although that hole is elaborated through a flex-
ible loop (3). Both Exo5 and Fen1 show a propensity to slide
along ssDNA; however, the hydrolytic activity of Fen1 is spe-
cific for the base of a flap substrate. No such preference has
been found for Exo5 (Fig. 2C). In fact, Exo5 is structurally
related to the Dna2 nuclease-helicase, which has a similar iron-
sulfur cluster arrangement (27). Another biochemical similar-
ity between Dna2 and Exo5 is that RPA enforces a 5–3 direc-
tionality onto the enzyme (Fig. 4 and Ref. 28). We show here
that this enforcement of directionality requires species-specific
hRPA-hEXO5 interactions as neither yeast RPA nor the inter-
action-defective hRPA-t11 mutant fulfill this function (Figs. 4
and 5). Directionality enforcement by RPA has been demon-
strated previously for enzymes and factors involved in nucleo-
tide excision repair and in theDNAdamage checkpoint, re-em-
phasizing the importance in carrying out these type of in vitro
studies with the cognate form of RPA (29, 30).
What might be the biochemical role of hEXO5 during DNA
repair? Given the sensitivity of hEXO5-depleted cells to UV
irradiation, methylmethane sulfonate, and ICL agents, the
enzyme may function in multiple pathways with partial redun-
dancy with other nucleases. hEXO5-depleted cells are very sen-
sitive to cisplatin andMMC, whichmay indicate that they have
a defect in the repair of interstrand cross-links. Alternatively,
because ICLs are generally detected during DNA replication (6,
31), hEXO5-depleted cells may also be defective in the process-
ing of stalled replication forks in general. The observation that
chromosome abnormalities such as triradials, which arise dur-
ing S phase, are increased in hEXO5-depleted cells in the
absence of damage supports this hypothesis.
Given its absolute requirement for single-stranded DNA,
hEXO5 can be visualized as functioning together with a DNA
helicase that generates 5-ssDNA through unwinding or with a
DNA polymerase that generates 5-ssDNA through strand dis-
placement synthesis. The identification of hEXO5-interacting
FIGURE 6. hEXO5 is required for DNA repair. A, localization. GFP-tagged hEXO5 cells were grown on coverslips, irradiated with 10 J/m2, and examined for
GFP-hEXO5 by fluorescence after the indicated times after irradiation. B, Western blot of FLAG-hEXO5. Human 293 cells expressing FLAG-hEXO5 were trans-
fected with hEXO5 siRNA, and protein levels were examined 72 h after transfection. Lane 1, control; lane 2, control (Ctrl) siRNA; lane 3, hEXO5 siRNA.
C, clonogenic survival after exposure to gradeddoses of ionizing radiation.Gy, grays. Twodifferent siRNAswere used as indicated, and their datawere virtually
superimposable. An ATM/ cell line was used as control.D, survival after exposure tomethylmethane sulfonate (MMS). Cells were treated withmethylmeth-
ane sulfonate for 4 h, washed, and incubated in fresh medium. E, survival after exposure to UV irradiation. F, frequency of -H2AX foci post-UV irradiation (10
J/m2) in cells with and without depletion of hEXO5. See “Experimental Procedures” for details. Error bars represent S.E.
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FIGURE 7.Chromosome aberrations in hEXO5-depleted cells. A, clonogenic survival of control 293 cells or those depleted for hEXO5 using either siRNA1 or
siRNA2 followed by exposure to the indicated concentrations of cisplatin. B, survival after exposure to MMC. C, representative images of metaphases with
chromosome aberrations. Exponentially growing cells with or without depletion of hEXO5 were treated without or with 15 g/ml cisplatin for 1 h, cells were
washed and incubated in freshmedium for 24 h, and then Colcemid was added to collect metaphases. Thin arrows indicate tri- or quadriradial chromosomes,
and thick arrows indicate breaks andgaps. Panel a, control siRNAwithout cisplatin treatment; panel b, hEXO5 siRNAwithout cisplatin treatment; panel c, hEXO5
siRNA irradiated with 2 grays; panel d, hEXO5 siRNA with cisplatin treatment. D and E, histograms showing the frequency of metaphases with aberrations in
control, control siRNA-, or hEXO5 siRNA-transfected cells after cisplatin (D) or MMC exposure (E) as described under “Experimental Procedures.” The data
presented are themean of three experiments, and for each experiment, 100metaphases were counted (significance according to Student’s t test: *, p 0.05;
**, p 0.01). Error bars represent S.E.
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proteins beyond humanRPA identified herewill aid in a further
understanding of the specific roles that this novel exonuclease
displays during the maintenance of genome integrity. In addi-
tion, our phylogenetic analysis suggests that fission yeast Exo5
may be more closely related to the human than to the budding
yeast enzyme, and in fact, a proteomics study has indicated both
nuclear and mitochondrial localization for Schizosaccharomy-
ces pombe Exo5 (32). We have initiated a study of Exo5 in this
genetically more tractable organism.
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 CHAPTER IIC 
S. pombe Exonuclease 5 plays a role in maintenance of both nuclear and mitochondrial 
genomes  
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ABSTRACT 
 Previously we described the biochemical and molecular characterization of the 
novel Exonuclease 5 family of enzymes from S. cerevisiae and humans. The Exo5 family 
consists of bi-directional, single-strand, DNA-specific exonucleases that all contain an 
iron-sulfur cluster as a structural motif, and all have various roles in DNA metabolism. In 
the Saccharomycetales order, that includes the budding yeast S. cerevisiae, Exo5 is a 
mitochondrial protein that is essential for mitochondrial genome maintenance. In 
contrast, the human ortholog is important for nuclear genome stability and DNA repair. 
Here, we identify the Exo5 ortholog in an unrelated yeast species, Schizosaccharomyes 
pombe. S. pombe Exo5 (spExo5) is a bi-directional, single-strand, DNA-specific 
exonuclease with approximately 100-fold higher activity than the human enzyme, but 
functions similarly in vitro. Both RPA and PCNA co-immunoprecipiate with spExo5 and 
these interactions mediate the lethality of spExo5 overexpression in S. pombe. Similar to 
results from knockdown experiments in human cells, DNA damage sensitivity assays 
show exo5∆ S. pombe strains are sensitive to various DNA damaging agents, particularly 
interstrand crosslinking agents. SpExo5 is in a redundant pathway with spRad2 (FEN1) 
in both nuclear and mitochondria genome maintenance. Deletion of both enzymes lead to 
depletion of the mitochondrial DNA, indicating spExo5 and spRad2 are essential for 
mitochondrial DNA metabolism.  
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 INTRODUCTION 
 Exonuclease 5 was discovered over two decades ago in a biochemical screen for 
exonucleases in S. cerevisiae; however, Exo5 was only recently analyzed (Burgers, Bauer et al. 
1988; Burgers, Stith et al. 2010). S. cerevisiae, mouse and human Exo5 orthologs are bi-
directional, single-strand, DNA-specific exonucleases. The human and mouse Exo5 nucleases 
slide along ssDNA prior to cleavage, but the S. cerevisiae enzyme does not slide; rather, it 
preferentially cleaves di-nucleotides as its major product. There is also apparent divergence in 
function of Exo5 in Saccharomycetales order, which includes S. cerevisiae, in which all the Exo5 
orthologs have strong consensus mitochondrial localization sequences (Burgers, Stith et al. 2010; 
Sparks, Kumar et al. 2012). However, most orthologs outside the Saccharomycetales order lack a 
mitochondrial localization sequence, indicating their main function may be nuclear (Sparks, 
Kumar et al. 2012). In S. cerevisiae Exo5 is essential for mitochondrial genome maintenance but 
has no apparent nuclear function (Burgers, Stith et al. 2010), whereas studies of the human Exo5 
ortholog revealed it to be a nuclear protein that is important for nuclear genome stability and 
DNA repair (Sparks, Kumar et al. 2012). We were interested a more genetically tractable model 
system to investigate the in vivo nuclear functions of Exo5 outside of the Saccharomycetales 
order, to better understand what DNA metabolism pathways human Exo5 may be involved. 
Schizosaccharomyces pombe, the fission yeast, was an attractive candidate with previous 
proteome studies clearly demonstrating that the S. pombe Exo5 (spExo5) ortholog is localized to 
both the nucleus and mitochondria (Matsuyama, Arai et al. 2006).  
 Additionally, knockdown of Exo5 in human cells hyposensitized to interstrand 
crosslinking agents compare to control cells (Sparks, Kumar et al. 2012). DNA Interstrand cross-
links (ICLs) are genotoxic lesions that covalently link the single-strands of the DNA duplex 
stably together. The ability to destabilize and separate DNA strands is an essential step in the 
processes of DNA replication and transcription. ICLs form potent obstructions of these 
fundamental processes leading to potent genotoxicity that must be efficiently repaired for cell 
viability. In S. pombe there are at least three pathways for repair of interstrand crosslinks (ICLs) 
that have been genetically investigated. The first pathway is considered to be a primitive Fanconi 
anemia pathway that requires the activity of the nuclease Fan1, human Fan1 ortholog, the helicase 
Fml1 that is the human FANCM homolog, and Rhp51 (Rad51) in S. pombe (Fontebasso, 
Etheridge et al. 2013). The second pathway requires the nuclease Pso2 and the nucleotide 
excision repair endonuclease Rad13, as well as Rhp51 (Fontebasso, Etheridge et al. 2013). 
Finally, the third pathway for repair of ICLs in S. pombe is dependent on the sumo ligase Pli1 
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(Fontebasso, Etheridge et al. 2013). These previous studies provide a framework for the 
investigation of the function of Exo5 in ICL repair. The mechanistic details of these pathways 
have not been studied and more work will be required to determine what other proteins are 
involved in these pathways. 
 In this paper we describe the biochemical and genetic characterization of the 
Schizosacchromyces pombe Exo5 homolog. We observe that spExo5 is a bi-directional single-
strand DNA specific exonuclease that has strikingly similar activities to the previously 
characterized human and mouse homolog. We demonstrate that spExo5 physically interacts with 
both the single-stranded, DNA-binding protein RPA, and the processivity clamp Pcn1 (PCNA), 
and that these interactions are important for the spExo5 overexpression phenotype of checkpoint 
activation and cell death. The exo5∆ strains are sensitive to UV-irradiation, methyl 
methanesulfonate (MMS) and to interstrand crosslinking agents in particular, closely 
recapitulating the previous Exo5 knockdown experiment in human cells. Finally, we demonstrate 
that spExo5 contains an internal ribosome entry site at methionine 58 that produces a short 
isoform of spExo5 that is important for mitochondrial genome maintenance, and that this short 
isoform plays a redundant role with spRad2 (FEN1) in the mitochondria. An exo5∆ rad2∆ double 
deletion strain of S. pombe is deficient for growth on plates containing glycerol as the sole carbon 
source, and genomic DNA digestion from this strain indicates an approximate 10-fold depletion 
of mitochondrial DNA, indicating these proteins perform a redundant function that is essential for 
mitochondrial genome maintenance. 
 
RESULTS 
S. pombe Exo5 (spExo5) is a bi-directional, ssDNA-specific exonuclease, homolgous to the 
human Exo5. 
 Comparison of the biochemical activity of human, mouse, and S. pombe Exo5 homologs 
on a 5’-labeled ssDNA oligonucleotide reveal that these proteins have identical sequence 
preferences in their cleavage patterns (Fig 1A). Similar to other Exo5 family members spExo5 is 
a bi-directional exonuclease able to degrade single-stranded oligonucleotides engineered to have 
only free 5’-ends or 3’-ends respectively, leaving a distribution of products similar to the human 
enzyme (Fig 1B). The spExo5 seems to slide along DNA prior to cleavage and to have divergent 
activity from the S. cerevisiae Exo5 ortholog (Fig 1B). These results indicate that spExo5 is a bi-
directional, ssDNA-specific exonuclease that possesses similar sliding activities to the human 
homolog (Fig 1B). Mutations of the conserved active site aspartates at amino acid 176 or 207 to 
alainines (D176A, D207A) abrogate the nuclease activity of spExo5 (Fig 1C). A full kinetic 
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analysis of both human Exo5 and spExo5 shows that the human enzyme binds ssDNA over 100-
fold more poorly than spExo5 (Fig. 1D). At saturating ssDNA concentrations, the catalytic 
activity of spExo5 is 100-fold greater than the human enzyme. From these experiments we 
hypothesized that S. pombe would be a more genetically tractable model system to study Exo5 
function in vivo. 
 
Exo5 interacts with RPA and PCNA in vivo. 
 Previously we demonstrated a species-specific physical interaction between human Exo5 
and the human single-strand DNA binding complex RPA (Sparks, Kumar et al. 2012). In an 
attempt to link Exo5 to a specific DNA repair pathway, we performed co-immunoprecipitation 
experiments to find Exo5 interacting proteins. We overexpressed Exo5 with a c-terminal 
3XFLAG tag to perform our pull-downs. Cell extracts were subjected to co-immunoprecipitation 
with 3XFLAG-beads (Sigma) and extensively washed prior to elution with the 3XFLAG peptide 
(Sigma). The elutions were analyzed by SDS-PAGE followed by commassie staining (Fig 2A). 
The upper and lower sections of the Exo5-3XFLAG lane were cut out and sent for mass 
spectrometry analysis (Fig 2A). Mass finger printing identified several DNA replication and 
repair proteins with the full list outlined in Supplemental Table 1. Both the processivity clamp 
PCNA (spPcn1) and the single-strand binding protein RPA are identified as co-purifying with 
spExo5. To further test this interaction we obtained antibodies against the S. pombe Ssb1 
(RPA70) and Pcn1 (PCNA) proteins. Indeed both RPA and PCNA are detected by western blot 
analysis in the Exo5 co-IPs but not in the controls, and the interaction is not mediated through 
DNA as treatment with DNase I does not eliminate these interactions (Figure 2B, C). The results 
from these Co-IP experiments identify spExo5 as possibly being involved at the replication fork 
through its interaction with the processivity clamp PCNA and RPA, but further work will be need 
to characterize this interaction. Exo5 does not have an apparent PCNA interaction motif and the 
PCNA interacting motif is within Exo5 is still unknown. The RPA interaction seems to be 
conserved from S. pombe to humans, but we still need to determine if spRPA loading on ssDNA 
has the same effect on Exo5 by enforcing a 5’-3’ directionality on the exonuclease activity as 
seen with the human homologs. We hypothesize these interactions are relevant in vivo and is 
consistent with Exo5 being involved in DNA replication and repair in the nucleus. 
 
Overexpression of Exo5 in S. pombe leads to checkpoint activation and cell death by titrating 
away RPA and PCNA from their function in replication. 
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 Concomitant with our spExo5-co-IP experiments we made the observation that 
overexpression of spExo5 was lethal to the cells and this lethality was not due to the nuclease 
activity of the protein, as demonstrated by overexpression of a nuclease-deficient mutant 
(D207A) showed similar lethality (Fig 3A). Examination of the cell morphology revealed that the 
cells are elongated, which is indicative of checkpoint activation in S. pombe (Fig 3B). The 
checkpoint is mediated through the Rad3 (ATR) kinase, where by overexpression of spExo5 in a 
rad3∆ background eliminates the cell elongation phenotype, but does not suppress the lethality of 
overexpression (Fig 3A, B). We hypothesized that overexpression of spExo5 mediated 
checkpoint activation and lethality could be the result of titrating away an essential replication 
factor from performing its essential function during replication. To test this hypothesis we made a 
series of point mutation in spExo5 to look for mutations that suppressed the lethality of 
overexpression. Two motifs in the N-terminus of the protein are found to be essential for the 
lethality of overexpression of spExo5 (Fig 3C). First, we noticed the very N-terminus of the 
protein has an acidic patch from amino acid 2-11 where there are three sets of di-acidic amino 
acids, and mutating any set of these di-acidic pairs to alanines suppresses the checkpoint 
activation and lethality of overexpression of Exo5 (Fig 3C, D). Recently a di-acidic motif was 
identified in several proteins that mediate the interaction with the basic cleft of the F-domain of 
RPA70 (Frank, Vangamudi et al. 2014). More work will be needed to determine if this motif in 
Exo5 is the RPA binding surface. The other motif that is essential for both checkpoint activation 
and lethality of Exo5 occurs just prior to the first cystiene of the iron-sulfur cluster (Fig 3C). 
Mutation of either Y74A or D79A also suppresses both the checkpoint activation and lethality of 
overexpression (Fig 3C, D). A co-immunoprecipiation experiment demonstrates that these 
mutations disrupt the ability of Exo5 to pull-down both RPA and PCNA as shown by western 
blot analysis (Fig 3E). The results from our experiments indicate that there may be two RPA 
interacting domains in spExo5. Our data would be consistent with a model where overexpression 
of Exo5 leads to squelching of the free RPA and PCNA in the cell, blocking some essential 
function that causes checkpoint activation and ultimately cell death. Further studies will be 
needed in order to fully characterize these interactions.  
 
S. pombe Exo5 is important for DNA repair. 
In order to determine possible spExo5 DNA repair pathways, we carried out in vivo 
survival assays to various DNA damaging agents using exo5Δ strains. We detect no sensitivity to 
γ-irradiation (Sup. Fig 1A), however the deletion strain is sensitive to UV-irradiation (Fig 4B), 
alkylating agents (Fig 4B,C), and crosslinking agents such as cis-platin (Fig 4B) and 8-
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methoxypsoralen (Fig 4A). Remarkably, these results largely recapitulate the results from the 
knockdown experiments in human cells (Sparks, Kumar et al. 2012). These results differ from the 
results of experiments in S. cerevisiae exo5∆ strains where no sensitive was observed to any DNA 
damaging agents tested (Burgers, Stith et al. 2010). These results allowed us to use S. pombe as a 
genetic tool to look for genetic interactions with known components of various DNA repair 
pathways that spExo5 might be involved. 
 We followed the damage sensitivity experiments by conducting a large set of epistasis 
experiments with deletions of known DNA repair genes. The results of these experiments are 
outlined in Supplementary Table 2. In S. pombe, rad2+ (FEN1) nuclease is required for Okazaki 
fragment maturation and long patch base-excision repair (Liu, Kao et al. 2004). Construction of a 
rad2∆ exo5∆ deletion reveals a synthetic sickness phenotype, even in absence of DNA damage 
treatment (Fig 5A). Treatment of the rad2∆ exo5∆ strain with either MMS or cis-platin reveals 
strong hypersensitivity to these DNA damaging agents that is consistent with a synergistic 
interaction (Fig 4C). Experiments with exo1+, the multifunctional nuclease Exo1, showing partial 
redundancy for mismatch repair, double strand break repair, Okazaki fragment maturation, and 
interstrand crosslink repair (Tran, Erdeniz et al. 2004; Barber, Ward et al. 2005; Mimitou and 
Symington 2009); additionally, pso2+, a nuclease required for interstrand crosslink repair 
(Lambert, Mason et al. 2003), reveals a strong hypersensitivity of the exo1Δ exo5Δ double mutant 
to UV-irradiation and MMS (Fig. 4B), and of exo1Δ exo5Δ and the pso2Δ exo5Δ double mutants 
to cis-platin (Fig. 4B,D). Experiments with hrq1+ the S. pombe ortholog of the human RecQ4L 
helicase, that is involved in NER and ICL repair, reveals hypersensitivity of the hrq1∆ exo5∆ 
mutant to cis-platin (Fig 4E). In contrast, we find little or no enhancement in damage sensitivity 
when the exo5Δ deletion combines with mre11Δ, rad13Δ, slx1∆, fan1∆, fml1∆, mus81∆, swi10∆, 
rhp51∆, rqh1∆, or uve1Δ (Supp. Fig. 1, 2, 3; Supp. Table 1). The results from these experiments 
are consistent with exo5+ playing a redundant role with rad2+ in DNA metabolism, even in the 
absence of exogenous DNA damage. The genetic interactions observed with exo5+ and exo1+, 
pso2+ or hrq1+ are consistent with additive interactions indicating these proteins are in different 
pathways that target different DNA lesions. These experiments are not sufficient when it comes 
to determining in what pathway or pathways Exo5 may be involved given that many pathways 
can utilize several different nucleases to accomplish the same function, making a clear, genetic 
delineation of the role of a specific nuclease difficult. Nevertheless, the integral role nucleases 
have in maintaining the genome can be appreciated from the degree of redundancy that is 
inherent in DNA repair pathways.  
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 In S. pombe there are at least three distinct redundant pathways for repair of ICLs. One 
pathway was shown to involve fan1+, fml1+, and rhp51+, a second requires pso2+, rad13+, and 
rhp51+, and a third is dependent on the E3-sumo ligase pli1+ (Fontebasso, Etheridge et al. 2013). 
Our data is consistent with these previously published results, and we have expanded these 
pathways (Fig 2A,B). We made triple and quadruple mutants to attempt to overcome the inherent 
redundancies of the nucleases in these pathways (Supp. Fig 2, 3, 4). Our results indicate that Hrq1 
and Swi10-Rad16 are epistatic with the Pso2-dependent ICL repair pathway and non-epistatic 
with the Fan1-dependent pathway (Supp. Fig 3A, B). Experiments with Rqh1, the BLM homolog 
in S. pombe, demonstrate synergistic sensitivity to cis-platin when combined with the Fml1 
helicase of the Fan1 dependent pathway (Supp. Fig 3C). On the other hand, we observe that Slx1 
and Exo1 are epistatic with the Fan1 pathway and non-epistatic with the Pso2 pathway (Supp. Fig 
2A, 4). The pathway that utilizes Exo5 is still unclear. The exo5∆ is epistatic with the Fan1 
pathway including Fan1 and Fml1 (Supp. Fig 2), but is also epistatic with several proteins in the 
Pso2 pathway including Swi10 and Rad13 (Supp. Fig 2, 3). It may be possible that Exo5 is 
involved in the Pli1 pathway, but more experiments are necessary to test that hypothesis. These 
experiments further delineate the proteins involved in either the Pso2 or Fan1 pathways of ICL 
repair, and builds context to place Exo5 in the repair of ICLs. Our proposed model for how these 
proteins fit into the previously characterized pathways of ICL repair are outlined in Figure 6A, B. 
 
S. pombe Exo5 and Rad2 play a redundant role in mitochondrial DNA metabolism. 
A proteomic localization study indicated both nuclear and mitochondrial localization for 
S. pombe Exo5 (Matsuyama, Arai et al. 2006). S. pombe is a petite negative yeast which requires 
a functional mitochondrial genome for growth (Haffter and Fox 1992). S. pombe exo5Δ strains 
are viable, indicating that spExo5 is not absolutely required for mitochondrial genome stability. 
Indeed, an exo5Δ strain transformed with an exo5+-containing plasmid grows indistinguishable 
from one transformed with a control vector on media containing glycerol as the non-fermentable 
carbon source (Fig 5A). Creation of an exo5∆ rad2∆ reveals a negative genetic interaction 
between exo5+and rad2+, leading to the double-deletion strains showing synthetic sickness at all 
temperatures tested (Fig 5B). Further analysis reveals that the double mutant fails to grow on 
plates containing glycerol as the sole carbon source (Fig 5C). Exogenous expression of exo5+(Fig 
5C) or rad2+ (data not shown) restores the growth of these strains on glycerol plates, and this 
restoration requires the nuclease activity of Exo5 (Fig 5C). 
S. pombe Exo5 contains several internal methionines that could serve as alternative 
translational start sites. Previously, human FEN1 was shown to have an alternative translation 
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start site leading to a short FEN1 isoform, and this shorter isoform is physiologically relevant and 
specifically localizes to the mitochondria, whereas the full-length protein localizes to the nucleus 
(Kazak, Reyes et al. 2013). When we express spExo5 in cells we observe two prominent Exo5 
bands by western blotting analysis; the first is consistent with the predicted molecular weight of 
spExo5-3XFLAG protein (51 kDa), but the lower band is consistent with a protein starting at 
methionine 58 (44 kDa) (Fig 2D). Expression of exo5-M58A mutant with methionine 58 changed 
to an alainine eliminates the detection of the shorter isoform by western blot, and expression of an 
N-terminal truncation mutant exo5-(58-409) is the correct molecular weight and is consistent with 
the lower isoform starting at methionine 58 (Fig 2D). Surprisingly, the expression of the short 
isoform (exo5-(58-409)) is able to restore growth of the exo5∆ rad2∆ on glycerol plates, but 
expression of exo5-M58A mutant, which eliminates the translation of the short spExo5 isoform, 
does not restore growth. This result indicates that the short isoform is important for mitochondrial 
genome maintenance but the full-length protein is dispensable (Fig 5C). These data support a 
model in which the short isoform, derived from the internal start at methionine 58, is localized to 
the mitochondria (mitochondrial isoform) and full-length spExo5 isoform is not based on the fact 
that the M58A mutant is not able to restore growth on glycerol plates (nuclear isoform). It is also 
interesting that neither of the mutants, neither the mitochondrial isoform nor the M58A mutant, 
fully complement the DNA-damage sensitivity of the exo5∆ rad2∆ (Fig 5C). Futher investigation 
is needed to determine the localization of these isoforms by microscopy.  
Restriction digestion of total DNA from exo5∆ rad2∆ strains reveal the ~10-fold loss of 
mitochondrial DNA in these strains compared to the wild type strain, demonstrating that Exo5 
and Rad2 are important for mitochondrial DNA metabolism (Fig 5D). The results from these 
experiments establish a redundant function in the mitochondria of Exo5 and Rad2, and 
demonstrate that two isoforms of Exo5 are produced in S. pombe, with the short isoform starting 
at methionine 58 is important for mitochondrial DNA metabolism. 
 
DISCUSSION 
 The data presented here indicates that S. pombe is a good model system to study the in 
vivo function of Exo5, and that these studies have the potential to give insight into the function of 
the human enzyme. The similarity between the sliding activity of the human and S. pombe 
enzyme indicates that this activity may be conserved and may have functional implications that 
are still unclear. The identification of both the single-strand DNA binding protein complex RPA 
and processivity clamp PCNA could support a model where Exo5 is involved at the replication 
fork, but more work will be needed to test this model. The RPA interaction appears to be 
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conserved from humans to S. pombe (Sparks, Kumar et al. 2012). There are two motifs that are 
important for this interaction. First is an acidic patch at the extreme N-terminus of the protein and 
the second is a hydrophobic patch in the vicinity of the first cysteine of the iron-sulfur complex. It 
still needs to be determined if this interaction is required for its function in DNA metabolism. The 
PCNA interacting motif is unclear in Exo5, with the protein not containing a canonical PCNA 
interacting motif (PIP). It will be important to investigate the physiological role these interactions 
play in the in vivo function of Exo5.  
 S. pombe has provided a good genetic tool for investigating the DNA repair pathways 
that Exo5 may play a role. The DNA damage sensitivity of an exo5∆ strain closely recapitulates 
the hExo5 knockdown experiments in human cells. The exo5∆ strains were particularly sensitive 
to DNA damaging agents that require replication-coupled repair including interstrand cross-
linking agents. The epistasis analysis is giving us the first glimpse of the pathways in which Exo5 
is involved. The exo5∆rad2∆ mutants show synergistic interactions, which is consistent with 
these proteins working in different pathways that target the same lesions. Rad2 (FEN1) is 
required for Okazaki fragment maturation and long patch base-excision repair (Liu, Kao et al. 
2004). It is possible that, similarly to the exonuclease/helicase Dna2, Exo5 plays a redundant 
function in Okazaki fragment maturation when ssDNA flaps become bound by RPA and Rad2 is 
no longer able to act (Murante, Rust et al. 1995; Bae, Bae et al. 2001; Ayyagari, Gomes et al. 
2003; Kao, Veeraraghavan et al. 2004). Much is known about the nuclear function of Rad2, but 
very little is known about mitochondrial function of this enzyme. Exo5 and Rad2 play an 
essential redundant function in the mitochondria in S. pombe. The exo5∆rad2∆ strain has a ten-
fold depletion of the mitochondrial DNA that leads to its inability to grow on plates with glycerol 
as the sole carbon source. Exogenous expression of either of these proteins restores growth on 
glycerol leading to a model where these proteins may play a redundant role in mitochondrial 
DNA replication or repair. One issue is the lack of understanding of the mechanism of 
mitochondrial replication in S. pombe. Both enzymes are single-strand specific exonucleases that 
may be required to remove single-strand DNA flaps during mitochondrial DNA replication. 
Another interesting aspect of the mitochondrial function of spExo5 is the apparent use of an 
alternative translation start at methionine 58, and the human Exo5 protein has a methionine that is 
similar to the S. pombe methionine 58. It is a possibility that the human enzyme has this 
conserved alternative translation start site that makes a shorter variant of the enzyme that is 
specific for localization to the mitochondria. It is also interesting that the short isoform still 
maintains all the cysteines required for forming the iron-sulfur cluster. Futher work will be 
needed to determine the function of these enzymes in the mitochondria.  
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 Exo5 deficient strains are sensitive to interstrand crosslinking agents such as cis-platin 
and 8-methyoxypsoralen. The repair of ICLs has only recently been investigated in S. pombe. 
These studies have begun to delineate the pathways for repair of ICLs, but there are still many 
questions that need to be investigated. There are at least three pathways that have been identified 
in S. pombe for ICL repair. One of these pathways involves the nuclease Fan1 and the helicase 
Fml1, which are Fanconi anemia homologs; the second pathway is dependent on the nuclease 
Pso2 and the nucleotide excision repair endonuclease Rad13 (XPG); the third pathway requires 
the sumo ligase Pli1 (Fontebasso, Etheridge et al. 2013). Exo5 is epistatic with the proteins of the 
Fan1 dependent pathway of repair and is non-epistatic with the Pso2 nuclease. Although Exo5 is 
epistatic with the Rad13 and Swi10-Rad16 endonucleases that are a part of the Pso2 dependent 
pathway, it is still a possibility that Exo5 is involved in the Pli1 dependent pathway. The Pli1 
pathway of repair has not been studied to date. There are also many other DNA repair proteins 
that have been implicated in ICL repair that have not been tested for their role in these pathways. 
We demonstrate that Exo1 is the multifunctional exonuclease (Tran, Erdeniz et al. 2004; Barber, 
Ward et al. 2005; Mimitou and Symington 2009) and Slx1, an endonuclease that forms a complex 
with Slx4, are epistatic with the Fan1 pathway and non-epistatic with the Pso2 pathway and 
indicating these proteins function with Fan1 in the repair of ICLs. On the other hand, Swi10-
Rad16 (XPF), an endonuclease of the NER pathway that has been shown in Xenopus laveis egg 
extracts to be essential for the unhooking step of ICL repair (Klein Douwel, Boonen et al. 2014), 
and the RecQ helicase Hrq1, involved in nucleotide excision and ICL repair (Groocock, Prudden 
et al. 2012), are epistatic with the Pso2 pathway and non-epistatic with the Fan1 pathway. These 
genetic interactions expand the proteins that are involved in these two pathways of ICL repair 
(Fig 6). Further work will be needed to establish the pathway of ICL repair that involves Exo5.  
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EXPERIMENTAL PROCEDURES 
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DNA damaging agents. Drugs used were all from SIGMA: cis-platin (diamminecis-platinum(II) 
dichloride), cat. no. P4394; methyl methanesufonate (MMS), cat. no. 129925; 8-MOP (8-
methoxypsoralen), cat. no. M3501. 
S. pombe strains. The exo5Δ strain was obtained from Bioneer Corporation. Double disruption 
mutants were obtained by crossing the exo5Δ strain with strains containing other repair gene 
disruptions. Genotypes of the double deletion strains were confirmed by diagnostic PCR. 
Plasmids and oligonucleotides. Plasmid pBL281 (S. pombe), pBL277 (human), and pBL282 
(mouse) contains the Schistosoma japonicum glutathione S-transferase (GST) gene fused to the N 
terminus of the Exo5 gene in vector pRS424-GALGST (Walker, Crowley et al. 1993). The GST 
tag is separated from the N terminus of the S. pombe, human, and mouse Exo5 gene by a 
recognition sequence for the human rhinoviral 3C protease (LEVLFQ/GP). Following cleavage 
by the protease, the N-terminal sequence of S. pombe Exo5 is extended with the GPEF sequence. 
Plasmid pBL281-207 has an active site mutation D207. Plasmid pBL281-176 has an active site 
mutation D716A. S. pombe expression plasmids pREP3x-spExo5 with spExo5 under the control 
of the strong nmt promoter. Plasmids and sequences are available upon request. 
Oligonucleotides were purchased from IDT (Coralville, IA) and purified by urea-
polyacrylamide gel electrophoresis (PAGE): c81, TTGCCGATGAACTTTTTTTTT 
TGATCGAGACCTT; v81 AAGGTCTCCATCAAAAAAAAAAGTTCATCGGCAA. The 5’-
32P-label was introduced on oligonucleotides c81 or 5’-5’ polarity switch oligonucleotide using 
[γ-32P] ATP and T4 Polynucleotide kinase. While the 3’-32P-label was added to 3’-3’ polarity 
switch oligonucleotide by incubation with [α-32P] dATP with terminal deoxynucleotide 
transferase under manufacturers’ conditions. 
Exo5 overproduction and purification.  Overproduction was carried out in S. cerevisiae strain 
FM113 (MATa ura-3-52 trp1-289 leu2-3112 prb1-1122 prc1-407 pep4-3) transformed with 
plasmid pBL277 (human Exo5), pBL281 (S. pombe Exo5-), pBL281-207 (S. pombe Exo5-
D207A), pBL281-176 (S. pombe Exo5-D176), or pBL282 (mouse Exo5). Growth, induction, and 
extraction were similar to the procedures described previously (Bylund, Majka et al. 2006). Cells 
were harvested and resuspended in 1/2 the volume of 3x buffer A (buffer A: 60 mM HEPES-
NaOH [pH 7.8], 0.4 M sodium acetate, 0.1 mM EDTA, 0.005% polyoxyethylene (10) lauryl 
ether, 50 mM sodium bisulfite, 50 µM pepstatin A, 50 µM leupeptin), then frozen in liquid 
nitrogen. The frozen cell pellets were then blended in dry ice powder. All further preparation was 
carried out at 0-4 ˚C. After the thawing of the lysate, 10% glycerol, 1 mM dithiothreitol (DTT), 
0.05 mM phenylmethylsufonyl fluoride (100 mM stock), and 150 mM ammonium sulfate (4 M 
stock), 0.45 % polymin P (10% stock, pH 7.3) were added to the lysate. The mixture was stirred 
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for 15 minutes, the lysate was cleared at 40,000 × g for 30 minutes, and the supernatant was 
precipitated with 0.31 g/ml solid ammonium sulfate. The precipitate was collected at 40,000 × g 
for 30 minutes and then redissolved in buffer A0 (subscript indicates the sodium acetate 
concentration) 10% glycerol, and 1 mM dithiothreitol until the lysate conductivity was equal to 
that of buffer A400. The lysate was then used for batch binding to 1 ml of glutathione-Sepharose 
4B beads (GE Healthcare), equilibrated with buffer A400, and gently rotated at 4 ˚C for two hours. 
GST-beads were collected at 1,000 rpm in a swinging-bucket rotor, followed by batch washes (3 
× 20 ml of buffer A400). The beads were transferred to a 10 ml column, and washed at 2.5 ml/min 
with 100 ml of buffer A400. The second washing was with 50 ml buffer A400 containing 5 mM 
Mg-acetate and 1 mM ATP. And the third washing used 50 ml of buffer A400 and 30 ml of buffer 
A200. Elution was carried out with a flow rate of 0.2 ml/min with buffer A200 containing 20 mM 
glutathione (pH adjusted to 8.0). The protein was eluted into four fractions. Fractions containing 
Exo5 were combined and diluted with buffer A0 to equal buffer A100, then loaded onto a 1-ml 
MonoQ column. Protein was eluted with a linear gradient of buffer A100 to A1200. The fractions 
containing pure protein were incubated over night at 4 ˚C with 30U of rhinoviral 3C protease, and 
diluted with A0 to equal A100, loaded on a 1-ml Mono Q column. Pure Exo5 protein was eluted at 
300mM to 400mM sodium acetate. Exo5 mutants were purified similarly throughout the 
procedures described. 
SpExo5 Co-immunoprecipitation 
Co-IPs were carried out in S. pombe strain PYP102 (exo5∆) by transformation of pREP3x-
spExo5 or mutant. Cells were grown in Edinburgh minimal media supplemented with 5mM 
thiamine overnight. Cells were then harvested and resuspended in 1/2 the volume of 3x buffer A 
(buffer A: 60 mM HEPES-NaOH [pH 7.8], 150 mM sodium chloride, 0.1 mM EDTA, 0.05% 
polyoxyethylene (10) lauryl ether, 10 mM sodium bisulfite, 10 µM pepstatin A, 10 µM 
leupeptin), then frozen in liquid nitrogen. The frozen cell pellets were then blended in dry ice 
powder. All further preparation was carried out at 0-4 ˚C. After the thawing of the lysate, 10% 
glycerol, 1 mM dithiothreitol (DTT), and 0.5 mM phenylmethylsufonyl fluoride (100 mM stock) 
were added to the lysates. The lysates were cleared at 40,000 × g for 30 minutes, and the cleared 
lysate was then used for batch binding to FLAG-M2-beads (SIGMA), equilibrated with buffer 
A150, and gently rotated at 4 ˚C for two hours. FLAG-M2-beads were collected at 1,000 rpm in a 
swinging-bucket rotor, followed by batch washes (3 × 500 µl of buffer A150). The second washing 
was with 500 µl buffer A150 containing 5 mM Mg-acetate and 1 mM ATP. And the third washing 
used (3 × 500 µl of buffer A150). Elution was carried out in buffer A150 containing 150 µg/ml 
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3XFLAG peptide (SIGMA). The protein was eluted into two fractions and analyzed by SDS-
PAGE followed by comassie Brilliant Blue staining. 
Exonuclease assays. The standard 10 µl assay mixture contains 100 mM Tris-HCl (pH 7.8), 500 
µg/ml bovine serum albumin, 5 mM DTT, 5 mM Mg-acetate, 50 mM NaCl, 50-100 fmol of 32P-
end-labeled oligonucleotide substrate, and enzyme. Incubations were carried out at 30 ˚C for the 
indicated time periods. Deviations for the standard assay conditions are indicated in the legends 
of the figures. Reactions were stopped with 10 mM final concentration of EDTA in addition to 
40% formamide and analyzed on a 17% PAGE-7 M urea electrophoresis. After the gels were 
dried they were subjected to phosphorImager analysis. 
S. pombe damage sensitivity assays. Strains were inoculated in 5 ml of liquid yeast extract 
supplemented (YES) medium and grown overnight at 30 ºC with shaking. The cells were then 
washed in phosphate-buffered saline and the cell density was determined by spectroscopy at 
595nm. Serial dilutions were carried out and plated on YES plates supplemented with various 
genotoxic agents, or irradiated with UV or X-rays. The plates were then incubated for 2-3 days at 
30 ºC. 
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Figure 1. SpExo5 is a bi-directional ssDNA specific exonuclease that slides along ssDNA 
prior to cleavage. (A) Comparison of activity of human, mouse, and S. pombe Exo5 on 34-
nucleotide oligonucleotide. Standard assay mixtures used 10 nM 5’-32P-labeled cexo81 a 34-
nucleotide ssDNA substrate. The concentration of human Exo5 from left to right are 1.5, 5, 15, 
50, 150 nM; mouse Exo5 from left to right are 1.5, 5, 15, 50, 150 nM; S. pombe Exo5 from left to 
right are 0.15, 0.5, 1.5, 5, 15 nM. The reactions were carried out at 30 ˚C for 4 min. The results 
were analyzed on a 7 M urea-17% polyacrylamide gel. (B) Comparision of activity of S. pombe 
and S. cerevisiae Exo5 on polarity switch poly-dT oligonucleotide. Standard assays conditions 
containing 10nM concentration of 5’-labeled (dT)65 or double 5’-ended (dT)70, or 3’-labeled 
double 3’-ended (dT)70 were incubated with 0.5, 0.15, 5, or 15 nM spExo5 for 30 s or with 0.05, 
0.15, 5, or 15 nM S. cerevisiae (S. cer) Exo5 for 30 s at 30 °C. Controls contained DNA 
polymerase Polδ. All samples were analyzed on 7 M urea-18% polyacrylamide gels and 
quantified by phosphorimaging. The asterisks indicate the position of the 32P label. (C) Activity 
of S. pombe Exo5 catalytic dead mutants on 34-nucleotide oligonucleotide. Standard assay 
mixtures used 10 nM 5’-32P-labeled cexo81 a 34-nucleotide ssDNA substrate. The concentration 
S. pombe Exo5 from left to right are 0.15, 0.5, 1.5, 5, 15 nM. The reactions were carried out at 30 
˚C for 4 min. The results were analyzed on a 7 M urea-17% polyacrylamide gel. (D) Dependence 
of hExo5 and spExo5 molar activity on DNA concentration. Data were fit to a Michaelis-Menten 
model. For spEXO5, Km = 26 ± 2.2 nM and Vmax = 60 ± 1.5 min-1; for hEXO5, Km = 3,200 ± 
800 nM and Vmax = 0.7 ± 0.1 min-1. 
 
Figure 2. SpExo5 physically interacts with spRPA and spPCNA in vivo. (A) Co-IP of 
spExo5-3XFLAG from S. pombe. Co-IP elution were analyzed on a 10%-SDS PAGE gel and 
stained with comassie brilliant blue. The red boxes indicate sections cut out of gel and sent for 
mass spectrometry footprinting. (B) Western analysis of co-IP samples either treated or mock 
treated with DNaseI. Antibodies used against 3XFLAG (spExo5) (SIGMA), spSSB1 (Hiroshi 
Iwasaki lab), and spPcn1 (Santa Cruz). Elutions were analyzed on a 10%-SDS PAGE gel and 
transferred to a PVDF membrane for western analysis. (C) DNase I control. Plasmid DNA was 
either incubated with mock treated or DNase I treated co-IP and sample was analyzed on a 1% 
agarose gel stained with ethidium bromide. (D) spExo5 mutant expression comparison by western 
analysis. spExo5-3XFLAG mutants were IP using FLAG-M2-beads (SIGMA) and elutions were 
analyzed by western analysis. 
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Figure 3. Overexpression of SpExo5 causes checkpoint activation and cell death mediated 
through interaction with spRPA and spPCNA. (A) Overexpression of spExo5 leads to cell 
death in S. pombe cells regardless of checkpoint proficiency. Cells either WT or rad3∆ containing 
pREP3x-spExo5 or pREP3x-spExo5-D207A were grown overnight in EMM-leu supplemented 
with 5µM thiamine. Cells were washed serially diluted on plates either containing 15 µM or 0 
µM thiamine and incubated 2-3 day at 30 ˚C. (B) Light microscopy of cells from (A) either 
grown on plates containing 15 µM or 0 µM thiamine for 2-3 days. (C) SpExo5 amino acid 
sequence illustrating point mutations used in (D). Point mutations are indicated by arrows and an 
A indicating the amino acid was change to an alanine. (D) Mutations that suppress the checkpoint 
activation and cell death of overexpression of spExo5. exo5∆ cells containing pREP3x-exo5+ or 
exo5 mutants were grown overnight in EMM-leu supplemented with 5µM thiamine. Cells were 
washed serially diluted on plates either containing 15 µM or 0 µM thiamine and incubated 2-3 
day at 30 ˚C. (E) Suppressor mutations eliminate spExo5 interactions with RPA and PCNA. Co-
IP elutions from expression of spExo5-3XFLAG or mutants was run on 10% SDS-PAGE gels 
and transferred to PVDF membrane for western analysis against 3XFLAG, ssb1, or Pcn1. 
 
Figure 4. Exo5 genetic interactions. (A) Sensitivity of exo5∆ or pso2 strains to acute psoralen 
treatment. Cells were grown to an OD of 0.4 and then either mock treated (-) with water or with 5 
µg/ml 8-MOP (+) and cells incubated for 15 minutes at 30 ˚C. Following incubation with 8-MOP, 
cells were irradiated with 365 nm light to activate the 8-MOP for various time point. The cells 
were then washed twice with PBS buffer and diluted for spotting on rich media (YES) plates. (B) 
Epistasis experiment using exo5∆, exo1∆, and exo5∆exo1∆ S. pombe strains as indicated, testing 
sensitivity to UV-irradiation, MMS and cis-platin. Cells were spotted in ten-fold dilutions (C) 
Epistasis experiment using exo5∆, rad2∆, and exo5∆rad2∆ S. pombe strains as indicated, testing 
sensitivity MMS and cis-platin. Cells were spotted in ten-fold dilutions (D) Epistasis experiment 
investigating interaction of exo5+ and pso2+, testing the sensitivity of the strains to cis-platin. (E) 
Epistasis experiment investigating interaction of exo5+, exo1+, and hrq1+, testing the sensitivity 
of the strains to cis-platin. (F) Graphic representation of the genetic interactions revealed in this 
study between spExo5 and other known DNA repair proteins. The arrows indicate epistatic 
interactions, arrows with + indicate additive interactions, and arrows with side arrow indicate 
synergistic interactions. 
 
Figure 5. A short isoform of Exo5 and the Rad2 play an essential redundant function in 
mitochondrial genome maintenance. (A) exo5∆ strain transformed either with vector or 
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pREP3x-spExo5 streaked on YEG plates and grown for 7 days at 30 ˚C (B) Epistasis experiment 
using exo5∆, rad2∆, and exo5∆rad2∆ S. pombe strains as indicated, testing growth on YES plates 
at various temperatures. Cells were spotted in ten-fold dilutions (C) Epistasis experiment using 
exo5∆, rad2∆, and exo5∆rad2∆ S. pombe strains transformed with either pREP3x, pREP3x-
spExo5, pREP3x-spexo5-D207A, pREP3x-spexo5-M58A, pREP3x-spexo5-58-409 as indicated, 
testing sensitivity to cis-platin and YEG. Cells were spotted in ten-fold dilutions (D) Genomic 
DNA digested with xhoI, nheI, mluI, and ageI; followed by analysis on a 0.6% agarose gel and 
ethidium bromide staining. 
 
Figure 6. Model for ICL repair and possible role of spExo5 and overview of spExo5 genetic 
interactions. Described in the text. 
 
SUPPLEMENTAL INFORMATION 
 
Supplemental Table 1. Mass spectrometry fingerprint of Exo5 Co-IP. Results acquired from 
co-IP of interacting proteins of spExo5-3XFLAG in Figure 2. 
 
Supplemental Table 2. Genetic interactions matrix revealed by epistasis analysis. Data 
collected from epistasis experiments are outlined in this table. (++) Indicates synergistic 
interaction, (L) Lethal interaction, (+) indicates additive interactions, (-) indicates epistatic 
interactions, and (n.t.) indicates that the interaction was not tested. 
 
Supp. Figure 1. Epistasis analysis. (A) Epistasis experiment using exo5∆, mus81∆, and 
exo5∆mus81∆ S. pombe strains as indicated, testing sensitivity to cis-platin. Cells were spotted in 
ten-fold dilutions. (B) Epistasis experiment using exo5∆, exo1∆, and exo5∆exo1∆ S. pombe 
strains as indicated, testing sensitivity to ionizing radiation. Cells were spotted in ten-fold 
dilutions. (C) Epistasis experiment using exo5∆, rhp51∆, and exo5∆rhp51∆ S. pombe strains as 
indicated, testing sensitivity to MMS. Cells were spotted in ten-fold dilutions. (D) Epistasis 
experiment using exo5∆, mre11∆, and exo5∆mre11∆ S. pombe strains as indicated, testing 
sensitivity to ionizing radiation. Cells were spotted in ten-fold dilutions. (E) Epistasis experiment 
using exo5∆, rad13∆, and exo5∆rad13∆ S. pombe strains as indicated, testing sensitivity to UV-
irradiation and cis-platin. Cells were spotted in ten-fold dilutions. (F) Epistasis experiment using 
exo5∆, uve1∆, and exo5∆uve1∆ S. pombe strains as indicated, testing sensitivity to UV-
irradiation. Cells were spotted in ten-fold dilutions. 
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Supp. Figure 2. SpExo5 is Epistatic with Fan1 pathway and non-epistatic with Pso2. (A) 
Epistasis experiment using exo5∆, fan1∆, pso2∆, exo1∆, and the pair wise double and triple 
mutants and the quadruple mutant S. pombe strains as indicated, testing sensitivity to cis-platin. 
Cells were spotted in ten-fold dilutions. (B) Epistasis experiment using exo5∆, exo1∆, fml1∆, 
pso2∆, and all the pair wise double and triple mutant S. pombe strains as indicated, testing 
sensitivity to cis-platin. Cells were spotted in ten-fold dilutions. 
 
Supp. Figure 3. Genetic interactions with Exo5, Hrq1, Slx1, and Rqh1. (A) Epistasis 
experiment using exo5∆, hrq1∆, pso2∆, exo1∆, fan1∆, fml1and the pair wise double mutant S. 
pombe strains as indicated, testing sensitivity to cis-platin. Cells were spotted in ten-fold 
dilutions. (B) Epistasis experiment using exo5∆, swi10∆, exo1∆, fml1∆, pso2∆, fan1∆ and the pair 
wise double and triple mutant S. pombe strains as indicated, testing sensitivity to cis-platin. Cells 
were spotted in ten-fold dilutions. (C) Epistasis experiment using exo5∆, rqh1∆, fml1∆, and the 
pair wise double mutant S. pombe strains as indicated, testing sensitivity to cis-platin. Cells were 
spotted in ten-fold dilutions. 
 
Supp. Figure 4. Genetic interactions with Exo5, Fml1, and Slx1. (A) Epistasis experiment 
using exo5∆, slx1∆, fml1and the pair wise double mutant S. pombe strains as indicated, testing 
sensitivity to cis-platin. Cells were spotted in ten-fold dilutions. 
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 Supplementary Table 1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Table 2 
 
 
 
 
 
 Exo5 Fan1 Rad2 Exo1 Fml1 Swi10 Rad13 Rhp51 Pso2 Slx1 Hrq1 Rqh1 Mus81 Mre11 
Exo5  - ++ + - - - - + - + - - - 
Fan1 -  n.t. - - ++ ++ n.t. ++ n.t. n.t. n.t. n.t. n.t. 
Rad2 ++ n.t.  L n.t. n.t. n.t. n.t. n.t. n.t. n.t. L n.t. n.t. 
Exo1 + - L  - n.t. n.t. n.t. ++ n.t. - n.t. n.t. n.t. 
Fml1 - - n.t. -  ++ ++ n.t. ++ - ++ ++ n.t. n.t. 
Swi10 - ++ n.t. n.t. ++  - n.t. - n.t. n.t. n.t. n.t. n.t. 
Rad13 - ++ n.t. n.t. ++ -  n.t. - n.t. n.t. n.t. n.t. n.t. 
Rhp51 - - n.t. n.t. n.t. n.t. n.t.  - n.t. n.t. n.t. n.t. n.t. 
Pso2 + ++ n.t. ++ ++ - - -  n.t. - n.t. n.t. n.t. 
Slx1 - n.t. n.t. n.t. - n.t. n.t. n.t. n.t.  n.t. n.t. n.t. n.t. 
Hrq1 + n.t. n.t. - ++ - n.t. n.t. - n.t.  n.t. n.t. n.t. 
Rqh1 - n.t. L n.t. ++ n.t. n.t. n.t. n.t. n.t. n.t.  n.t. n.t. 
Mus81 - n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t.  n.t. 
Mre11 - n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t. n.t.  
Score Protein Name MW % Coverage 
Upper 
Band    
616 Exo5  48365 53.3 
412 DNA replication factor A subunit Ssb1 68154 41.1 
123 AAA family ATPase Rvb1 50021 12.1 
102 AAA family ATPase Rvb2 51529 22.4 
86 AAA family ATPase Cdc48 90069 8.8 
42 single-stranded telomeric binding protein Tgc1 37980 16.9 
25 TFIIH regulator Mms19 114597 0.9 
21 crm1-N1 protein 123650 0.7 
Lower 
Band    
1000 Exo5  48365 54.3 
266 14-3-3 protein Rad24 30357 29.5 
190 14-3-3 protein Rad25 30350 24.4 
174 DNA polymerase delta processivity factor 28951 42.7 
160 single-stranded DNA binding protein Ssb2 30372 45.5 
71 Rim1 17129 25.3 
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Reconstitution of RNase H2-initiated Ribonucleotide Excision Repair (RER) 
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 PREFACE TO THE CHAPTER 
 This chapter of the dissertation discusses the phenomenon of ribonucleotide incorporation 
into the genome by replicative polymerases, and how a pathway initiated by the heterotrimeric 
enzyme RNase H2 repairs these non-canonical bases. Section IIIA relates the study of 
ribonucleotide incorporation and repair by biochemical reconstitution of the system in vitro using 
a 7.3 kb primed single-strand plasmid. The rate of incorporation by either Polδ or Polε is 
approximately two-rNMPs per kilobase replicated. The RNase H2 dependent pathway of repair 
of genomic rNMPs requires RNase H2 to cleave at the ribonucleotide, and RNase H1 is unable 
to complement for RNase H2. It also requires the replication machinery RFC, PCNA, and either 
Polδ or Polε. Additionally, it requires either FEN1 or Exo1 to perform strand displacement 
synthesis along with the polymerases, and finally DNA ligase to close the nick. Peter Burgers 
and I performed all the biochemical assays for this work. Other labs provided purified protein, 
Robert Crouch’s lab provided RNase H2 and RNase H1 and Eric Johansson provided purified 
Polε for this study. 
 Section IIIB of this chapter describes how the different functions of RNase H2 contribute 
to the phenotype of an RNase H2 deletion in yeast. Making mutants of RNase H2 that are either 
only able to process single-rNMPs or sites of multiple-rNMPs (R-loops) allow for correlation of 
the two functions with different phenotypes of RNase H2 deletion in S. cerevisiae. RNase H2’s 
ability to process single-rNMPs from the genome is responsible for preventing small deletions at 
di-nucleotide repeats in the genome; RNaseH2’s ability to process sites of multiple-rNMPs is 
important in the context of an sgs1∆ in yeast. I contributed one of the biochemical assays and 
analysis with Peter Burgers’ assistance for the attached paper. 
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SUMMARY
Ribonucleotides are incorporated into DNA by the
replicative DNA polymerases at frequencies of about
2 per kb, which makes them by far the most abun-
dant form of potential DNA damage in the cell. Their
removal is essential for restoring a stable intact chro-
mosome. Here, we present a complete biochemical
reconstitution of the ribonucleotide excision repair
(RER) pathway with enzymes purified from Saccha-
romyces cerevisiae. RER is most efficient when the
ribonucleotide is incised by RNase H2, and further
excised by the flap endonuclease FEN1 with strand
displacement synthesis carried out by DNA poly-
merase d, the PCNA clamp, its loader RFC, and com-
pleted by DNA ligase I. We observed partial redun-
dancy for several of the enzymes in this pathway.
Exo1 substitutes for FEN1 and Pol ε for Pol d with
reasonable efficiency. However, RNase H1 fails to
substitute for RNase H2 in the incision step of RER.
INTRODUCTION
DNA polymerases show an extraordinary ability to distinguish
deoxyribonucleotide from ribonucleotide precursors for DNA
replication (reviewed in Joyce [1997]). Replicative DNA polymer-
ases typically show a specificity ratio of 104-105 (rNTPs
incorporated per dNTP incorporated). However, because the
cellular concentrations of rNTPs in yeast are estimated to be
10- to 100-fold higher than those of dNTPs (Nick McElhinny
et al., 2010b), the actual misincorporation of ribonucleotides
into genomic DNA is likely to be much higher as well and could
reach ratios on the order of 103. Compared to a deoxyribonucle-
otide, a ribonucleotide has a reactive 20 hydroxyl on the sugar
moiety that renders the DNA backbone more susceptible to
strand cleavage. This could potentially reduce genome stability
and affect its replication during a subsequent cell cycle (Nick
McElhinny et al., 2010a; Watt et al., 2011). Therefore, repair
mechanisms exist to deal with ribo-damage. The one initiated
by ribonuclease H2 (RNase H2), called ribonucleotide excision
repair (RER), is considered to be the most common repair
pathway.
Ribonuclease H enzymes cut RNA/DNA hybrids. RNase H1 is
most active on RNA/DNA hybrids containing several consecutive
ribonucleotides, and no incision activity has been observed on
a DNA substrate with a single embedded ribonucleotide (Cerri-
telli and Crouch, 2009). Consecutive RNA residues are not
expected to result from the occasional, stochastic insertion of
ribonucleotides by DNA polymerases, or at least these occur-
rences should be extremely rare. On the other hand, RNase H2
shows prominent activity on a single ribonucleotide embedded
within double-stranded DNA (Eder and Walder, 1991; Rychlik
et al., 2010). RNase H2 incises the DNA 50 of the ribonucleotide,
generating DNA containing 30-hydroxyl and 50-phospho-ribonu-
cleotide ends (see Figure 4). This product is expected to be
an ideal substrate for the Okazaki fragment maturation system
that normally deals with 50-RNA-terminated DNA fragments
(Burgers, 2009), however, whether repair actually proceeds by
this or a similar pathway remains to be determined. Ribonucleo-
tide-containing DNA can also be incised by Topoisomerase I
(Kim et al., 2011; Sekiguchi and Shuman, 1997), whose reaction
mechanism proceeds through a 30-phospho-tyrosyl interme-
diate. If this covalent intermediate is localized at the ribonucleo-
tide, it can be resolved aberrantly through nucleophilic attack by
the vicinal 20-OH group resulting in the generation of a 20-30-
cyclic phosphate with concomitant release of Topo I generating
a single-strand break. Currently, it is not clear whether or how
these cyclic phosphate intermediates are processed. However,
based on genetic analysis in yeast, Topo I-mediated cleavage
is likely a minor pathway for ribo-repair (Kim et al., 2011).
Mutations in RNase H2 are associated with Aicardi-Goutie`res
syndrome, an autosomal recessive disorder. Patients have pro-
gressive microencephaly and show complex neurological de-
fects in motor function and altered interferon response (Crow
et al., 2006). However, defects in other enzymes, such as the
30-exonuclease TREX1 (Stetson et al., 2008), and SAMHD1, a
dNTP triphosphatase (Powell et al., 2011), also cause Aicardi-
Goutie`res syndrome, making a direct connection between the
syndrome and ribonucleotide excision repair less straightfor-
ward. A homozygous null mouse for RNase H2 shows embryonic
lethality at the gastrulation stage of development (Reijns et al.,
2012). On the other hand, yeast RNase H2 null mutants are
viable. Nonetheless, growth defects and even lethality result
980 Molecular Cell 47, 980–986, September 28, 2012 ª2012 Elsevier Inc.
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when a rnh201Dmutation is combined with other defects in DNA
metabolism (Budd et al., 2005; Lazzaro et al., 2012).
Ribonucleotide excision repair (RER) initiated by RNase H2
has so far not been studied in a reconstituted, purified system.
Earlier studies in crude yeast extracts already implicated RNase
H2 and the flap endonuclease FEN1 in RER. Reduced incision at
a ribonucleotide in DNA was observed in extracts from strains
with a deletion of RNH201, encoding the catalytic subunit of
RNase H2, or a deletion of RAD27, encoding FEN1 nuclease
that is involved in Okazaki fragment maturation (Rydberg and
Game, 2002). However, these studies did not identify additional
components of the repair pathway. Here, we present a complete
biochemical analysis of the RER pathway with recombinant
proteins. We used, as substrate for RER, DNA replicated by
the replicative DNA polymerases in reactions containing physio-
logical concentrations of dNTPs and rNTPs, rather than using
preformed DNA substrates with embedded ribonucleotides. In
this fashion, context effects due to the use of a specific oligonu-
cleotide substrate are eliminated, and events that are most likely
to occur during DNA replication are substrates for RER. Our data
show (1) that ribonucleotide misincorporation during leading and
lagging strand DNA replication in vitro is comparable; (2) that
RNase H2-initiated RER can be efficiently reconstituted with
FEN1, Pol d, PCNA, and DNA ligase I; and (3) that RER shows
redundancy for both the nuclease and the DNA polymerase
involved in the repair pathway.
RESULTS
The cellular concentrations of each of the dNTP and rNTPs under
normal growth conditions have been determined (Nick McEl-
hinny et al., 2010b). The rNTP/dNTP ratios range from 35 for
[CTP]/[dCTP] up to almost 200 for [ATP]/[dATP]. When we exam-
ined the probability of stable ribonucleotide incorporation by
replicative DNA polymerases at these physiologically relevant
rNTP/dNTP ratios using defined oligonucleotide template primer
as substrates, we found that sequence contexts greatly affected
rNMP incorporation probabilities at individual nucleotide posi-
tions (Nick McElhinny et al., 2010a). Therefore, in this study, to
examine RER of true ribonucleotide replication errors, we first
determined the frequency of ribonucleotide incorporation during
the replication of a 7.3 kb long single-stranded (ss) viral DNA
template (ssM13mp18) under physiological rNTP and dNTP
concentrations. Under these conditions, many sequence con-
texts should be sampled, including those most likely to be
made during replication, and a mean distribution of ribonucleo-
tide incorporation can be obtained. We carried out this analysis
with both the leading strand polymerase, Pol ε, and the lagging
strand polymerase, Pol d, under conditions of processive DNA
replication by interaction of the polymerase with the replication
clamp PCNA (proliferating cell nuclear antigen). The replicated
DNA was treated with 0.3M NaOH at 55C, which cleaves DNA
at the ribonucleotide positions, and sized by electrophoresis
on a denaturing agarose gel.
Replication of the viral ssM13mp18 DNAwith or without rNTPs
was compared. The ssDNA was coated with yeast RPA in all
experiments. Replication assays without rNTPs actually con-
tained 100 mM ATP, in order to effect efficient loading of PCNA
by its clamp loader replication factor C (RFC), which is an ATP-
dependent process. Replication assays with rNTPs contained
a total of 5.9 mM rNTPs, and additional magnesium was added
so that the free magnesium concentration in the assay remained
the same. Inclusion of rNTPs in the replication assay reduced the
rate of processive replication by Pol d or by Pol ε to about 40%
(Figure S1A). However, complete replication of the entire 7.3
kb M13mp18 circle was accomplished after 6 min by Pol d,
and after 15 min by Pol ε (Figure S1B). Alkaline treatment of
M13mp18 circles replicated by either Pol d or by Pol ε without
rNTPs showed no sensitivity to alkali as indicated by the pres-
ence of predominantly full-length products (Figure 1A). In sharp
contrast, M13mp18 circles replicated in the presence of physio-
logical rNTPs were sensitive to treatment with alkali, resulting in
a broad distribution of products. In order to convert the radioac-
tivity distribution into product length distribution, the radioac-
tivity distribution was divided by the length distribution in kb.
From this normalized distribution, the median length of alkali-
stable DNA produced by Pol d was determined at 0.61 kb and
was not significantly different from that produced by Pol ε (0.54
kb, Figure 1B). The average frequency of ribonucleotide incorpo-
ration can be obtained by also taking into consideration that the
maximum linear product length is 7.3 kb and, second, the
Figure 1. Ribonucleotide Incorporation during DNA Synthesis
(A) Primed RPA-coated SS-M13mp18 DNA was fully replicated by either
Pol d or Pol ε with PCNA under standard conditions, with or without rNTPs
(Experimental Procedures). Replication products were alkali treated and
separated on an alkaline agarose gel.
(B) The radioactivity distribution was scanned and divided by the DNA size
distribution to obtain a normalized molar product distribution (see Supple-
mental Information for details).
(C) The standard assay (lane 3) was modified in lane 1 to omit PCNA and RFC,
reduce salt to 20 mM NaCl, increase Pol d from 3 nM to 500 nM, and increase
the incubation time from 8 min to 3 hr. In lane 2 the standard assay was
modified to reduce salt to 20 mM. See also Figure S1.
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presence of incompletely replicated molecules that skew the
distribution to a lower size. After taking these factors into consid-
eration (see Supplemental Information), the resulting average
rNMP insertion frequency is 1 per 720 nt for Pol d and 1 per
640 nt for Pol ε. In several experiments, this average rNMP inser-
tion frequency varied from 1 per 0.6–0.9 kb.
These misincorporation values by the two replicative DNA
polymerases are significantly higher than previously determined
on oligonucleotide templates (Nick McElhinny et al., 2010b). In
our previous oligonucleotide system, replication was carried
out by the polymerase without accessory factors present. In
the current system, the ssDNA is coated with the yeast single-
stranded DNA binding protein RPA, and processive replication
is performed by either the PCNA-Pol d or PCNA-Pol ε complex.
To assess whether PCNA affected ribonucleotide misincorpora-
tion frequencies, we carried out replication by Pol d without
PCNA (Figure 1C). In order to get full-length synthesis of the
M13mp18 template by Pol d alone, we had to reduce the salt
concentration from 100 to 20 mM NaCl and increase enzyme
concentration and incubation time (Figure S1C). No significant
differences in rNTP misincorporation were observed between
Pol d alone and the processive PCNA-Pol d complex at 20 mM
NaCl, when compared to the standard assay at 100 mM NaCl
(Figure 1C).
RER Requires RNase H2 and FEN1
A previous study showed defects in the incision of ribonu-
cleotide-containing DNA in extracts from strains deleted for
RNH201 and RAD27 (Rydberg and Game, 2002). Specifically,
the incision step at the ribonucleotide position was severely in-
hibited in rnh201D extracts, while the subsequent liberation of
this ribonucleotide was attenuated in rad27D extracts. However,
actual repair of the DNA was not demonstrated in this study. To
establish a reconstituted RER assay with purified proteins, we
set up a two-stage repair assay (Figure 2). In the first step, ss-
M13mp18 DNA was replicated by the PCNA-Pol d complex at
physiological dNTP and rNTP concentrations resulting in the
average incorporation of 10 ribonucleotides per circle. Iden-
tical controls were carried out without rNTPs. In the second
step, RNase H2, FEN1, and DNA ligase I were added. The prod-
ucts were analyzed by neutral agarose electrophoresis in the
presence of ethidium bromide, which detects completely repli-
cated covalently closed circles (top panel), and by alkaline
agarose gel electrophoresis, after alkaline digestion of the repli-
cation products (bottom panel).
Replication of M13mp18 DNA with or without rNTPs yielded
full-length products (Figure 2, top, lanes 1 and 6), that matured
into covalently closed circular molecules upon addition of
FEN1 and DNA ligase I, indicating that the nicked product was
matured and sealed with high efficiency (top, lanes 2 and 7).
When challenged with alkali, only the DNA replicated in the pres-
ence of rNTPs was digested to smaller size products (bottom,
compare lanes 2 and 7). Complete repair was achieved by add-
ing RNase H2, which yielded full-length alkali-stable products
comparable to those made in the absence of rNTPs (compare
lane 10 with 5). Addition of RNase H2 had no effect on the alkali
stability of replication products made without rNTPs (compare
lanes 2 and 5). Additional controls show that all three enzymes,
RNase H2, FEN1, and DNA ligase are required in order for any
detectable repair. A mutant form of RNase H2, containing the
catalytically dead Rnh201-D39A mutation, was completely de-
fective for RER (Figure S2). Therefore, each of the 10 ribonu-
cleotides present in fully replicated M13mp18 DNA required
the action of RNase H2, FEN1, and DNA ligase I in order to incise
the ribo-containing DNA, remove the ribonucleotide by nick
translation with FEN1 and Pol d, and finally seal the nick by
DNA ligase.
Role of PCNA in RER
All four enzymes involved in RER show interactions with
PCNA. PCNA mediates processive DNA synthesis by Pol d and
increases the nuclease efficiency of FEN1 (Li et al., 1995). On
the other hand, DNA ligase I binds PCNA, but ligation efficiency
is not significantly enhanced by PCNA (Vijayakumar et al., 2007).
Rather, the PCNA-binding domain of DNA ligase aids in local-
izing the enzyme to replication foci (Montecucco et al., 1998).
RNase H2 is a three-subunit enzyme. The largest subunit is the
catalytic subunit, and the second subunit has a PCNA-binding
Figure 2. Ribonucleotide Excision Repair Assay
Primed RPA-coated SS-M13mp18 DNA was fully replicated by Pol d with
PCNA under standard conditions with or without rNTPs. After 8 min at 30C,
RNase H2, FEN1, and DNA ligase I were added as indicated, and incubation
continued for 4min. Each reaction was split in two, and one half was separated
on a 1% agarose gel in the presence of 0.5 mg/ml of ethidium bromide; the
other half was treated with 0.3 M NaOH. The products were recovered by
ethanol precipitation and separated on a 1% alkaline agarose gel. Migration
positions of nicked circles and covalently closed circles on the neutral agarose
gel (top panel) are indicated. Migration positions of circular ssDNA (a), linear
ssDNA (b), and denatured forms of dsDNA (c) on the alkaline agarose gel
(bottom panel) are indicated. See also Figure S2.
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domain with unknown function (Chon et al., 2009). The PCNA-
binding domain of RNase H2 is essential for localizing it to repli-
cation foci in mammalian cells (Bubeck et al., 2011). The activity
of an archaeal form of RNase H2 that also contains a PCNA-
interaction motif is stimulated by PCNA (Bubeck et al., 2011).
However, in model studies with oligonucleotides, we failed to
see such stimulation for either the yeast or the human enzyme
by its cognate PCNA (Chon et al., 2009).
In order to test the potential importance of PCNA in RER, we
synthesized ribonucleotide-containing DNA as described above,
isolated the DNA, and then used this substrate in a subsequent
assay with Pol d, RNase H2, FEN1, DNA ligase, either with or
without PCNA (and its loader RFC) present. In parallel, the
same assay was carried out with RNase H2 lacking the PCNA-in-
teracting motif (DPIP). While PCNA greatly stimulated RER, we
observed no dependence on the PCNA-interacting motif of
RNase H2 (Figure 3A). Sometimes, a role for PCNA in stabilizing
the factor under investigation can be revealed by carrying out the
assay under suboptimal conditions, e.g., at low concentrations
of the factor and/or at high salt. However, under limiting condi-
tions for RNase H2, at which all other factors were saturating
and the rate of DNA repair was dependent on the RNase H2
concentration, both mutant and wild-type RNase H2 showed
a comparable inhibition of the rate of DNA repair at increasingly
higher concentrations of NaCl (Figure S3). We conclude that
either RNase H2 can access the ribonucleotide substrate effi-
ciently without prior interaction with PCNA, or that our studies
have failed to reveal a functional interaction in vitro.
RNase H1 Does Not Substitute for RNase H2 in RER
Both RNase H1 and RNase H2 incise RNA-containing DNA;
however, while RNase H2 incises efficiently at single ribonucleo-
tide positions, RNase H1 is only active on double-stranded DNA
containing three of more consecutive ribonucleotides (Tadokoro
and Kanaya, 2009). Potentially, interactions of RNase H1 with
other repair factors might aid in promoting incision at single ribo-
nucleotides. Therefore, we compared the efficiency of RNase
H1 and RNase H2 in RER. RNase H1 was completely defective
in promoting RER, even at the highest concentrations tested
(Figure 3B).
FEN1 and Exo1, and Pol d and Pol ε Show Redundancy
for RER
In our proposed scheme for RER, nick translation is an impor-
tant step in removing the incised ribonucleotide residue (Fig-
ure 4). Exo1 can partially substitute for FEN1 during Okazaki
fragment maturation, as both nucleases can promote nick trans-
lation by Pol d (Stith et al., 2008; Tran et al., 2002). Indeed,
substituting FEN1 by Exo1 in the RER reaction allowed
complete repair of misincorporated ribonucleotides (Figure 3C).
However, the rate of repair promoted by FEN1 was about 2- to
3-fold that of Exo1. In contrast, Dna2 nuclease, which only acts
on long 50-flaps, is completely defective for RER. This agrees
with our understanding of Dna2 function during Okazaki frag-
ment maturation, wherein long flaps trimmed by Dna2 still
require further processing by FEN1 (Burgers, 2009). Similarly,
Pol ε can also function in Okazaki fragment maturation, albeit
less efficiently than Pol d (Garg et al., 2004). In a reconstituted
reaction, Pol ε carried out RER at a rate about half of that of
Pol d (Figure 3D).
DISCUSSION
Here we have reconstituted, for the first time, the excision repair
of ribonucleotides in a highly purified system. Our results extend
a previous study that used crude extracts to show incisions at
single ribonucleotides in DNA by RNase H2 and FEN1. We
demonstrate complete and efficient repair of ribonucleotides
incorporated into DNA by the major leading and lagging strand
replicases for the nuclear genome. The basic mechanism out-
lined in Figure 4 shows an employment of PCNA, Pol d, FEN1,
and DNA ligase that is analogous to that used during Okazaki
Figure 3. Factor Requirements and Redundancies in RER
(A–D) Primed RPA-coated SS-M13mp18DNAwas fully replicated by Pol dwith
PCNA under standard conditions with rNTPs for 8min. In panels (A) and (D), the
replicated DNA was isolated and purified, and the DNA incubated in a second
reaction with: (A) RPA, RFC, Pol d, RNase H2 or RNase H2-DPIP, FEN1, DNA
ligase I, and the indicated concentrations of PCNA for the times indicated; (D)
RPA, PCNA, RFC, RNase H2, FEN1, DNA ligase I, and either Pol d or Pol ε for
the indicated times. In panels (B) and (C), the replication reaction was sup-
plemented with: (B) FEN1, DNA ligase I, and the indicated concentrations of
either RNaseH1 or RNaseH2 for 10min; (C) RNaseH2, DNA ligase I, and either
no nuclease, FEN1, Exo1, or Dna2 for the times indicated. The products were
treated with alkali and separated on an 1% alkaline agarose gel. In (A), the
median product distributionwas determined as in Figure 1B and Supplemental
Information. See also Figure S3. The SE for two independent experiments is
given.
Molecular Cell
RNase H2-Initiated Ribonucleotide Excision Repair
Molecular Cell 47, 980–986, September 28, 2012 ª2012 Elsevier Inc. 983
86
fragment maturation or during PCNA-dependent base-excision
repair (Matsumoto, 2001). Repair is absolutely dependent on
RNase H2, and RNase H1 does not substitute for RNase H2.
However, both enzymes contribute to genome stability (Lazzaro
et al., 2012), indicating that RNase H1 has a role in processing
RNA-DNA substrates other than a single embedded ribonucleo-
tide, and that a defect in this role results in cellular stress. For
example, R-loops formed during transcription, or a stretch of
several consecutive ribonucleotides left on the DNA as a result
of incorrect maturation of Okazaki fragments would require the
activity of RNase H1 in a rnh201D mutant.
On the other hand, there is redundancy for DNA polymerase
and nuclease activities in RER. The observed redundancy
between FEN1 and Exo1 for RER would indicate that RAD27
(FEN1) mutants should not be defective for RER, yet a defect
in RER was observed in extracts from a rad27D strain (Rydberg
and Game, 2002). Possibly, since Exo1 has a very low abun-
dance compared to FEN1 (Ghaemmaghami et al., 2003) and is
very sensitive to proteolysis (Fiorentini et al., 1997), extracts
may have been largely deficient for Exo1, thereby emphasizing
a dependence of FEN1. Our data suggest that after a first
cleavage by RNase H2 in a PCNA-independent manner, PCNA
is required for nick translation by Pol d and FEN1, which is the
coupling of strand displacement synthesis by the polymerase
with flap cutting by the nuclease (Figure 4).
The incorporation of a relatively large percentage of ribonucle-
otides into DNA during DNA replication has only recently been
appreciated (Nick McElhinny et al., 2010b). They can be consid-
ered ‘‘damage’’ because they are only weakly proofread during
replication by Pol ε (Williams et al., 2012) and because, in the
absence of RNase H2-dependent repair, they result in 2–5
base pair deletions that are independent of DNAmismatch repair
(Clark et al., 2011). Ribonucleotides represent by far the largest
pool of potential DNA damage in the cell. Based on our current
data, indicating one ribonucleotide incorporation event per
0.7 kb replicated by either Pol d or Pol ε (Figure 1B), 50,000
ribonucleotides would be incorporated during each yeast cell
cycle. Are all of these repaired in an RNase H2-dependent
pathway? If so, then alkali treatment of DNA isolated from a
RNase H2 deletion strain should produce products of a similar
size. One study showed a broad distribution of alkali-sensitive
Figure 4. Model for Ribonucleotide Excision
Repair
Redundant functions of FEN1 with Exo1 and Pol
d with Pol ε are indicated. See text for details.
sites in the yeast chromosomal DNA
isolated from an rnh201D strain that
centered in the 2–20 kb range (Nick McEl-
hinny et al., 2010a). Interestingly, a higher
frequency of alkali-sensitive sites was de-
tected in a double mutant of rnh201Dwith
a Pol ε mutant that in vitro was shown to
display an increased frequency of ribonu-
cleotide incorporation. Importantly, chro-
mosomal DNA isolated from a strain that
is wild-type for RNase H2 is much less alkali-labile, indicating
that RNase H2 is critical for the repair of ribonucleotides in DNA.
There are two potential reasons why the in vivo occurrence of
alkali-sensitive sites in chromosomal DNA from a rnh201D strain,
1 per several kb, is less than the in vitro occurrence, 1 per 0.7
kb. First, the local concentration of dNTPs at replication foci
could be higher than that of the overall cellular concentration
that we used in this study, e.g., through the localization of
dNTP precursor enzymes at replication sites. Currently, this
idea lacks conclusive experimental support, either in yeast or
in human cells (Lee and Elledge, 2006; Pontarin et al., 2008).
Second, alternative repair systems may exist for the repair of
ribonucleotides. Topoisomerase I can incise ribonucleotide-
containing DNA, via the covalent 30-phosphotyrosyl linkage
formed at the ribose moiety, into a 20,30-cyclic phosphate termi-
nated chain (Kim et al., 2011; Sekiguchi and Shuman, 1997). In
the cell, this intermediate can be aberrantly processed to yield
2–5 nt deletions within short tandem repeats, suggesting that
topoisomerase I may initiate a secondary pathway that can ulti-
mately result in ribonucleotide removal. The enzymes that act
downstream of Topoisomerase 1 to ultimately repair ribonucleo-
tides with consequent mutagenesis are as yet unknown. The
complexity of processing ribonucleotides in DNA is further
revealed by the fact that survival of yeast in the absence of
both RNase H1 and H2 partly depends on two lesion tolerance
pathways, Rad5-dependent template switching, and translesion
synthesis by Pol z (Lazzaro et al., 2012). This is interesting, given
our evidence here that RNase H1 does not initiate repair of ribo-
nucleotides incorporated by Pols d and ε in vitro. Collectively, the
results suggest that the cytotoxic lesions in strains defective in
both yeast RNases H could be (1) an R-loop formed during tran-
scription (Huertas and Aguilera, 2003); (2) a stretch of several
consecutive ribonucleotides placed into DNA during priming of
Okazaki fragments or perhapsmore rarely by aDNApolymerase;
or (3) multiple interrupted ribonucleotides incorporated by a DNA
polymerase within a short tract of DNA.
EXPERIMENTAL PROCEDURES
Proteins
Sources are listed in Supplemental Information.
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RER Assay
The repair assay is generally carried out in two stages. In the first stage, single-
stranded M13mp18 DNA is replicated at physiological cellular concentrations
of rNTPs and dNTPs. After replication is complete, the DNA is either isolated or
the second stage is initiated without prior isolation, by addition of factors
required for RER. Stage 1: The standard 40 ml assay contained 30 mM Tris-
HCl, pH 7.8, 13 mMmagnesium-acetate, 0.2 mg/ml of bovine serum albumin,
1 mM dithiothreitol, 100 mM NaCl, 16 mM dATP, 14 mM dCTP, 12 mM dGTP,
30 mM dTTP, 3000 mM ATP, 500 mM CTP, 700 mM GTP, and 1700 mM UTP.
[a-32P] dATP was added as radioactive tracer. In ‘‘dNTPs only’’ assays,
100 mM ATP replaced all rNTPs, and the Mg concentration was lowered to
8 mM. Further additions were 60 fmol of singly primed single-stranded
M13mp18 DNA (the 36-mer primer is complementary to nt 6330–6295), 15
pmol of replication protein A (RPA), 600 fmol PCNA as trimer (3 pmol for
assays with Pol ε), and 120 fmol of replication factor C (RFC). Reactions
were assembled on ice, preheated at 30C for 1 min, and initiated by addition
of 120 fmol of Pol d or Pol ε. After 8 min (20 min for Pol ε), when replication
was complete, either the RER enzymes (FEN1, DNA ligase 1, and RNase H2
as detailed below) were added, or the reaction was stopped with 0.3%
SDS and 20 mM EDTA, heated at 55C for 10 min, and purified by phenol/
chloroform extraction and ethanol precipitation. The DNA was then dissolved
in the same assay mixture (buffer/Mg/dNTPs/rNTPs/NaCl), and the follow-
ing RER enzymes were added for Stage 2: 5 pmol RPA, 600 fmol PCNA, 120
fmol RFC, 120 fmol Pol d, 120 fmol FEN1, and 600 fmol DNA ligase 1. After
preheating to 30C for 30 s, the reaction was initiated with 120 fmol of
RNase H2. Aliquots were stopped with 0.3% SDS and 20 mM EDTA and incu-
bated at 54C for 10 min. 2.5 M NaOH was added to 0.3 M final, and after 2 hr
incubation at 55C in order to hydrolyze the DNA at ribonucleotide positions,
the reaction was cooled, 2 M acetic acid was added to 0.4 M, ammonium
acetate to 1 M, carrier DNA to 10 mg/ml, 2 mg of glycogen, and 2 volumes of
ethanol. After cooling at 20C for 20 min, the DNA was spun down for
20 min at 17,000 3 g, and the pellet was washed with 70% ethanol, dried,
and redissolved in TE with 0.1% SDS/50 mM NaCl. The samples were
analyzed by electrophoresis on a 1% alkaline agarose gel at 1.3 V/cm for
16 hr. The gel was neutralized, dried, and analyzed by Phosphorimaging.
Size distribution determinations were carried out as described in Supple-
mental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at http://dx.doi.org/10.1016/j.molcel.2012.06.035.
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EXPERIMENTAL PROCEDURES 
Proteins - RPA (Henricksen et al., 1994), PCNA (Eissenberg et al., 1997), RFC (Gomes et al., 2000), FEN1 
(Gomes and Burgers, 2000), RNase H1 (Cerritelli et al., 1993), and RNase H2 (Jeong et al., 2004), and RNase 
H2 mutants (Chon et al., 2009) were purified from E. coli overexpression systems, while Pol  (Fortune et al., 
2006), Pol  (Chilkova et al., 2003), Dna2 (Ayyagari et al., 2003), Exo1 (Gelperin et al., 2005), and DNA ligase 
(Ayyagari et al., 2003) were purified from yeast overexpression systems. 
 
Determination of average ribonucleotide misincorporation frequency - This frequency follows from the 
median size of alkali-resistant replication products. First, the radioactivity distribution, between 10 kb and 0.2 
kb, was divided up in ~500 segments and the radioactivity value in each segment divided by the size of the 
DNA in each segment (determined from size markers). This essentially converts the radioactivity distribution 
into a size distribution of alkali-resistant DNA molecules, from which the median length of the DNA population 
can be determined. Second, we need to account for the presence of a nick in the completely replicated DNA, and 
for DNA breakage due to alkaline treatment and handling that is unrelated to the presence of incorporated 
ribonucleotides.  Since the size distributions, on a neutral gel, of M13mp8 DNA replicated with or without 
rNTPs are the same (Fig. S1B), the median size of alkali-resistant replication products synthesized without 
rNTPs forms a suitable control. From this we can determine the frequency of ribonucleotide incorporation as: 
 
a=median size with dNTPs, b=median size with dNTPs + rNTPs.  
rNTP incorporation frequency = a/(a/b - 1). 
 
Under the conditions used:  
for Pol : a = 4.1 kb, b = 0.61 kb --> rNTP incorporation frequency = 1/720 
for Pol : a = 3.5 kb, b = 0.54 kb --> rNTP incorporation frequency = 1/640 
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SUPPLEMENTARY FIGURES 
 
 
 
 
 
 
Fig. S1. Associated with Fig. 1. Replication of M13mp18 DNA in the presence of rNTPs. (A) rNTPs slow 
down replication rates.  DNA replication assays were carried out as described in Materials and Methods under 
standard conditions with PCNA and either Pol  or Pol , with or without rNTPs. Aliquots were taken and acid-
precipitable radioactivity determined. (B,C) Complete replication of M13mp18 DNA. (B) Selected aliquots 
from (A) were electrophoresed on a 1% agarose gel.  Note the decrease in the size of replication products at the 
early time points in the presence of rNTPs. Marker positions are SS-M13mp18 DNA and nicked DS-M13mp18 
DNA, and gapped DS-M13mp18 DNA, as shown. (C) The standard assay (lane 3) contains dNTPs plus rNTPs, 
100 mM NaCl, 1.5 nM primed M13mp18 DNA, RPA, 15 nM PCNA, 3 nM RFC and 3 nM of Pol  for 8 min. In 
lane 1, PCNA and RFC were omitted, NaCl was reduced to 20 mM, Pol  increased to 500 nM, and the 
incubation time to 180 min. In lane 2, the assay was the same as standard except for 20 mM NaCl. Replication 
products were analyzed on a 1% neutral agarose gel (shown here), or digested with NaOH and analyzed on an 
alkaline agarose gel (shown in Fig. 1C). Marker positions are as indicated. 
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Fig. S2. Associated with Fig. 2. RER requires the catalytic function of RNase H2. 
Primed M13mp18 DNA was replicated with dNTPs plus rNTPs, RPA, PCNA, RFC 
and Pol  for 8 min. Then FEN1, DNA ligase and either wild-type RNase H2 or 
catalytic-dead RNase H2-D39A was added as indicated, and incubation continued for 
an additional 4 min. Replication products were digested with NaOH and analyzed on 
an 1% alkaline agarose gel. Size markers are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S3. Associated with Fig. 3. The PCNA-interaction motif 
of RNase H2 is not required for efficient RER. Primed 
M13mp18 DNA was replicated with dNTPs plus rNTPs, RPA, 
PCNA, RFC and Pol  for 8 min. Then, the indicated levels of 
NaCl were added followed by 3 nM FEN1, 15 nM DNA ligase I, 
and 0.6 nM RNase H2 or RNase H2-PIP, and incubation 
continued for 3 min. Replication products were digested with 
NaOH and analyzed on an 1% alkaline agarose gel. Size markers 
are shown. 
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ABSTRACT
Ribonuclease H2 (RNase H2) protects genome in-
tegrity by its dual roles of resolving transcription-
related R-loops and ribonucleotides incorporated
in DNA during replication. To unlink these two func-
tions, we generated a Saccharomyces cerevisiae
RNase H2 mutant that can resolve R-loops but
cannot cleave single ribonucleotides in DNA. This
mutant definitively correlates the 2–5bp deletions
observed in rnh201D strains with single rNMPs in
DNA. It also establishes a connection between
R-loops and Sgs1-mediated replication reinitiation
at stalled forks and identifies R-loops uniquely pro-
cessed by RNase H2. In mouse, deletion of any of
the genes coding for RNase H2 results in embryonic
lethality, and in humans, RNase H2 hypomorphic
mutations cause Aicardi–Goutie`res syndrome
(AGS), a neuroinflammatory disorder. To determine
the contribution of R-loops and rNMP in DNA to the
defects observed in AGS, we characterized in yeast
an AGS-related mutation, which is impaired in pro-
cessing both substrates, but has sufficient R-loop
degradation activity to complement the defects of
rnh201D sgs1D strains. However, this AGS-related
mutation accumulates 2–5bp deletions at a very
similar rate as the deletion strain.
INTRODUCTION
RNA and DNA worlds are not entirely separated and
frequently come together during replication and transcrip-
tion, forming transient RNA–DNA structures that when
become stable can jeopardize genome integrity. These
structures can be divided into two groups: (i) RNA, con-
sisting of one or more ribonucleotides, covalently attached
to DNA and opposite to DNA (RpD/DNA) and (ii) RNA
opposite to DNA (RNA/DNA, later referred as RpR/
DNA), in vivo as part of an R-loop or reverse transcripts
(1–3). The former are present during replication, as part of
the primers for lagging strand synthesis, or when
ribonucleotides are erroneously incorporated into DNA
by the replicative polymerases, which, if not removed,
leads to mutagenesis (4–6). R-loops are formed during
transcription when the RNA exiting the RNA polymerase
fails to associate with the posttranscriptional machinery
and instead remains annealed to the DNA (7–9). R-loops
have the template DNA strand annealed to the RNA,
whereas the other DNA strand is in a single-stranded
form. Stable R-loops constitute a barrier to transcription
and replication fork progression; stalling replication and
inducing fork collapse (10,11).
Ribonucleases H (RNase H) comprise a group of
enzymes devoted to the removal of both types of
RNA–DNA structures. There are two main classes of
RNases H, grouped by primary sequence and substrate
specificity (12). Type 1 RNases H are able to cleave
R-loops (RpR/DNA), but because the enzyme recognizes
the RNA via contacts with the 20-OH residues of four
ribonucleotides, they are unable to hydrolyze single
rNMPs (13). Type 2 RNases H recognize the transition
from ribonucleotide to deoxyribonucleotide (RpD),
hydrolyzing at the 50-end of the ribonucleotide, leaving it
attached to the 50-end of the DNA (14). Eukaryotic
RNases H2 cleave both RpD/DNA and RpR/DNA struc-
tures with similar efficiencies, in contrast to bacterial
RNases H2, which have a clear preference for RpD sub-
strates (15). Both types of RNases H are dispensable for
viability in bacteria and single-cell eukaryotes (16,17)
although genomic instability increases in their absence
(18). In higher eukaryotes, both enzymes are essential.
RNase H1 is present in nuclei and mitochondria, and it
is necessary for mitochondrial DNA replication (19).
RNase H2 has been associated with ribonucleotide
removal from genomic DNA in yeast and mouse, where
it is required for embryonic development (20,21).
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Mutations in the three genes encoding human RNase H2
(Hu-RNase H2) leads to Aicardi–Goutie`res syndrome
(AGS), a severe neuroinflammatory disorder, with charac-
teristics similar to in utero viral infection (22).
The crystal structure of Thermotoga maritima RNase
H2 (Tm-RNase H2) in complex with a DNA containing
a single ribonucleotide revealed the crucial role of a
conserved tyrosine in the recognition and hydrolysis of
the RpD structure (23). This residue displaces the strand
to be cleaved and positions the phosphate between the
ribose and deoxyribose to coordinate one of the two
divalent metal ions required for catalysis. This displace-
ment could not occur efficiently with an RpR structure,
and accordingly Tm-RNase H2 cleaves RNA/DNA
hybrids very poorly. The conserved Tyr in eukaryotic
RNases H2 may have a slightly different position
allowing both RpD and RpR cleavages.
Some organisms, such as Bacillus stearothermophilus,
have two proteins with primary amino acid sequences
(Figure 1A) and three-dimensional structures similar to
type 2 RNases H (24). However, one (RNase H2) has
enzymatic properties similar to bacterial RNases H2,
recognizing an RpD transition and cleaving 50 of the
ribonucleotide attached to DNA, whereas the other
(RNase H3) has properties similar to RNases H1,
requiring a short string of ribonucleotides for hydrolysis.
We reasoned that we could use the cocrystal structure of
Tm-RNase H2 as a guide to superimpose the structure of
B. stearothermophilus RNase H3 (Bst-RNase H3) and
thereby identify the residues involved in single and
multiple rNMPs recognition. Using our model, we made
changes in the catalytic subunit of Saccharomyces
cerevisiae RNase H2 (Sc-Rnh201) to create an enzyme
that retains the ability to hydrolyze RpR/DNA hybrids
but is unable to cleave RpD substrates. Constructing
such a mutant allowed us to unlink the two activities of
RNase H2 and assign in vivo phenotypes to each activity.
MATERIALS AND METHODS
Modeling the structure of Bst-RNase H3 in complex with
substrates
To model a structure of Bst-RNase H3 in complex with a
substrate, we used the crystal structures of Bst-RNase H3
(PDB: 2D0B), human RNase H1 in complex with RNA/
DNA hybrid (PDB: 3PUF) and Tm-RNase H2 in complex
with duplex DNA containing single ribonucleotide (PDB:
3O3G). The structures of Bst-RNase H3 and human RNase
H1-substrate complexes were superimposed onto that
of Tm-RNase H2-substrate complex using DaliLite
pairwise comparison (http://www.ebi.ac.uk/Tools/dalilite/).
In addition, the substrate in human RNase H1 was
moved to fit on the substrate of Tm-RNase H2 based on
the two nucleotides around the cleavage sites using Pymol
(http://www.pymol.org/). This program was also used to
display structures in designing mutants.
Purification of yeast RNase H2
Previously, we coexpressed and purified the three subunits
of yeast RNase H2 with all the subunits C-terminally
fused to an His-tag (25). In this study, we constructed
an expression system to facilitate purification of the
trimeric complex, in which only Rnh201p subunit was
C-terminally tagged with 6XHis. The polycistronic
coexpression system (pET-yH2ABC) was constructed as
described previously for Hu-RNase H2 (15). For over-
expression, Escherichia coli BL21(DE3) was transformed
with pET-yH2ABC and cultured in Luria-Bertani (LB)
media at 30C. When the optical density at 600 nm
(OD600) reached around 0.5, 1mM IPTG was added to
the culture medium and cultivation was continued for
additional 3 h. Cells were harvested by centrifugation at
5000 rpm for 10min, resuspended in buffer A (20mM
Tris–HCl, pH 7.5, 1mM EDTA and 1mM DTT), dis-
rupted by sonication and centrifuged at 15 000 rpm for
30min. The supernatant was loaded onto a Hitrap
Heparin HP column (1ml) (GE Healthcare) equilibrated
with buffer A. The protein was eluted from the column
with a linear gradient of 0–1M NaCl. The fractions con-
taining yeast RNase H2 trimeric complex were collected
and applied to the Histrap crude column (1ml) (GE
Healthcare) equilibrated with buffer B (20mM Tris–HCl
pH 7.5, 500mM NaCl and 15mM imidazole). The protein
was eluted from the column with 60mM imidazole,
dialyzed against 20mM Tris–HCl pH 7.5 containing
1mM EDTA, 1mM DTT and 150mM NaCl and
concentrated. The protein purity was confirmed by
SDS–PAGE, followed by staining with Coomassie bril-
liant blue R250. Expression and purification of yeast
RNase H2 mutants were carried out as described for
wild-type protein.
RNase H assays
Enzymatic reactions were performed in buffer containing
15mM Tris–HCl (pH 7.9), 50mM NaCl, 1mM DTT,
100 mg/ml BSA, 5% glycerol and 10mM MgCl2. Activity
assays using a uniformly a32P-ATP-labeled poly-rA/
poly-dT substrate and the 50g-32P-labeled short RNA/
DNA (the sequences of the oligonucleotides are given in
Figure 1 and Supplementary Figure S1) were performed as
described previously (15).
Crystallization and structure solution
Tm-RNase H2 G21S was purified as previously described
(23). Nucleic acid for crystallization was prepared by an-
nealing high-performance liquid chromatography–purified
oligonucleotides: cleaved strand 50-GACACcTGATTC
(single ribonucleotide in small caps) and complementary
DNA strand 50-GAATCAGGTGTC (both purchased
from Metabion, Martinsried, Germany). Before crystal-
lization, Tm-RNase H2 G21S (2mg/ml final concentra-
tion) was mixed with the oligos at 1.2:1 substrate:protein
molar ratio. The complexes were mixed with the reservoir
solution [50mM CaCl2, 45% PEG 200 and 0.1M MES
(pH 6.0)] at equal volume and crystallized by the sitting
drop vapor diffusion method at 18C. For data collection,
the crystals were flash frozen in liquid nitrogen.
Diffraction data were collected at Berliner Elektron-
enspeicherring-Gesellschaft fu¨r Synchrotronstrahlung syn-
chrotron at beamline MX-14 (26) on a Mar225 CCD
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Figure 1. Comparison of RNase H2 and H3. (A) Alignment was generated for human RNase H2A (Hu2A), S. cerevisiae RNase H2A (Sc2A), T.
maritima RNase H2 (Tm2), B. stearothermophilus RNase H3 (Bst3), Streptococcus pneumonia RNase H3 (Spn3) and Thermovibrio ammonificans
HB-1 RNase H3 (Tam3). a-Helices are indicated with pink letters, and b-sheets are indicated with orange letters. Active site residues are highlighted
in yellow. Amino acid substitutions in S. cerevisiae RNase H2A are noted above the first row of alignment D39A, G42S, P45D, S or E and Y219A—
along with the conserved DSK triplet. The ‘GRG’ motif, DSK and the conserved Tyr of RNase H2 are also highlighted in grey. (B) The
50-32P-labeled 12 mer substrates indicated above the gels were digested by yeast and Tm-RNase H2 in the presence of 10mM MgCl2. The lanes
marked with 0 contained no enzyme, and lanes marked with triangle contained increasing amount of the proteins (0.16, 1.6, 16 and 160 nM in the
case of Tm-RNase H2, 0.011, 0.11, 1.1 and 11 nM in the case of yeast RNase H2 and 0.011, 0.11, 1.1 and 11 nM in the case of Bst-RNase H3).
Products of the hydrolysis were analyzed by 20% TBE-urea gels. The sizes of products were measured based on molecular size markers indicated as
M (products of digestion of 32P-labeled strands without complementary strand by phosphodiesterase I). Major cleavage sites of the substrates are
summarized on the bottom of each gel. (C) Relative activity of Bst-RNase H3 D103N and D103A mutants compared with the wild-type protein was
analyzed by liquid RNase H assay using poly-rA/poly-dT substrate as previously done (15).
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detector at 100K (Supplementary Table S2) and processed
in HKL2000 (27). The structure was solved using molecu-
lar replacement in Phaser (28) and refined using Coot (29)
and Phenix suite (30). Figures and analyses were prepared
in PyMol (www.pymol.org). Atomic coordinates and
structure factors have been deposited in Protein Data
Base with accession code, 4HHT.
Yeast expression plasmid for Rnh201 expression from its
native promoter
C-terminally FLAG tagged RNH201 gene coding for WT,
D39A, G42S or P45D-Y219A, flanked with 50-terminal
608 bp and 30-terminal 404 bp genomic sequence, was
cloned into HindIII/NgoMIV site of ycplac111 containing
ARS/CEN and LEU2 marker to make ycNPH2-FL2
plamid expressing WT and mutant RNH201. RNH202
wt and PIP (with a stop codon that makes a protein
11 amino acids shorter eliminating the PIP sequence)
was also expressed from plasmid ycplac111 using its own
promoter.
Construction of yeast strains
Strain Cy8338 (W303-1A but sgs1::HIS3) (31) was used to
first replace the RNH201 and RNH202 genes with the
CORE-I-SceI cassette from pGSHU (32). Polymerase
chain reaction (PCR) products with the cassette flanked
by 60 nucleotides of sequence upstream and downstream
of the genes open reading frames were introduced in the
strain, generating deletion/replacement of the correspond-
ing gene by homologous recombination (HR). Proper re-
placement was confirmed by PCR and sequencing. Then,
to introduce the desired mutations, WT and mutant genes
from plasmid ycNPH2-FL2 were PCR amplified and
introduced in the deletion strains (SMC306 and
SMC307, Supplementary Table S1), which were growing
in the presence of galactose to facilitate HR by I-SceI–
mediated double-stranded break. Transformants were
selected in 5-FOA plates and confirmed by PCR analysis
and sequencing.
Yeast expression plasmid for Rnh1 overexpression under
TPI promoter
Yeast RNase H1 gene was cloned into EcoRI and SalI site
of pYX242 (16) to make pYX242-YH1. KanMX4 cassette
was cloned into SfoI site of pYX242 and pYX242-YH1.
Growth rate determination and microscopic analysis
Overnight cultures grown in liquid Yeast Extract Peptone
Dextrose (YPD) were inoculated into fresh YPD medium
for OD600 to be about 0.1. The OD600 was measured
every hour for 10 h to determine the doubling times.
Multiple isolates were analyzed for each strain. Yeast
cells fixed with 70% ethanol were stained with
40,6-diamidino-2-phenylindole (DAPI). The cells were
immobilized on polylysine-coated slides and photo-
graphed in a fluorescent microscope.
Analysis of spontaneous mutation in pol2-M644G rnh201D
strain transformed with plasmid expressing rnh201 WT
and mutants
The pol2-M644G rnh201D yeast strain (5) was transformed
with ycNPH2-FL2 WT and derivatives. Cells were grown
in SD-Leu medium and plated on SD-Leu lacking arginine
and supplemented with 60 mg/ml canavanine. Genomic
DNA was isolated from independent canavanine-resistant
mutants, PCR amplified and sequenced. Spontaneous
mutation rates were measured by fluctuation analysis
(33), using FALCOR (Fluctuation Analysis CalculatOR)
program (http://www.mitochondria.org/protocols/
FALCOR.html). Rates of individual mutation classes
were calculated by multiplying the proportion of each
mutation type by the total mutation rate.
RESULTS
How RNase H3 recognizes RpR, but not RpD in duplex
substrates
We first compared the activities of yeast RNase H2,
Tm-RNase H2 and Bst-RNase H3 using RpD and RpR
substrates (Figure 1B). Sc-RNase H2 showed the same
substrate preference as Hu-RNase H2 (34), cleaving
RNA12, RNA6-DNA6 and DNA5-RNA1-DNA6 strands
with similar efficiencies when annealed to complementary
DNA, although it preferred RpD over RpR sequences
when present in the same substrate, cleaving 50 of the
ribonucleotide attached to DNA (Figure 1B, left). In
contrast, Tm-RNase H2 only recognized RpD sequences,
cutting 50 of the ribo (Figure 1B, middle), and Bst-RNase
H3 hydrolyzes regions containing a stretch of several
ribonucleotides and could not process a single ribonu-
cleotide embedded into DNA (Figure 1B, right), even
when a large excess of enzyme (110 nM) was used, or
when Mn2+ replaced Mg2+ (data not shown). Hu-RNase
H2 recognizes RpR or RpD structures only when
hybridized to DNA (34), whereas some bacterial
enzymes can cleave the strand containing RpD junction
with RNA or DNA in the opposite strand (35). Sc-RNase
H2 acted like the human enzyme cleaving only in regions
of RNA/DNA (Supplementary Figure S1, left); however,
Tm-RNase H2 could cleave RpD substrates even when the
noncleaved strand was RNA (Supplementary Figure S1,
right), similar to other bacterial RNases H2 from E. coli
and Thermus thermophilus (2).
To determine the reason for the different specificity
between RNase H2 and RNase H3, we examined which
residues of RNase H3 are involved in catalysis by
superimposing the structure of Bst-RNase H3 (PDB:
2D0B) and the structure of Tm-RNase H2 in complex
with a substrate containing a RpD junction (PDB:
3O3G) (Figure 2A and C). We then replaced the RpD
junction substrate with the structure of the RNA/DNA
hybrid co-crystallized with Hu-RNase H1 (PDB: 3PUF),
and determined the interactions of the Bst-RNase
H3/Tm-RNaseH2 superimposition (Figure 2 B and D).
Instead of the Tm-RNase H2 Tyr residue essential for
catalysis, Bst-RNase H3 has an Asp (D103) that,
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according to the modeled structure, was within 3.3 and 3.2
A˚ from the 20-OH of the ribose residues at positions +1
and +2, respectively. Moreover, the second catalytic
residue (Glu-98 of Bst-RNase H3 and Glu-19 of Tm-
RNase H2) could interact with the 20-OH at position -1,
suggesting that RNase H3 interacts with at least three
consecutive ribonucleotides of the cleaved strand. We
tested the activity of Bst-RNase H3 with D103N or
D103A substitutions and found that these enzymes have
reduced RNase H activity (Figure 1C); especially
Bst-RNase H3-D103A that could not form hydrogen
bonds with either of the 20-OH at position+1 or+2, con-
firming the important role of D103 in substrate recogni-
tion and interaction with two consecutive 20-OH.
Creating an Sc-RNase H2 that cleaves RpR not RpD
sequences
In RNase H3, the residue corresponding to the conserved
junction-binding tyrosine from RNase H2 is an alanine
(Figure 1A). Tyr to Ala in Sc-Rnh201, the catalytic sub-
unit, resulted in an enzyme with less than 0.1% residual
activity with all substrates (Figure 3 and Table 1), as pre-
viously shown for Hu-RNase H2, indicating that the Tyr
is important for cleavages of both RpD and RpR sub-
strates. To see whether substitution of Y219 by amino
acids with OH moieties could provide interaction with
the RNA 20-OH, we replaced Y219 with S, D or E.
Rnh201-Y219D and Rnh201-219E were inactive with all
substrates, whereas Rnh201-Y219S was inactive for the
cleavage of RpD substrates but has higher activity than
Rnh201-Y219A with hybrids containing RpR junctions
(Figure 3A and B). The structure modeled in Figure 2
suggested that D103 in Bst-RNase H3 plays a role
similar to Tm-Y163 in contacting the ribose 20-OH at
position +1. D103 of Bst-RNase H3 is in the same
spatial location as P45 of Sc-Rnh201 (Figure 1A, 2C
and 2D). Because D103 is a Ser or Glu in other RNases
H3 (Figure 1A), we changed P45 residue to D, E or S in
the Sc-Rnh201-Y219A. Sc-RNases H2 containing
Rnh201-P45D-Y219A or Rnh201-P45E-Y219A had
about 40% activity of the wt enzyme for the cleavage of
poly-rA/poly-dT substrate, whereas Sc-RNase H2 with
Rnh201-P45S-Y219A substitution was less efficient
(Figure 3A). In contrast, RpD molecules were essentially
not hydrolyzed by yeast RNase H2 enzyme containing
Rnh201-Y219A-P45D (Figure 3B). With substrates con-
taining RpR and RpD junctions in the same hybrid (top
panel of Figure 3B), the mutant Rnh201- P45D-Y219A
showed about 3.1% of the wt activity on RpR structures,
while it was less than 0.1% as active as the wt for the RpD
cleavage (Table 1). Actually, activity on the 6R substrate
may be low due to length of RNA, sequence preferences,
or poor stability related to the sequence or the proximity
to the end (see Figure 1B). Thus, the accuracy of our
model was confirmed. Y219A mutation in Sc-Rnh201
eliminated recognition of RpD and RpR, but the add-
itional replacement of P45 with D provided a key inter-
action with a 20-OH of two consecutive ribonucleotides
conferring specificity for RpR/DNA cleavage. Therefore,
we have converted Sc-RNase H2 into an enzyme that
solely cleaves RpR/DNA substrates.
Tm-RNase H2 substrate specificity
To examine whether we could change the specificity of
Tm-RNase H2 to cleave RpR sequences similarly to eu-
karyotic RNases H2, we substituted C24 by D and Y163
Figure 2. Models of Bst-RNase H3 and Tm-RNase H2 in complex with substrates. The ribbon models of Bst-RNase H3 (in green) and Tm-RNase
H2 (in orange) are superimposed, and the complexes with (A) duplex DNA containing single ribonucleotide (DNA in blue and RNA in red) and (B)
RNA/DNA hybrid are shown. Active site residues (DEDD motif in Tm-RNase H2 and DEDE motif in Bst-RNase H3) and residues involved in
recognition of (C) DpRpD and (D) RpRpR substrates (GRG/Y motif in Tm-RNase H2, GTGD motif in Bst-RNase H3) are shown. Possible
hydrogen bonds are indicated by dotted lines. The nucleotides are numbered relative to the scissile phosphate, which is indicated with an arrow. Four
catalytic residues (DEDD for Tm-RNase H2 and DEDE for Bst-RNase H3) are also indicated in numerical order.
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Figure 3. Cleavage of poly-rA/poly-dT substrate and oligo substrates with Sc-RNase H2 WT and mutants. (A) The uniformly 32P-labeled poly-rA/
poly-dT substrate (1mM) was digested by the Sc-RNase H2 WT and mutants indicated above the gel in the presence of 10mM MgCl2. The lanes
marked with 0 contained no enzyme, and lanes marked with triangle contained increasing amount of the proteins (1 pM, 11 pM, 110 pM, 1.1 nM
and 11 nM). Products of the hydrolysis were analyzed by 12% TBE-urea gels and visualized by Phosphorimager. (B) The 50-32P-labeled 12 mer
substrates indicated on the left of the gels were digested by Sc-RNase H2 in the presence of 10mM MgCl2. The lanes marked with 0 contained no
enzyme, and lanes marked with triangle contained increasing amount of the proteins (0.011, 0.11, 1.1 and 11 nM). Products of the hydrolysis were
analyzed by 20% TBE-urea gels. The sizes of products were measured based on molecular size markers indicated as M. Cleavage at the 50 of RpD
junction is indicated by an arrow.
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by A in Tm-RNase H2, which are the equivalents to the
Sc-Rnh201 P45D-Y219A substitutions. The Tm-RNase
H2 WT enzyme in the presence of Mg2+ cleaves exclu-
sively at the 50-end of the ribonucleotide of the RpD
junction. In the presence of Mn2+, the WT enzyme is
able to cleave RpR structures although with lower
affinity than RpD sequences. Tm-RNase H2-Y163A
had undetectable activity with Mg2+ and very low
activity in the presence of Mn2+ with all the substrates
(Supplementary Figure S2). Tm-RNase H2-C24D-
Y163A was inactive with Mg2+ and only partially active
in Mn2+. For the cleavage of RNA6-DNA6/DNA12 sub-
strate, this enzyme cleaves at the 50-end of both the RpD
and RpR sequences, whereas the WT cuts only 50 of the
RpD, suggesting that the mutant lost selectivity for the
RpD junction. This indicated that we have identified in
the yeast and Tm-RNases H2 the amino acids that confer
selectivity for RpD and RpR hydrolysis.
The Gly residue, which in the Tm-RNase H2 co-crystal
is part of the GRG motif interacting with the 20-OH of the
RpD substrate, is important for substrate specificity (23).
This glycine in the catalytic Hu-RNase H2A is particularly
interesting because it is substituted for Ser in patients pre-
senting a severe form of AGS (22). Tm-RNase H2-G21S
has low Mn-dependent activity on all substrates and
reduced RpD processing (23) in the presence of Mg2+.
To understand the effect of the G37S-equivalent
mutation in the prokaryotic protein, we solved the
crystal structure of Tm-RNase H2-G21S in complex
with a duplex DNA containing a single ribonucleotide
(Supplementary Figure S3). Surprisingly, in the crystal
structure, interactions between the substrate and protein
were only modestly perturbed. The main chain of the
GRG motif was slightly deformed, still allowing full rec-
ognition of the 20-OH (Supplementary Figure S3C).
Moreover, the role of the conserved Tyr in the recognition
of the 20-OH of the scissile phosphate and in the stacking
interaction with D of RpD junction was intact, suggesting
Tm-RNase H2-G21S retains the ability to recognize RpD
junctions. The mutation affected the dihedral angle of the
loop containing G21S and the surrounding residues due to
the presence of the side chain of Ser21, which needs to be
accommodated at the center of protein–nucleic acid inter-
face. These small perturbations around the active site dis-
turbed the binding of metal ion B. The structure suggested
that G21S substitution in the GRG loop results in a
general defect in catalysis, not a selective loss of RpD or
RpR hydrolysis. We made the corresponding change
in the catalytic subunit of Sc-RNase H2 and found that
the G42S substitution showed reduced activity with the
different substrates, having about half the activity with
the single-ribonucleotide embedded duplex DNA
sequence than with longer stretches of ribonucleotides
(Table 1). Similar results have been reported for the
mouse (36–38), human (15,34), yeast (25) and Tm-
RNase H2 (23).
Recognition of single ribonucleotide by RNase H2 is
essential for in vitro ribonucleotide excision repair assay
We examined the ability of WT and mutant forms of
Sc-RNase H2 to perform in an in vitro ribonucleotide
excision repair (RER) assay. Three independent experi-
ments reproducibly gave the results shown in Figure 4.
This replication assay relies on several proteins to
produce mp18 dsDNAs devoid of misincorporated
ribonucleotides as shown in Figure 4A. Alkali treatment
results in DNA strand scissions at the ribonucleotide lo-
cations as seen in Figure 4A. When Sc-RNase H2 is
present, the majority of dsDNA becomes insensitive
to alkali treatment (Figure 4A, WT lane after 3min incu-
bation) indicating the misincorporated ribonucleotides are
repaired in an RNase H2-dependent manner. Proliferating
Cell Nuclear Antigen (PCNA) is loaded onto the circular
DNA by RFC and increases the activities of DNA poly-
merase d, FEN1 and ligase1 by interacting with their
PCNA-interacting peptide (PIP). However, as we have
shown before (39), interaction with PCNA is not necessary
for the repair activity of RNase H2, because an RNase H2
with an Rnh202 subunit missing the last 11 amino acid
including the PCNA-interacting peptide (PIP) was as
active as the wild-type enzyme (Figure 4A, PIP lane
after 3min incubation). Accordingly, the in vitro activity
of the PIP protein with different substrates is equivalent
to the activity of the WT enzyme (Table 1).
The RNase H2 containing the catalytic subunit
Rnh201-P45D-Y219A mutation, which could not cleave
RpD substrates in vitro (Figure 3 and Table 1), also did
not function to repair misincorporated ribonucleotide in
this assay (Figure 4A). Sc-RNase H2-G42S exhibited low
activity in single ribonucleotide cleavage (Table 1) and in
the RER assay showed a modestly larger distribution of
products compared with the catalytically dead Sc-RNase
H2-D39A and the Sc-RNase H2-P45D-Y219A mutants
(Figure 4B). The in vitro activity of these mutants correl-
ates well with their capacity to process rNMPs in the RER
assay.
Mutants defective in RpD cleavage have the same mutator
effect as deletion of RNH201
Yeast cells lacking RNH201 accumulate 2–5 bp dele-
tions within short tandem repeats in a topoisomerase
1-dependent manner (6). In combination with error-prone
replicative DNA polymerase e mutant (pol2-M644G),
deletion of RNH201 increased the spontaneous mutation
rate and the frequency of the 2-5 bp deletions (5).
We transformed the double mutant strain, pol2-M644G
rnh201D, with single copy plasmids expressing
Table 1. Relative activities of yeast RNase H2 derivatives
1Ra 6Ra 12Ra poly-rA/
poly-dT
WT 100 100 100 100
Y219A <0.1 <0.1 <0.1 <0.1
P45D Y219A <0.1 3.1b (<0.1)c 25 40
G42S 2.2 5.1 4 8
D39A <0.1 <0.1 <0.1 <0.1
Rnh202-PIP 109 85 112 118
a12 mer substrates shown in Figure 1B.
bEfficiency for the cleavage at RpR.
cEfficiency for the cleavage at RpD.
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RNH201-WT, rnh201-G42S or rnh201-P45D-Y219A
driven by their own promoter and a control empty
vector. The transformants were analyzed for the spontan-
eous mutation rate and mutational specificity at the CAN1
locus (Figure 5A). Plasmid-expressed WT RNH201
decreased the mutation rate and showed a mutation
spectrum mostly of base substitutions, similar to
wild-type cells. However, pol2-M644G rnh201D cells ex-
pressing rnh201-P45D-Y219A had similar mutation rates
and spectra as the deletion strain pol2-M644G rnh201D
harboring an empty vector (Figure 5A). Cells expressing
rnh201-G42S had a slightly reduced rate of 2–5 bp dele-
tions, compared with pol2-M644G rnh201D cells express-
ing rnh201-P45D-Y219A, but still had a much higher
accumulation of deletions than wild-type cells. Western
analyses demonstrated that WT, G42S and
P45D-Y219A Rnh201p were expressed at similar levels
in these strains (Supplementary Figure S4).
Mutants defective in RpD cleavage can participate in
R-loop processing
Next, we determined whether these enzymes can function
in vivo in the processing of RNA/DNA hybrids. We chose
a system that requires R-loop processing for viability.
Loss of Top1 in combination with RNH1 and RNH201
deletions leads to R-loop accumulation and consequent
cell death in yeast (40,41). We used yeast strain
YAEH275 (PGAL-TOP1 rnh1D rnh201D), in which the
TOP1 gene is expressed from the galactose-inducible
GAL1 promoter. Expression is repressed when cells are
grown on glucose with associated lethality. YAEH275
was transformed with plasmids expressing wild-type or
mutant forms of RNH201 or a control empty vector,
and cultures were grown and spotted on selection plates
containing either galactose or glucose (Figure 5B).
RNH201-WT and rnh201-P45D-Y219A rescued lethality,
whereas rnh201-G42S was only partially effective, in ac-
cordance with the lower activity on RNA/DNA hybrid
Figure 4. In vitro RER assay. (A) In vitro RER assay is schematically
shown. The 7.3-kb mp18 single-stranded circle DNA was replicated by
Pold and cofactors in the presence of the physiological levels of dNTPs,
rNTPs and 32P-labeled dATP at 30C. After 12min incubation, FEN1,
Ligase1 and wild-type or mutant RNase H2 were added, and the reac-
tions were continued. After 1 or 3min, aliquots were taken and treated
with NaOH for hydrolysis at RpD linkage due to misincorporation of
ribonucleotide during replication. DNA was extracted from the aliquots
and loaded onto 1% alkali agarose gel. The alkali agarose gel was
visualized by Phosphorimager. (B) The radioactivity distribution was
scanned and divided by the size distribution to obtain a normalized
product distribution as described before (39).
Figure 5. In vivo phenotypes of strains rnh201D carrying plasmids har-
boring RNH201 WT and mutants. (A) Saccharomyces cerevisiae strain
pol2-M644G rnh201D was transformed with plasmid expressing
RNH201WT and mutants and empty vector. Strains were plated in
canavanine plates and the rates of individual mutations types at
CAN1 determined. N, number of mutants sequenced; indel, insertion/
deletion/; BS, base substitution. 95% confidence intervals are in paren-
thesis below total rates. (B) Saccharomyces cerevisiae strain YAEH275
(BY4741 but PGAL1-3HA-TOP1 (KanMx6) rnh201D (NatMx6) rnh1D
(HphMx6)) was transformed with plasmids expressing RNH201-WT,
rnh201-G42S, -P45D-Y219A and -D39A and also an empty vector.
The transformants were grown at 30C in liquid SD-Leu medium con-
taining 2% galactose, and series of dilutions were spotted on SD-Leu
plates with 2% galactose or 2% glucose and incubated for 3 days at
30C.
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substrates of the RNase H2 enzyme containing this
mutant protein (Table 1). The catalytically dead
rnh201-D39A protein did not rescue lethality in glucose.
These results indicate that R-loop removal in vivo parallels
that seen in vitro (Table 1).
RNase H2 R-loop processing is sufficient to correct
rnh201Dsgs1Dsynthetic sickness
In S. cerevisiae, Sgs1 is crucial for HR repair of
double-stranded DNA breaks and for re-establishing of
replication after fork collapse (42,43). Deletion of any
of the three genes that code for the subunits of the hetero-
trimeric RNase H2 together with deletion of SGS1 confers
a synthetic-sickness phenotype (44), suggesting that the
loss of RNase H2 creates a need for recombinational
repair.
To examine whether RER or R-loop processing is ne-
cessary in the absence of SGS1, we analyzed a set of
isogenic strains that were both sgs1D and mutated in
RNH201 to either eliminate catalytic activity completely
(D39A) or eliminate RER but retain R-loop processing
(P45D-Y219A or G42S). The growth rate was examined
by colony size on YPD plates and by the analysis of
doubling time in liquid medium. The doubling time was
determined at least four times for each strain. The error
bars represent standard deviation (Figure 6A). Chromo-
somal RNH201-WT, -rnh201-P45D-Y219A or -G42S sup-
pressed the slow growth phenotype, while the strain with
active site mutant rnh201-D39A showed the same poor
growth as the parental sgs1D rnh201Dstrain (Figure 6A).
These data were confirmed using plasmid complementa-
tion assays (Supplementary Figure S5).
To eliminate the possibility that an RNase H2-
independent suppressor mutation had restored the
normal growth of the sgs1D strain expressing rnh201-
G42S and -P45D-Y219A, we replaced the rnh201-G42S
and -P45D-Y219A alleles by KanMX-cassette, recreating
the rnh201D and thereby reproducing the slow growth
rate (data not shown). Taken together, these results
Figure 6. Effect of RNase H2-mutations in sgs1D yeast strain. (A) Doubling time of the yeast strains with RNase H2-mutations in genomic DNA
was determined at 30C in YPD medium. Error bars are standard deviations with P< 0.1 measured by the Ttest in Excel. (B) Representatives of
normal cells and abnormal cells from sgs1 rnh201 background stained with DAPI are shown. (C) Fraction of abnormal cells from log-phase
culture was analyzed by gating enlarged cells by FACS, which was correlated with the ratio of abnormal cells observed by microscope (data not
shown).
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suggest that the growth defect of the sgs1D
rnh201Dstrain is caused by R-loops that become stable
in the absence of RNase H2 and Sgs1 and that the
residual activity of the enzymes containing P45D-Y219A
and, surprisingly, G42S mutants is sufficient to comple-
ment these defects.
In the sgs1D rnh201Dstrain, there was an increase of
nonproliferative abnormal cells arrested in G2/M phase
(Figure 6B), that seem to be unable to complete the cell
cycle, presumably due to replication and repair impair-
ments. By microscopic analysis, we initially noticed
increased levels of enlarged dumbbell-shaped cells or
cells with abnormal shape as shown in Figure 6B. Next,
analysis of the cells for DNA content (propidium iodide
(PI) staining) and cell size (side scattering) by
Fluorescence-activated cell sorting (FACS) (data not
shown) suggested an increased portion of enlarged G2/
M-arrested cells in sgs1D rnh201D mutant, which is in
agreement with the microscopic analysis. In Figure 6C,
enlarged cells observed by side scattering of FACS data
were used to determine the fraction of abnormal cells.
The strain with sgs1D rnh201-D39A had elevated level of
abnormal cells as sgs1D rnh201D mutant, whereas strains
sgs1D rnh201-G42S and sgs1D rnh201-P45D-Y219A had
the same amount of abnormal cells as single mutant
sgs1D Figure 6C, indicating that RNase H2 R-loop reso-
lution prevents increased formation of abnormal cells.
To determine whether interaction with PCNA was im-
portant in this genetic background, we mutated RNH202
by gene replacement in the strain carrying sgs1D to make
an RNase H2 enzyme devoid of the PIP sequence.
RNase H2-PIP complemented the deletion of RNH202
(Figure 6A), indicating that interaction with PCNA is not
necessary for R-loop processing.
RNase H1 overexpression did not complement sgs1D
rnh201Dsynthetic sickness
R-loop processing can be accomplished by either RNases
H1 or H2. This seems to be the case for the R-loops in
nucleoli (40). To determine whether RNase H1 can also
participate in the processing of the substrates that accu-
mulate in the sgs1D rnh201D mutant, we transformed the
sgs1D rnh201D strain with a plasmid that carries the
RNH1 gene under the strong triosephosphate isomerase
(TPI) promoter and looked for complementation of the
growth defect of the double mutant. RNase H1 was
overexpressed and active (data not shown), but these
high levels of RNase H1 did not restore the growth of
sgs1D rnh201D mutant strain to the rate of the single
mutant sgs1D (Supplementary Figure S6), suggesting
that RNase H1 cannot act on or have access to the
RNase H2 substrates that accumulate in the absence of
Sgs1.
DISCUSSION
Eukaryotic RNases H1 and H2 are important participants
in maintaining genome stability by resolving R-loops that
form during transcription and by initiating the removal of
rNMPs in DNA. Only RNase H2 can process single
ribonucleotides in DNA but both enzymes are capable
of eliminating RNA/DNA hybrids. Roles of RNase H1
or RNase H2 are usually examined by deleting one or
both enzymes, which in S. cerevisiae leads to modest in-
creases in sensitivity to DNA damaging agents (16), but in
mouse has devastating consequences, causing embryonic
lethality (1,20,21). R-loops naturally form due to tran-
scription errors and are removed by RNase H1 and
RNase H2. However, under high transcription (40) and
when RNA biogenesis factors are defective (8,9,18),
R-loop formation is increased, inducing genome instabil-
ity. Stable R-loops constitute a block to replication fork
progression causing fork collapse, recombination and
chromosomal breaks (45,46). The deleterious conse-
quences of the R-loops can be at least partially reversed
by overexpression of RNase H1, indicating that normal
levels of RNase H1 and RNase H2 are insufficient when
there are more abundant R-loops.
In contrast to transcription-induced R-loop formation,
single ribonucleotides in DNA occur during genome du-
plication, and RNase H2 is essential to initiate their
removal. In the absence of RNase H2, rNMPs in the
genome are aberrantly processed by Top1 (6), originating
2–5 base pairs deletions within short tandem repeats.
R-loops and single ribonucleotides in DNA are quite
distinct structures that created different challenges to
genome integrity, and loss of RNase H2 may result in
an accumulation of defects in transcription, replication
and repair. Therefore, deletion of the RNH201 gene
does not permit the specific assignment of contributions
of R-loops and single rNMPs to genome instability.
To assess the separate roles of RNase H1, and particu-
larly RNase H2 in R-loop degradation and RER, we
designed a Sc-RNase H2 variant with only two amino
acid substitutions in the catalytic subunit (Rnh201-
P45D-Y219A), which behaves like a bacterial RNase
H3, i.e. the enzyme can participate in R-loop processing
but not in the removal of single rNMPs misincorporated
in DNA. This mutant constituted an invaluable tool to
understand the functions of RNase H2 under normal
and pathological condition.
This mutant allowed us to conclusively correlate the
2–5 bp deletions observed in rnh201D strains (6) with
single ribonucleotide misincorporation in the genome. It
also suggested a connection between R-loops and Sgs1-
mediated replication reinitiation at stalled forks, as well
as identifying R-loops that can be processed by RNase
H2, but not by RNase H1 (Figure 7).
Genome instability in yeast is greater when both RNH1
and RNH201 genes are deleted than when single deletions
are present, although in combination with defects of RNA
biogenesis factors, the deletion of RNH1 is more deleteri-
ous than that of RNH201 (18). This seems to indicate that
RNases H1 and H2 have partially overlapping specificities
in the resolution of R-loops, but RNase H1 is the major
player in removing transcription-associated R-loops
(Figure 7B). Conversely, our results suggest that there
are R-loops that are uniquely processed by RNase H2.
These loops might be involved in DNA transactions
during replication/repair processes (Figure 7C), and
RNase H2 could have access to them by interaction with
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PCNA and the replication machinery via the PIP motif of
the Rnh202 subunit. Although no phenotype has been
associated thus far with the deletion of the PIP motif, it
is likely than under stress circumstances or other condi-
tions not yet tested, the PIP might be required for the
function of RNase H2. Moreover, the PIP sequence may
not be the only means of RNase H2 interaction with DNA
replication/repair machines.
Both RNases H complemented the lethal defects caused
by the accumulation of R-loops created under high tran-
scription in a topoisomerase-defective rnh1D rnh201D
mutant, as did the Rnh201-P45D-Y219A mutant that
still processes R-loops (Figure 5B). However, only
RNase H2 was effective in correcting the slow growth of
sgs1D rnh201D strains (Figure 6 and Supplementary
Figure S6). The synthetic defect of sgs1D rnh201D could
be due to misincorporated rNMPS in DNA, especially
because sgs1D rnh1D strains do not exhibit a slow
growth phenotype. However, the fact that the mutant
completely devoid of single-ribonucleotide processing
activity could reverse the slow growth defect of sgs1D
rnh201D (Figure 6A) indicated that persistent R-loops
have deleterious effects in this strain.
R-loops present from bacteria to humans constitute a
block to replication leading to replication fork stalling
(10). Replication after fork arrest can be reinitiated by
HR (46), for which Sgs1 is essential (47). Sgs1 recruits
the intra-S phase checkpoint kinase Rad53 to stalled
forks and contributes to replication fork stability by
dissolving fold-back structures and Holliday junctions
formed at collapsed forks (48). Our study establishes a
link between stable R-loops and Sgs1-mediated replication
restart.
The forms of RNase H2 containing the AGS-related
mutation Rnh201-G42S, which in vitro has low activity
on RNA/DNA hybrids, could reverse the slow growth
and accumulation of abnormal cells in the sgs1D back-
ground, indicating that even a very impaired enzyme has
sufficient activity to process the small number of hybrids
formed in this strain. However, the mutant RNase
H-G42S was only partially effective in YAEH275
(PGAL-TOP1 rnh1D rnh201D), possibly related to the
higher abundance of R-loops in this strain, which might
exceed the capacity of the defective RNase H2-G42S.
Alternatively, for the resolution of R-loops in the sgs1D
strain, RNase H2 could be part of a larger complex that
may confer stability to the mutant enzyme and conse-
quently increasing enzymatic activity.
In vitro, the mutant RNase H2-G42S had low but de-
tectable activity on single rNMP (Table 1) and was
Figure 7. Effects of RNase H2 mutations in single ribonucleotide processing and R-loop resolution. (A) Single ribonucleotides incorporate in the
genome can be processed by RNase H2. RNase H2-P45D-Y219A mutant cannot remove single rNMPs and the AGS-related RNase H2-G42S has
low but detectable activity. Both mutations lead to the accumulation of 2–5 bp deletions in genomic DNA, although RNase H2-G42S at a lower rate.
(B) R-loops that form during transcription are processed primarily by RNase H1. RNase H2 WT and P45D-Y219A mutant can process equally well
these structures, whereas RNase H2-G42S is not as effective. (C) R-loops involved in replication fork collapse have unique access to RNase H2. The
WT enzyme and the mutants, RNase H2-G42S and RNase H2-P45D-Y219A, are equally active on these substrates.
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partially effective in the RER assay (Figure 4). In vivo,
although the RNase H2-Rnh201-P45D-Y219A mutant
strain exhibited a 3.9-fold increase over the wt in
mutation rate, the same as the Rnh201 deletion, the
Sc-RNase H2 containing Rnh201-G42S has an increase
slightly lower (3-fold over wt) mutation rate, and fewer
2–5 bp deletions (Figure 5A), indicating that this mutant
and presumably the human enzyme with the correspond-
ing mutation are able to remove single rNMPs in the
genome at some low frequency (Figure 7A).
In agreement with the in vitro and in vivo results, the
Tm-RNase H2 G21S structure in complex with a single
ribonucleotide–substituted duplex DNA showed pre-
served interactions of the RpD junction with the
conserved Tyr and with the GRG (SRG in the mutant)
motif, indicating the enzyme has reduced enzymatic
activity while maintaining substrate specificity. These
data are important to understand the defects associated
with the corresponding mutation in the human enzyme,
which is responsible for a severe form of AGS, providing a
note of caution in interpreting data when both activities
are decreased or absent.
Recently, defects in mouse due to deletion or low ex-
pression of RNase H2 (20,21) have been attributed to
genome instability associated with the presence of
rNMPs in DNA, without considering the possible effects
of unresolved R-loops, and RNA/DNA hybrids formed
during retroelements reverse transcription. However, the
deletion of another AGS-inducing gene, Trex1, has been
shown to cause the accumulation of single-stranded DNA
derived from endogenous retroelements (49). In addition,
antiretroviral drugs prevented autoimmune response and
restored the viability of Trex1-knockout mice (50). Also
SAMHD1, a more recently described AGS-associated
protein (51), has been found to restrict the infection of
dendritic and other myeloid cells by human immunodefi-
ciency virus type 1 (HIV-1) by hydrolyzing intracellular
dNTPs (52). Low concentrations of dNTPs, due to the
action of SAMHD1, inhibit the synthesis of the viral
RNA by reverse transcriptase (RT). In the absence of
SAMHD1, higher levels of dNTPs could facilitate
reverse transcription of endogenous retroelements. AGS
substrates arising via reverse transcription of endogenous
RNAs would lead to standard RNA/DNA duplexes that
could be resolved by RNase H2 and RNase H1. The fact
that RNase H1 does not cause AGS suggests that RNase
H2 has unique access to these substrates. The mutant
described in this study that could degrade RNA/DNA
hybrids formed by RT but could not remove single
rNMPs in DNA will be enormously important to
address the defects associated with AGS.
Here, we have shown that the multiple activities of
RNase H2 can provide quite different functions in vivo.
Our mutant RNase H2 lacking RpD substrate cleavage
allows us and others to precisely analyze the contributions
of R-loops and single rNMPs in DNA to the in vivo
phenotypes until now associated with deletion of RNase
H2. It will be particularly interesting to see the pattern of
changes in gene expression when the rnh201-P45D-Y219A
gene is present compared with the 349 changes
when RNH201 is deleted (53), and how the loss of
single-ribonucleotide activity of RNase H2 affects the
general genomic instability described by Wahba et al. (18).
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Supplementary Figure S1.  Cleavage of short substrates with yeast and Tm-RNases H2. 
 The 5’-32P labeled 12 mer substrates indicated above the gels were digested by Yeast and Tm-
RNase H2 in the presence of 10 mM MgCl2.  The lanes marked with 0 contained no enzyme, and 
lanes marked with triangle contained increasing amount of the proteins (0.16, 1.6, 16 and 160 
nM in the case of Tm-RNase H2, 0.011, 0.11, 1.1 and 11 nM in the case of yeast RNase H2). 
Products of the hydrolysis were analyzed by 20% TBE-urea gels. The sizes of products were 
measured based on molecular size markers indicated as M (products of digestion of 32P-labeled 
strands without complementary strand by phosphodiesterase I). Major cleavage sites are 
summarized on the bottom. 
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Supplementary Figure S2.  Effect of RNase H3-like double mutation in Tm-RNase H2.   
The 5’-32P labeled 12 mer substrates schematically shown on the left of the gels were digested by 
Tm-RNase H2 WT, Y163A and C24D-Y163A mutants in the presence of 10 mM MgCl2 and 1 
mM MnCl2.  The lanes marked with 0 contained no enzyme, and lanes marked with triangle 
contained increasing amount of the proteins (1.6, 16, 160 and 1600 nM). Products of the 
hydrolysis were analyzed by 20% TBE-urea gels. The sizes of products were measured based on 
molecular size markers indicated as M (products of digestion of 32P-labeled strands without 
complementary strand by phosphodiesterase I). 
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Supplementary Figure S3.  Crystal structure of Tm-RNase H2 G21S mutant in complex 
with DNA containing single ribonucleotide.  
Overall structures of wild-type and G21S mutant are shown. (A) N-terminal domain is colored 
with purple for beta-sheet and orange for loop and alpha-helix. C-terminal domain is in yellow. 
Residues (G21, K47 and Y163) and RpD junctions are shown in sticks. Cartoon model of the 
substrate is shown in blue for DNA and red for single ribonucleotide. (B) Protein structure 
except S21 (in purple), Y163 (in yellow) is shown in gray. (C) Close-up view for the recognition 
of RpD junction by Tm-RNase H2 WT and G21S mutant. G21S mutant is shown in gray except 
the G21S mutation (in magenta). The scissile phosphate is indicated with an arrow. (D) Close-up 
view for the correlation between the recognition of RpD junction by Y163 and catalysis. 
Structure of G21S mutant is shown in gray. Calcium ions of WT complex is shown in green. The 
scissile phosphate is indicated with an arrow. (E) Sample of electron density of the GRG(S) 
motif, Y163 and the RNA-DNA junction. The RNA is shown in red and DNA in blue. A 2Fo-Fc 
map contoured at 1.0 sigma is overlaid on the structure. 
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Supplementary Figure S4.  Expression of C-terminally FLAG-tagged RNase H2A from the 
plasmid, ycNPH2-FL2 and its variants 
(A) Yeast cells expressing C-terminally FLAG-tagged Rnh201 WT (lane 2), D39A (lane 3), 
G42S (lane 4), P45D-Y219A (lane 5) or no protein (lane 1) from the plasmids with Rnh201 gene 
flanked by its own native promoter were analyzed with western analysis using anti-FLAG M2 
antibody. (B) The PVDF membrane for Figure S4A was stained with Ponceau-S. 
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Supplementary Figure S5.  Complementation of slow growth phenotype of sgs1Δ rnh201Δ 
strain with plasmids. 
Transformants of sgs1Δ rnh201Δ strain with plasmids expressing Rnh201-WT, G42S, P45D-
Y219A or D39A were streaked on YPD plate and cultured at 30°C. The table shows doubling 
time of the yeast strains analyzed in YPD medium.  
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Supplementary Figure S6.  Effect of overexpression of RNase H1 on growth rate of sgs1Δ 
rnh201Δ strain.   
sgs1Δ rnh201Δ strain was transformed with a plasmid overexpressing Sc-RNase H1 and the 
doubling time was measured in YPD medium containing G418 at 30°C. The relative growth rate 
is shown. 
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Supplementary Table S1. List of yeast strains and plasmids    
Strain  Genotype   Source 
W303‐1A   MATa ade2‐1 can1‐100 his3‐11,‐15 leu2‐3,112 trp1‐1 ura3‐1  (55) 
Cy8338   W303‐1A but sgs1::HIS3   (56) 
SMC306   W303‐1A but sgs1::HIS3 rnh201::HYG‐URA3‐GAL1‐IsceI   This study 
SMC311   W303 genotype but sgs1::HIS3 Rnh201‐D39A   This study 
SMC308   W303 genotype but sgs1::HIS3 Rnh201‐G42S   This study  
SMC310   W303 genotype but sgs1::HIS3 Rnh201‐P45D‐Y219A   This study 
SMC307   W303 genotype but sgs1::HIS3 rnh202::HYG‐URA3‐GAL1‐IsceI   This study 
SMC314   W303 genotype but sgs1::HIS3 Rnh202‐ΔPIP::KanMX   This study 
YAEH275   MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 PGAL1‐3HA‐TOP1 ::KanMx6 
rnh201::NatMx6 rnh1::HphMx6  
(40) 
Δ|(‐2)|‐7B‐YUNI300    MATa CAN1 his7‐2 leu2‐Δ::kanMX ura3‐Δ trip1‐289 ade2‐1       
lys2‐ΔGG28899‐2900  pol2‐M644G rnh201Δ::HYG‐R  
(5) 
     
Plasmid   Description  Source 
ycplac111   LEU2, ARS/CEN   Novagen  
ycNPH2‐FL2   C‐terminally FLAG‐tagged Rnh201 flanked by its own native 
promoter in ycplac111  
This study 
pYX242‐Kan   LEU2, 2micro, KanMX4 at SfoI site   Novagen  
pYX242‐YH1‐Kan   Sc‐Rnh1 was cloned under TPI promoter of pYX242, KanMX4 at 
SfoI site  
This study 
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Supplementary Table S2. Crystallographic data collection and refinement statistics  
                                              for the Tm‐RNase H2 G21S‐substrate complex.  
Data collection 
Space group  C 2 
Cell dimensions 
   a, b, c (Å)   106.95, 47.63, 77.45 
   a, b, g (°)    90, 131.26, 90 
Wavelength (Å)  0.91841 
Resolution (Å)*  50.00 – 3.10 (3.15‐3.10) 
Rmerge (%)  14.6 (37.3) 
I / s(I)   9.8 (2.2) 
Completeness (%)  96.9 (76.3) 
Redundancy  3.3 (2.2) 
Refinement  
Resolution (Å)  3.1 
No. reflections  5022 
Rwork / Rfree (%)  17.8/25.4 
No. atoms  2189 
Protein  1676 
Nucleic acids  487 
Ligands/ions  2 
Water  24 
Avg. B‐factor  40.1 
Protein  38.7 
Nucleic acids  45.3 
Ligands/ions  35.9 
Water  30.3 
Root‐mean‐square deviation 
Bond lengths (Å)  0.009 
Bond angles (°)  1.255 
* Values in parentheses are for highest‐resolution shell. 
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Supplementary Table S3. MolProbity.  
All-Atom 
Contacts 
Clashscore, all atoms: 28.21 88th percentile* (N=59, 2.85Å – 9999Å) 
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms. 
Protein 
Geometry 
Poor rotamers 8.67% Goal: <1% 
Ramachandran outliers 0.46% Goal: <0.2% 
Ramachandran favored 93.52% Goal: >98% 
Cβ deviations >0.25Å 0 Goal: 0 
MolProbity score^ 3.07 77
th percentile* (N=2114, 3.100Å ± 
0.25Å) 
Residues with bad bonds: 0.00% Goal: 0% 
Residues with bad angles: 0.00% Goal: <0.1% 
Nucleic Acid 
Geometry 
Bad backbone 
conformations#: 0 Goal: 0 
Residues with bad bonds: 0.00% Goal: 0% 
Residues with bad angles: 0.00% Goal: <0.1% 
All-atom structure was validated for macromolecular crystallography (5). 
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 CHAPTER IV 
Reconstitution of Top1-initiated Ribonucleotide removal and consequent mutagenesis 
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 PREFACE TO THE CHAPTER 
This chapter of the dissertation focuses on the role of Topoisomerase 1 in the repair of genomic 
rNMPs and the mechanism of Topoisomerase induced 2-5 bp deletions at di-nucleotide repeats 
in the absence of RNase H2 in S. cerevisiae. Top1 cleaves at an rNMP in dsDNA leaving a 2’, 
3’-cyclic phosphate terminated ssDNA nick. Subsequently, a second Top1 cleavage event 
happens two-nucleotides to the 5’-side of the cyclic-phosphate and the intervening two-
nucleotides can dissociate, trapping Top1 on the DNA. From there, if the trapped Top1 is in a di-
nucleotide repeat sequence, the Top1 can lead to the realignment of the DNA to allow for 
religation causing the deletion of two nucleotides. On the other hand, if the site is not in a di-
nucleotide repeat it must be repaired by another pathway. The trapped Top1 can be removed in a 
TDP1 dependent pathway leading to repair. I carried out all of the biochemical assays for this 
work and purified most of the protein. Carrie Stith also purified several proteins used in these 
experiments.  
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ABSTRACT 
 Replicative polymerases frequently incorporate ribonucleoside monophosphates (rNMPs) 
into the genome that are normally repaired by the RNase H2-initiated ribonucleotide excision 
repair. In S. cerevisiae deletion of rnh201, the catalytic subunit of RNase H2, results in rNMPs 
remaining in the genome and leads to ~100-fold increase in the frequency of 2-5 bp deletions at 
di-nucleotide repeat sequences that are dependent on topoisomerase I (Top1) activity. Top1 has 
endoribonuclease activity against rNMPs in RNA/DNA hybrids. Here we present an in vitro 
reconstitution of the mechanism of Top1-dependent deletions at di-nucleotide repeat sequences 
and a mechanism for Top1-initiated removal of rNMPs outside of the context of these repeat 
sequences in S. cerevisiae. Top1 attack of rNMP leads to the formation of a 2’, 3’ cyclic 
phosphate terminated ssDNA nick, allowing for subsequent formation of a Top1-cleavage 
complex (Top1-cc). If the rNMP is in the context of a di-nucleotide repeat there can be 
realignment of the DNA allowing for religation and release of Top1, leading to a small deletion. 
If the rNMP resides outside a repeat sequence the realignment is not possible and a different 
pathway must repair the Top1-cc. Tdp1-dependent repair of Top1-cc requires prior proteolytic 
processing of the Top1-cc before it can be removed, leaves a 3’-phosphate that can be removed 
by Tpp1, Apn1, or Apn2 and forms a substrate suitable for repair by DNA polymerase δ, FEN1 
and DNA ligase. 
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INTRODUCTION 
 DNA replicative polymerases misincorporate approximately two ribonucleotides per 
kilobase of DNA replicate (Sparks, Chon et al. 2012). These incorporated ribonucleotides 
(rNMPs) constitute the most abundant replication error in cells. Removal of these rNMPs from 
the genome is important to maintain genomic stability (Nick McElhinny, Kumar et al. 2010). 
RNase H2-intiated ribonucleotide excision repair is the main pathway that removes 
ribonucleotides from the genome. In Saccharomyces cerevisiae, strains lacking functional RNase 
H2 are relatively normal but maintain large numbers of ribonucleotides in their genome (Nick 
McElhinny, Kumar et al. 2010), indicating yeast may have alternative mechanisms for replicating 
through rNMP containing DNA. In humans, mutations in any of the three subunits of RNase H2 
are responsible for a genetic syndrome known as Aicardi-Goutières syndrome (AGS) (Crow, 
Leitch et al. 2006). The mechanistic details of the pathogenesis are only recently becoming clear, 
but many questions still remain about what function(s) the RNase H2 mutations disrupt that lead 
to the disease. Further work in yeast may lead to an understanding of how incorporated rNMPs 
are processed in the absence of RNase H2. Our data may have relevance for understanding the 
underlying cause of the pathology of RNase H2 mutations.  
 RNase H2 deficient yeast strains show a distinct mutational pattern that is characterized 
by an increase in 2-5 bp deletions, specifically at sites of di-nucleotide repeats (Nick McElhinny, 
Kumar et al. 2010; Kim, Huang et al. 2011). The increase in 2-5 bp deletions in the RNase H2-
deficient cells is dependent on topoisomerase 1 (Top1) (Kim, Huang et al. 2011). Top1 is a type 
IB topoisomerase characterized by going through a covalent intermediate with the 3’-phosphate 
of the attacked strand. If Top1 is unable to religate the scissile DNA strand by displacement or 
loss of the 5’-hydroxyl then the Top1 can become covalently linked to the DNA through the 3’-
phosphate. These covalent complexes are termed Top1-cleavage complexes (Top1-cc). Human 
and vaccinia viral topoisomerase 1 proteins have been shown to possess endoribonuclease activity 
toward ribonucleotides in RNA/DNA hybrids (Sekiguchi and Shuman 1997; Kim, Huang et al. 
2011). The rNMP possesses a 2’-hydroxyl that can attack the covalently linked 3’-phosphate, 
which releases the Top1 and leaves a nick with the 3’-terminus as an rNMP with a 2’, 3’-cyclic 
phosphate (Sekiguchi and Shuman 1997). A model has been proposed for the Top1 induced 
mutagenesis based on these studies in which Top1 first cleaves the incorporated rNMP and leaves 
a 2’, 3’-cyclic phosphate terminated nick within or near a di-nucleotide repeat sequence. 
Subsequently, a second Top1 cleavage occurs to the 5’-side of the nick, within six nucleotides, 
which allows the diffusion of the short intervening oligonucleotide, including the rNMP, and 
leads to the formation of a Top1-cc (Cho, Kim et al. 2013). Resolution of this Top1-cc would 
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result from realignment on the non-cleaved DNA strand, allow proximity of the 5’-hydroxyl to 
the 3’-phosphate, permit religation of the DNA, and release of the Top1 protein (Cho, Kim et al. 
2013). The following round of replication or processing by mismatch repair pathway would lead 
to the 2-5 bp deletion in one of the daughter cells (Strand, Prolla et al. 1993). No direct 
biochemical studies have been undertaken to test this model in vitro. Top1-dependent rNMP-
initiated mutagenesis phenomenon is similar to the Transcription-Associated-Mutagenesis (TAM) 
in yeast, which also occurs specifically at di-nucleotide repeats in regions of highly transcribed 
sequences and is dependent on Top1. TAM is thought to occur by collision between the RNA 
polymerase and Top1 forming Top1-cc that must be resolved (Lippert, Kim et al. 2011). The 
mechanistic details of how Top1-cc leads to this mutagenesis is still unclear, and in vitro 
reconstitution will be important in understanding how Top1 causes these short deletions. 
 Resolution of Top1-cc has been an intense focus of study for some time, as several 
classes of therapeutic cancer drugs target Top1 and stabilize the cleavage complex leading to 
DNA damage. Several pathways have been shown to resolve Top1-cc in cells. One pathway has 
been extensively studied, the TDP1 (tyrosyl-DNA phosphodiesterase 1)-dependent pathway. 
Biochemical studies support a model in which Top1-cc must be partially unfolded and/or partially 
proteolyzed before Tdp1 is able to remove Top1 (Debethune, Kohlhagen et al. 2002). Several cell 
biological studies support a role of the proteasome in the Top1 proteolysis (Lin, Ban et al. 2008). 
The partially proteolyzed Top1-peptide can be removed by attack of the phospho-tyrosyl bond of 
the Top1 active site with the 3’-phosphate of the DNA (Debethune, Kohlhagen et al. 2002). Tdp1 
activity leaves a 3’-phosphate that must then be removed by several redundant pathways. These 
pathways include protein phosphatases Tpp1, Apn1, and Apn2 (Vance and Wilson 2001). Tpp1 
(three prime phosphatase 1) is a 3’-phosphatase that is distantly related to the T4 polynucleotide 
kinase but does not have the kinase domain. Apn1 and Apn2 are apurinic/apyrimidinic 
endonucleases that have endonuclease, 3’-diester, and 3’-5’ exonuclease activity. Genetic 
evidence supports a redundant role for these proteins in removal of the 3’-phosphate after Tdp1 
removal of the Top1-peptide (Vance and Wilson 2001). There have been several genetic studies 
that have implicated other pathways for resolving the Top1-cc, including roles for the Rad1-
Rad10 endonuclease as well as the homologous recombination machinery (Liu, Pouliot et al. 
2002). Further studies will be needed to resolve the mechanistic detail of these other pathways. 
Along with mutagenic effect of Top1 at sites of rNMPs a recent study has clearly demonstrated 
that, in the absence of RNase H2, Top1 leads to the repair of a small portion of the rNMPs which 
are incorporated into the yeast genome (Williams, Smith et al. 2013). The mechanistic details of 
how Top1 leads to the repair of incorporated rNMPs are unclear. 
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  In this study, we set out to investigate the mechanism of Top1-initiated repair of 
incorporated rNMPs using in vitro reconstitution, and to test the model previously proposed for 
the Top1-initiated mutagenesis. Our data supports a previously proposed model by Kim et al., in 
which Top1 cleaves on the 3’-face of rNMPs and is released by attack of the phosphate by the 2’-
hydroxyl. The resulting product is a single-strand nick with a 3’-terminal 2’, 3’-cyclic phosphate, 
and a 5’-hydroxyl. Top1 subsequently attacks the nicked strand, 2-5 nucleotides to the 5’-side of 
the ribonucleotide, which leads to the release of a short oligonucleotide including the rNMP. The 
release of the 2-nt oligonucleotide leads to Top1 covalently linked to the 3’-phosphate of the 
DNA. If the rNMP resides within a di-nucleotide repeat it leads to realignment of the cleaved 
strand leading to Top1 religation and subsequent loss of two nucleotides. The position of the 
rNMP in the di-nucleotide plays a major role in the ability of the realignment and subsequent 
religation by Top1. For rNMPs cleaved outside di-nucleotide repeats, our results favor a model in 
which the Top1-cc must be processed either by a Tdp1-dependent pathway or an endonuclease-
dependent pathway for repair to occur. We have reconstituted the Tdp1-dependent removal of the 
Top1-cc leading to the repair of the rNMP. We show that the Tdp1 pathway requires Top1 to be 
partially unfolded and or degraded before it can be a substrate for Tdp1 as previously reported 
(Debethune, Kohlhagen et al. 2002). Tdp1 leaves a 3’-phosphate that can be removed by Tpp1 or 
Apn1, which results in a substrate that can be extended by the replication machinery. We also 
have evidence that the tRNA ligase is able to resolve the 2’, 3’-cyclic phosphate to a 2’-
phosphate, but have been unable to determine how this product is resolved in cells. More work 
will need to be carried out to determine if there are other pathways involved in resolving the 2’, 
3’-cyclic phosphate product.  
 
RESULTS  
S. cerevisiae Top1 possesses endoribonuclease activity leaving a 3’-terminal 2’, 3’-cyclic 
phosphate.  
We began our study by overexpressing and purifying S. cerevisiae Top1 and testing the ability of 
the purified protein to cleave at incorporated rNMPs. We used an oligonucleotide system that 
reflects the sequence of a di-nucleotide repeat, identified as a Top1-dependent deletion hotspot in 
the S. cerevisiae CAN1 gene (Kim, Huang et al. 2011). The double-stranded oligonucleotides 
contain a single ribonucleotide at position either proximal or internal to the GA di-nucleotide 
repeat on the 32P-labeled strand. The addition of S. cerevisiae Top1 to the 5’-32P-labeled rNMP-
proximal substrate yielded two products; the first is consistent with the protein cleaving on the 3’-
side of the rNMP, and the second is a high molecular weight product that remains in the well of 
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the gel (Fig 1A). These products are dependent on the presence of the rNMP in the substrate and 
are not observed in the absence of rNMP (Supp. Fig 1; lanes 7 and 13). Addition of Top1 to a 3’-
32P-labeled substrate again shows a cleavage event on the 3’-side of the incorporated rNMP 
(Supp. Fig 1; lanes 7 and 8). The 3’-labeled cleavage product is resistant to alkaline phosphatase 
as is an RNase A cleavage product indicating Top1 cleavage leaves a 5’-hydroxyl terminus  
(Supp. Fig 1B; lanes 3, 4 and 7, 8). RNase H2, on the other hand, leaves a 5’-phosphate that is 
susceptible to alkaline phosphatase treatment (Supp. Fig1B; lanes 5 and 6). These data support 
our hypothesis that S. cerevisiae Top1 has endoribonuclease activity when ribonucleotides are 
incorporated into DNA. This cleavage leaves a 5’-hydroxyl and a 3’-phosphate. It was previously 
shown that vaccinia virus topoisomerase I cleaves rNMPs in DNA, leaving a 2’, 3’-cyclic 
phosphate at the 3’-terminus of the rNMP (Sekiguchi and Shuman 1997). We hypothesized S. 
cerevisiae Top1 cleavage at the rNMP would also result in the formation of the 2’, 3’-cyclic 
phosphate at the 3’-terminus. We set up a system to investigate the DNA end left by the Top1 
cleavage. The 5’-Cy3-label Top1 rNMP cleavage product is resistant to alkaline phosphatase 
treatment, which is able to remove 2’ or a 3’-phosphate, but unable to remove a 2’, 3’ cyclic 
phosphate (Fig 1B; lane 3). Also, the yeast 3’-DNA specific phosphatase Tpp1 is not able to 
remove the 2’, 3’ cyclic phosphate (Fig 1B; lane 4). Additionally, prior treatment with Trl1, the 
yeast tRNA ligase, is able to unhook the cyclic phosphate leaving a 2’-phosphate that can be 
removed by alkaline phosphatase but not Tpp1 (Fig 1C; lanes 5, 6 and 7). T4 polynucleotide 
kinase was used as a control since it was shown to be able to unhook 2’, 3’-cyclic phosphates and 
subsequently remove the 3’-phosphates from DNA (Fig 1C; lane 8) (Das and Shuman 2013). It is 
still unclear if Trl1 unhooks a 3’-terminal 2’, 3’-cyclic phosphate in dsDNA in vivo, and if the 
resulting 2’-phosphate is resolved in S. cerevisiae. More work will be needed to determine if Trl1 
has a role for resolving these lesions in vivo. We have been unable to find any other proteins that 
are able to resolve the cyclic phosphate in S. cerevisiae. It will be important to determine if the 
cyclic phosphate may be a dead-end product of the reaction in vivo.  
 
Top1-dependent rNMP nicks cause the formation of Top1-cc. 
A high molecular weight product is observed that increases with increasing Top1 concentrations, 
and is dependent on the presence of the rNMP in the substrate (Fig 1A). The 5’-labeled 
oligonucleotide remains in the wells of the gel, and addition of SDS does not change the running 
of the high molecular weight product. We hypothesized this product was the formation of a Top1-
cc in which Top1 was covalently linked to the DNA through a 3’-phosphotyrosyl bond. The 
formation of the covalent DNA-Top1complex increases over time (Fig 1C). The formation of the 
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Top1-cc results from Top1 cutting within six nucleotides of a persistent nick in the DNA which 
allows the short oligonucleotide to diffuse away, trapping Top1 (Cho, Kim et al. 2013); we have 
data about the precise distance from the rNMP nick that we will present later in this manuscript. 
Our results demonstrate that S. cerevisiae Top1 forms two products that are dependent on the 
presence of an rNMP in the dsDNA. First, we observe the previously reported 2’, 3’-cyclic 
phosphate at the rNMP; and, second, a Top1-cc where Top1 is covalently linked to the cleaved 
strand. We set out to understand the order of the reaction in the formation of these two products. 
 We hypothesize the formation of the rNMP-terminated nick by formation of a 2’, 3’-
cyclic phosphate precedes the formation of the Top1-cc. The formation of both the cyclic 
phosphate product and the Top1-cc were monitored over time (Fig 1D). The Top1-DNA complex 
was resolved on the urea-PAGE gel by first degrading the Top1 protein with proteinase K, which 
gave several products that corresponded to different lengths of Top1-peptide linked to the 
ssDNA. We observe an early accumulation (5%) and subsequent decrease of the 2’, 3’-cyclic 
phosphate cleavage product (Fig 1E). The formation of Top1-cc is slower than the 2’, 3’ cyclic 
phosphate and accumulates over time (81%) (Fig 1E). Our data is consistent with a model where 
Top1 first cleaves at the rNMP leaving the 2’, 3’-cyclic phosphate. Subsequently, a second Top1 
cleavage event occurs upstream of the nick and allows for the diffusion of the short 
oligonucleotide, including the rNMP, which causes Top1 to be covalently linked to the DNA (Fig 
2B) (Kim, Huang et al. 2011; Cho, Kim et al. 2013).  
   
rNMP-induced Top1-cc can be resolved by Tdp1. 
One pathway for removal of Top1-cc is through the Tdp1-dependent pathway. We tested the 
ability of purified S. cerevisiae Tdp1 to remove the covalently linked Top1 from our DNA 
substrate. As previously reported, the full length Top1-cc is resistant to Tdp1 treatment (data not 
shown) (Debethune, Kohlhagen et al. 2002). We then set up a reaction where the rNMP 
containing substrate was first treated with Top1 and subsequently stopped by addition of EDTA, 
SDS, and proteinase K to degrade Top1 down to small peptides. The purified double stranded 
oligonucleotide was then used for subsequent reactions. The proteinase K treatment leads to 
several different Top1-peptide-DNA products corresponding to different peptide lengths (Fig 3A; 
lane 1). Using this substrate, Tdp1 is efficiently able to remove the Top1-peptides from the 3’-
phosphate of the ssDNA (Fig 3A, lane 2). Tpp1 (Fig 3A; lane 3), Apn1 (Supp Fig2; lane 8), or 
Apn2 (Supp Fig2; lane 9) are able to remove the remaining 3’-phosphate with varying 
efficiencies. The resulting product is consistent with the second Top1 cleavage; it occurs 
primarily one-nucleotide 5’ of the rNMP (89%) and leads to the release of a di-nucleotide, 
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including the rNMP, and leaving a two-nucleotide gap (Fig 3A; lane 3). We also observe a small 
amount of product that is consistent with the second cleavage occurring two (4%), three (5%), or 
four (2%) nucleotides from the rNMP-terminated nick and leaving a three, four, or five nucleotide 
gap, respectively. Our data demonstrates the second Top1-dependent cleavage event happens 
preferentially, two-nucleotides 5’ to the nick with minor products that are three to five 
nucleotides 5’ to the nick.  
 
When an rNMP is in the context of di-nucleotide repeat sequence Top1 alone can lead to 2-
nucleotide deletions in vitro.  
Previously it was demonstrated that Top1 was capable of cleaving at incorporated rNMPs, and 
that in the context of a rnh201 deletion in S. cerevisiae Top1is able to remove a small portion of 
incorporated rNMPs, but causes short deletions that specifically occur at di-nucleotide repeat 
sequences in the process (Kim, Huang et al. 2011; Williams, Smith et al. 2013). We set out to test 
whether the location of the rNMP, either internal or proximal to a di-nucleotide repeat, affects the 
processing activity of Top1 treatment. The treatment of two, 32-nucleotide rNMP containing 
dsDNA substrates, with the rNMP either internal (GAGArGA) or proximal (GAGAGArU) to the 
di-nucleotide repeat sequence, reveals different Top1-dependent products (Fig 3A). First, Top1 
treatment of the rNMP internal substrate (GAGArGATGC) leads to the 2’, 3’-cyclic phosphate 
cleavage and the Top1-cc, but surprisingly we also observe the appearance of a small fraction of a 
30-nucleotide religation product (5%) at 90 minutes (Fig 3A). Top1-treatment of the rNMP 
proximal substrate (GAGAGArUGC) also leads to the formation of the 2’, 3’-cylic phosphate 
terminated nick and the Top1-cc, but no religation products are observed (Fig 3A). This is the 
first biochemical reconstitution of the Top1-dependent deletions at di-nucleotide repeats. To 
further test the importance of the sequence context of the di-nucleotide repeat we increased the 
length of the di-nucleotide repeat by one repeat unit (GAGAGArGATGC), and repeated the Top1 
treatment. As expected, the increase in repeat-length increases the kinetics of religation, and the 
fraction of religation product increases from 5% to 46% after 90 minutes (Fig 3A). We then 
hypothesized that changing ribo-guanine to a ribo-cytosine would disrupt the realignment of the 
Top1-cc and decrease religation; in fact, this is what we observe with the change of the rGA to a 
rCA. The efficiency is drastically reduced from 46% religation product to 5% after 90 minutes. A 
comparison of the accumulation of Top1-dependent products between the rGA and rCA 
sequences demonstrates that the kinetics of the first Top1 cleavage event and formation of the 
Top1-cc are identical; but, on the rGA substrate the Top1-cc is then converted to the 32-mer 
religation product, whereas the rCA substrate Top1-cc remains stable with little religation (Fig 
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3B). Similar religation activity is seen with a different di-nucleotide repeat (TATA) and the 
rNMP positioned internally, so that realignment of the DNA 3’-oligonucleotide is required. 
Treatment of repeat sequence (GArUATGC) allows for possible realignment on the 3’-side of the 
2-nucleotide gap, formed after the formation of the Top1-cc, and is also able to form the 
religation product with faster kinetics and even more efficiency (81%) after 90 minutes (Fig 3A). 
The starting substrate is susceptible to cleavage by NaOH, consistent with the presence of an 
rNMP in the substrate; whereas the Top1-dependent religation product is resistant to NaOH, 
which supports our hypothesis that the rNMP is removed from the religation product by Top1 
(Fig 3C). The removal of the rNMP by Top1 would be one possible mechanism of rNMP removal 
previously observed (Williams, Smith et al. 2013). Our data supports the previously proposed 
model by Chon et al. (Fig 5). These results are also relevant for another Top1-dependent 
mutagenic phenomenon, transcription associated mutagenesis (TAM), characterized by 
accumulation of short deletions specifically at di-nucleotide repeat sequences in highly 
transcribed regions of the genome (Lippert, Kim et al. 2011). We were also interested in how 
Top1 would lead to repair of incorporated rNMPs outside of the context of di-nucleotide 
sequences, as these incorporation sites would represent the majority of rNMP incorporations in 
the genome. We began by investigating the ability of the Tdp1 dependent pathway to remove 
Top1-cc that are stable when the ssDNA ends are unable to realign to allow for religation by 
Top1.  
 
Tdp1-pathway leads to substrate for strand displacement synthesis by Pol δ. 
We used the Top1-peptide linked oligonucleotide and hybridized it to a template that contained 
both a 5’ and 3’-biotin to allow for binding to streptavidin. The streptavidin does not allow RFC 
loaded PCNA to slide off of the DNA and allows more efficient replication by polymerase δ (Pol 
δ). Therefore, preloading PCNA onto this substrate with dNTPs does not allow the addition of Pol 
δ to extend the peptide-linked oligonucleotide primer (Fig 4; lane 2). Neither is it able to extend 
the oligonucleotide treated with Tdp1 or Tpp1 alone (Fig4; lanes 4 and 6). Pol δ is only able to 
extend the oligonucleotide when both Tdp1 and Tpp1 are both added to the reaction leaving a 3’-
hydroxyl, and the extended product is resistant to treatment with sodium hydroxide which is 
consistent with the rNMP being removed from the substrate (Fig 4; lane 8 and 9). We also 
observe that both Apn1 and Apn2 are able to remove the Top1- peptides from the DNA with 
different efficiencies and leaving a 3’-hydroxyl with subsequent 3’-exonuclease activity, as 
previously observed (Supp. Fig 2) (Liu, Pouliot et al. 2002). The genetic data from previous 
studies indicate that Apn1 and Apn2 may not remove Top1 from DNA in vivo because epistasis 
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experiments demonstrate that Tdp1 is epistatic with Apn1 and Apn2, indicating these proteins are 
in the same pathway (Liu, Pouliot et al. 2002). The authors believe Apn1 and Apn2 play a 
redundant role with Tpp1 in removal of the 3’-phosphate left by Tdp1 activity. Our data 
demonstrates that a Tdp1-dependent pathway can efficiently remove the Top1-cc caused by the 
rNMP. First, the covalently linked Top1 must be partially unfolded and degraded, leaving DNA-
linked peptides that can be removed by Tdp1 and a 3’-phosphate that can be subsequently 
removed by Tpp1, Apn1, or Apn2, resulting in a 3’-hydroxyl. The replication clamp PCNA and 
Polδ are then able to carry out strand displacement synthesis with the help of FEN1 and ligase 
that allow for repair of the ssDNA gap (Fig 5). There are several pathways for removal of Top1-
cc that have been described genetically and all of these pathways will likely play a role in 
removal of the Top1-cc left at after attack of an rNMP in vivo. More work will be needed to 
reconstitute these pathways in vitro.    
 
DISCUSSION 
 Topoisomerase 1 has been clearly demonstrated to cause short-deletions at di-nucleotide 
repeat sequences in yeast, including transcription-associated mutagenesis (TAM) and rNMP-
induced mutagenesis, in the absence of a functional RNase H2 complex. How Top1 leads to these 
deletions has been a mystery, and it was unclear if other factors were involved in this process. 
Chon et al. proposed a model for Top1-dependent deletions based on genetic evidence. Here we 
present the first reconstitution of the Top1-mediated deletions using purified S. cerevisiae Top1. 
We believe that the data presented here is relevant to both Top1-dependent mutagenic 
phenomena, both being mediated through a Top1-cc formed in a di-nucleotide repeat sequence. 
 Our data supports a model where Top1 first cuts at the rNMP in the context of a repeat 
sequence, leaving a 2’, 3’-cyclic phosphate terminated nick and allowing for the formation of a 
Top1-cc two nucleotides to the 5’-side of the nick. Next, the repeat sequences allow for 
realignment of the cleaved strand with the terminal nucleotides perfectly base paired to allow for 
religation of the cleaved strand by Top1 (Fig 5). It is possible that other factors influence, either 
in a positive or negative fashion, the creation of these deletions but more work will be needed to 
test that hypothesis. Our model explains the requirement of repetitive DNA sequence to allow for 
realignment of the DNA ends to allow for perfect base pairing, and bulging of nucleotides 
downstream from the religation. We have also reconstituted one mechanism of repair of rNMPs 
outside these repeat sequences where we see no evidence of Top1-dependent religation. Our 
results support a model where Top1-cc must be processed by a repair pathway such as the Tdp1-
dependent pathway. The majority of rNMP incorporation events likely occur outside of the 
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context of a repeat sequence leading to the majority of Top1-dependent rNMP removal leading to 
a stable Top1-cc that must be repaired. These lesions will most likely be deleterious to the cell 
which fits nicely with in vivo studies in the context of an rnh201∆ and pol2-M644G, a Polε 
mutant that incorporates rNMPs at a higher frequency than wild type Polε; these cells have 
constitutive checkpoint activation and increased sensitivity to replication stress that is dependent 
of Top1 (Williams, Smith et al. 2013).  
 Further studies will need to be carried out to determine if there are other factors that 
contribute to the Top1-dependent deletions. It will also be interesting to determine if Trl1 is able 
to lead to the removal and religation of the 2’, 3’-cyclic phosphate terminated intermediate 
formed by Top1 attack at an rNMP.  
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EXPERIMENTAL PROCEDURES 
 Proteins and oligonucleotides- RPA (Henricksen, Umbricht et al. 1994), PCNA 
(Eissenberg, Ayyagari et al. 1997), RFC (Gomes, Gary et al. 2000), FEN1 (Gomes and Burgers 
2000), and RNaseH2 (Jeong, Backlund et al. 2004) were purified from E. coli overexpression 
systems, while Pol δ (Fortune, Stith et al. 2006) were purified from yeast overexpression systems. 
Top1 was overexpressed by pRS425-GGT-TOP1 containing Schistosoma japonicum glutathione 
S-transferase (GST) gene fused to the N-terminus of the TOP1 gene in vector pRS425-GALGST-
term (Walker, Crowley et al. 1993). The GST tag is separated from the N-terminus of the Top1 
by a recognition sequence for the human rhinoviral 3C protease (LEVLFQ/GP). Following 
cleavage by the protease, the N-terminal sequence of Top1 is extended with the GPEFDIKL 
sequence. Tpp1, Trl1, Apn1, and Apn2 proteins were overexpress from the Open Biosystems S. 
cerevisiae open reading frame library in the vector backbone BG1805.  
 Oligonucleotides were purchased from IDT (Coralville, IA) and purified by HPLC 
chromatography: NTS-GCT, TTTGAAATACCGTGGCATCTCTCGTGACGAGT; TS-GCT, 
ACTCGTCACGAGAGATGCCACGGTATTTCAAA; NTS-GCT-Biotin, 
/biotin/CTACAGCACCAGATTCAGCAATTAAGCTCTAATTTGAAATACCGTGGCATCTC
TCGTGACGAGT/biotin/; TS-TC-rU5’Cy3, 
/Cy3/ACTCGTCACGAGAGArUGCCACGGTATTTCAAA; TS-TC-rG5’Cy3, 
/Cy3/ACTCGTCACGAGArGATGCCACGGTATTTCAAA; NTS-GAGAGAGA, 
TTTGAAATACCGTGGCATCTCTCTCGTGACGAGT; TS-GAGAGArGA5’Cy3, 
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/Cy3/ACTCGTCACGAGAGArGATGCCACGGTATTTCAAA; NTS-GAGAGArU, 
TTTGAAATACCGTGGCATATCTCTCGTGACGAGT; TS-GAGAGArU, 
/Cy3/ACTCGTCACGAGAGArUAAGCCACGGTATTTCAAA; NTS-CTCTCTATTC, 
TTTGAAATACCGTGGCTTATCTCTCGTGACGAGT ; TS-GAGAGArUAA5’Cy3, 
/Cy3ACTCGTCACGAGAGArUAAGCCACGGTATTTCAAA; NTS-CTCTCTATAT, 
TTTGAAATACCGTGGTATATCTCTCGTGACGAGT; TS-GAGAGArUATA5’Cy3, 
/Cy3ACTCGTCACGAGAGArUATACCACGGTATTTCAAA. The 5’-32P-label was introduced 
on oligonucleotides using [γ-32P] ATP and T4 Polynucleotide kinase, while the 3’-32P-label was 
by incubation with [α-32P] dATP and terminal deoxynucleotide transferase under manufacturers’ 
conditions. Labeled oligonucleotides were hybridized with a two-fold excess of the relevant 
complimentary oligonucleotide.  
Top1 overexpression and purification- Top1 overproduction was carried out in S. 
cerevisiae strain FM113 (MATa ura-3-52 trp1-289 leu2-3112 prb1-1122 prc1-407 pep4-3) 
transformed with plasmid pRS425-GGT-TOP1. Growth, induction, extraction preparation, and 
ammonium sulfate precipitation (0.3 g/ml) were similar to the procedures described previously 
(Bylund, Majka et al. 2006). The ammonium sulfate precipitate was resuspended in buffer A0 
(buffer A: 60 mM HEPES-NaOH [pH 7.4], 10% glycerol, 1 mM dithiothreitol (DTT), 1 mM 
EDTA, 0.01% polyoxyethylene (10) lauryl ether, 1 mM sodium bisulfite, 1 µM pepstatin A, 1 
µM leupeptin; subscript indicates the mM sodium chloride concentration), until the lysate 
conductivity was equal to that of buffer A400. The lysate was then used for batch binding to 
glutathione-Sepharose 4B beads (GE Healthcare), equilibrated with buffer A400, and gently 
rotated at 4 ˚C for two hours. The beads were collected at 1,000 rpm in a swinging-bucket rotor, 
followed by batch washes (3 × 20 ml of buffer A400). The beads were transferred to a 10 ml 
column, and washed at 2.5 ml/min with 100 ml of buffer A400. The second washing was with 50 
ml buffer A400 containing 5 mM Mg-acetate and 1 mM ATP. And the third washing used 50 ml of 
buffer A400 and 30 ml of buffer A200. Elution was carried out at a flow rate of 0.2 ml/min with 
buffer A150 containing 30 mM glutathione (pH adjusted to 8.1). Fractions containing Top1 were 
combined and incubated overnight at 4 ˚C with 30 U of rhinoviral 3C protease. The following day 
the Top1 protein was loaded on a heparin column in buffer A150 without protease inhibitors. The 
column was washed with 10 column volumes of buffer A300, the protein was eluted with buffer 
A750. Fractions containing pure Top1 were collected and dialyzed overnight to A200 without 
protease inhibitors.  
Protein overexpression and purification- Trl1, Tpp1, Apn1, and Apn2 were purified in 
an identical manner. Overproduction was carried out in S. cerevisiae strain FM113 (MATa ura-3-
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52 trp1-289 leu2-3112 prb1-1122 prc1-407 pep4-3) transformed with plasmid BG1805 
containing TRL1, TPP1, APN1, or APN2 respectively. Growth, induction, and extraction 
preparation were similar to the procedures described previously (Bylund, Majka et al. 2006). 
Extraction and wash buffer B300 except extraction buffer used HEPES-NaOH [pH7.8](Buffer B: 
50 mM HEPES-NaOH [pH 7.4], 10% glycerol, 5 mM dithiothreitol (DTT), 4 mM MgCl, 1 mM 
EDTA, 0.02% NP40, 1 mM sodium bisulfite, 1 µM pepstatin A, 1 µM leupeptin; subscript 
indicates the mM sodium chloride concentration). Cell extracts were cleared by centrifugation at 
18000K for 30 min. The cleared cell extracts were batch bound with B300 equilibrated Igg beads () 
rotating at 4 ˚C for two hours. The beads were then collected and washed with twenty column 
volumes of B300. Followed by a second wash with buffer B300 containing 5 mM Mg-acetate and 1 
mM ATP. The beads were then equilibrated with cleavage buffer (50 mM HEPES-NaOH [pH 
7.4], 10% glycerol, 1 mM dithiothreitol (DTT), 1 mM EDTA, 0.01% NP40, 500 mM NaCl). The 
beads were then rotated overnight in one column volume of cleavage buffer with 30U of 
rhinoviral 3C protease at 4 ˚C. The following day the supernatant was eluted from the beads and a 
second cleavage step was carried in one column volume of cleavage buffer.  
rNMP repair assay- The standard 10 µl assay mixture contains 100 mM Tris-HCl (pH 
7.8), 500 µg/ml bovine serum albumin, 5 mM DTT, 5 mM Mg-acetate, 50 mM NaCl, 100 fmol of 
32P-end-labeled oligonucleotide substrate or 250 fmol Cy3-end-labeled oligonucleotide, and 
enzyme. Incubations were carried out at 30 ˚C for the indicated time periods. Deviations for the 
standard assay conditions are indicated in the legends of the figures. Reactions were stopped with 
stop buffer containing 10 mM final concentration of EDTA, 0.05% SDS, and 40% formamide. 
Samples were analyzed on a 17% 7 M urea-PAGE electrophoresis. After the gels were dried they 
were subjected to phosphorImager analysis, or directly imaged for Cy3-signal.  
 Repair assays were generally carried out in two stages. In the first stage, the rNMP 
containing substrate was treated with two-fold excess concentration of Top1 to produce a mixture 
of full length substrate, rNMP 2’, 3’-cyclic phosphate nicked substrate, and Top1-covalently 
linked substrate. The reactions were stopped with stop buffer as previously described. To purify 
the 2’, 3’-cyclic phosphate containing substrate the DNA was ethanol precipitated and used for 
subsequent reactions. The Top1-covalent linked substrate was purified by first treatment with 
proteinase K at 50 ˚C for 30 minutes followed by phenol-chloroform extraction and ethanol 
precipitation. The replication substrates were purified as previously stated, but then the ssDNA 
was purified by 7M-urea-PAGE purification. The oligo was then hybridized to NTS-GCT-Biotin 
template strand.   
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LEGENDS TO FIGURES 
 
Figure 1. Top1 is an endoribonuclease forming a 3’-terminal 2’, 3’-cyclic phosphate 
followed by formation of Top1-cc. 
(A) Activity of Top1 on dsDNA with single rNMP. Standard assay mixtures used 10 nM 5’-32P-
labeled 32-oligonucleotide in dsDNA substrate. The concentrations of Top1 from left to right are 
1.5, 5, 15, 50, 150 nM. The reactions were carried out at 30 ˚C for 10 min. The results were 
analyzed on a 7 M urea-17% polyacrylamide gel. (B) 5’-cy3-labeled ssDNA with a single-rNMP 
in dsDNA substrate was treated with Top1 under standard assay conditions for 1 hour at 30 ˚C. 
The DNA containing 2’, 3’-cyclic phosphate terminated nick was then isolated and purified, and 
the DNA was incubated in a second reaction with 25 nM DNA substrate supplemented with T4 
polynucleotide kinase, alkaline phosphatase, Tpp1 (25 nM), Trl1 (25 nM), or in combination as 
indicated for 10 minutes at 30 ˚C, except T4 PNK treatment was 60 minutes at 37 ˚C. The results 
were analyzed on a 7 M urea-17% polyacrylamide gel. (C) Formation of Top1-cc on rNMP 
containing dsDNA substrate. Standard assay mixtures used 25 nM 5’-cy3-labeled 32-nucleotide 
ssDNA oligonucleotide containing a single rNMP in dsDNA substrate. The concentration of 
Top1 used was 100 nM. The reactions were carried out at 30 ˚C for times indicated. The reactions 
were results were analyzed by 11% PAGE. (D) and (E) Top1 first forms 2’, 3’-cyclic phosphate 
prior to formation of Top1-cc. Standard assay mixtures used 25 nM 5’-cy3-labeled 32-nucleotide 
ssDNA oligo containing a single rNMP in dsDNA substrate. The concentration of Top1 was 100 
nM. The reactions were carried out at 30 ˚C for times indicated. The reactions were then stopped 
with 10 mM EDTA and 0.5% SDS and treated with proteinase K to release ssDNA from Top1 
protein. The reactions were results were analyzed by 7 M urea-17% polyacrylamide gel. (E) 
Quantitation of gel in (D) left y-axis represents percent cyclic phosphate and the right y-axis 
represents percent Top1-cc formation.  
 
Figure 2. Top1-cc formed by Top1 cleavage two-nucleotides to the 5’-side of 2’, 3’-cyclic 
phosphate. (A) 5’-cy3-labeled ssDNA with a single-rNMP in dsDNA substrate was treated with 
Top1 under standard assay conditions for 1 hour at 30 ˚C. The DNA containing 2’, 3’-cyclic 
phosphate terminated nick and Top1-cc was then treated with proteinase K at 42 ˚C for 30 
minutes followed by isolation and purification. Then DNA was incubated in a second reaction 
with 25 nM DNA substrate supplemented with Tdp1 (25 nM), Tpp1 (25 nM), Apn1 (25 nM), 
Apn1-D192 (nM), or Apn2 (25 nM) or in combination as indicated for 10 minutes at 30 ˚C. The 
results were analyzed on a 7 M urea-17% polyacrylamide gel. (B) Our model for the formation of 
2’, 3’-cyclic phosphate terminated nick dsDNA, and subsequent formation of Top1-cc. See text 
for details.  
 
Figure 3. Top1 leads to deletions when rNMP is in the context of repetitive DNA sequences. 
(A) The Top1 dependent deletions are observed through the religation activity of Top1 on dsDNA 
with single rNMP either internal or proximal to di-nucleotide repeat sequence. Standard assay 
mixtures used 25 nM 5’-cy3-labeled oligonucleotide with a single rNMP either internal or 
proximal to a GA or TA di-nucleotide repeat hybridized to its template strand substrate. The 
concentration of Top1used was 250 nM. The reactions were carried out at 30 ˚C for the time 
indicated. The results were analyzed on a 7 M urea-17% polyacrylamide gel. (B) Graphic 
representation of the quantification of the four products of the Top1 religation reactions. The 
quantitation of the rGA reaction from (A) is represented in solid curves, where the quantitation of 
the rCA reaction from (A) is represented in dashed curves. The 34-mer is the starting substrate 
(green), where the 32-mer is the religation product (red), the Top1-DNA is the Top1-cc (blue), 
and finally the 16-mer represents the cyclic-phosphate product formed by Top1 cleavage at the 
ribonucleotide (black). The rGA and rCA 16-mer curves were identical and combined for clarity 
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purposes. (C) The rNMP is removed in the Top1 religation products. Standard assay mixtures 
used 25 nM 5’-cy3-labeled oligonucleotide with a single rNMP internal GA di-nucleotide repeat 
hybridized to its template strand substrate. The concentration of Top1used is 250 nM. The 
reactions were carried out at 30 ˚C for the time indicated. Samples as indicated were treated with 
0.3 M NaOH at 50 ˚C for 30 minutes. Then the samples were neutralized with 0.3 M acetic acid. 
The results were analyzed on a 7 M urea-17% polyacrylamide gel. 
 
Figure 4. Reconstitution of the Tdp1-dependent pathway of Top1-cc resolution. 5’-cy3-
labeled 34-nucleotide oligonucleotide with a single-rNMP was hybridized with ssDNA template. 
The substrate was treated with Top1 under standard assay conditions for 1 hour at 30 ˚C. The 
DNA containing Top1-cc was then treated with proteinase K at 42 ˚C for 30 minutes followed by 
isolation and purification by 7 M urea-17% polyacrylamide gel. Then DNA was then hybridized 
to a 64-nucleotide template contain both 5’ and 3’ biotin bumpers was incubated in a second 
reaction with 25 nM DNA substrate supplemented with streptavidin (100 nM), PCNA (50 nM), 
RFC (100 nM), RPA (50 nM), 100 µM ATP as well as Tdp1 (25 nM), Tpp1 (25 nM), or in 
combination as indicated for 10 minutes at 30 ˚C either in the presence of absence of 50 nM Polδ. 
Samples treated with 0.3 M NaOH at 55 ˚C for 30 minutes and quenched with acetic acid 0.3 M 
are indicated. The results were analyzed on a 7 M urea-17% polyacrylamide gel. 
 
Figure 5. Model for Top1-dependent rNMP removal either in the context of di-nucleotide 
repeat sequence or in non-repetitive DNA. See text for details.  
  
 
Supplemental Figure 1. Top1 cleavage is dependent on the presence of rNMP in dsDNA and 
the cleavage leaves 5’-hydroxyl terminus. Activity of Top1 on a 3’-labeled single-rNMP 
containing dsDNA substrate. Standard assay mixtures used 10 nM 3’-32P-labeled 32-nucleotide 
dsDNA substrate either with or without single rNMP in labeled strand. The concentration used in 
the assay for Top1 50 nM and RNase H2 1 nM. The reactions were carried out at 30 ˚C for 10 
min. The results were analyzed on a 7 M urea-17% polyacrylamide gel. 
 
Supplemental Figure 2. Apn1 and Apn2 are capable of cleaving phospho-tyrosyl bond of 
Top1 peptides. 5’-cy3-labeled ssDNA with a single-rNMP in dsDNA substrate was treated with 
Top1 under standard assay conditions for 1 hour at 30 ˚C. The DNA containing 2’, 3’-cyclic 
phosphate terminated nick and Top1-cc was then treated with proteinase K at 42 ˚C for 30 
minutes followed by isolation and purification. Then DNA was incubated in a second reaction 
with 25 nM DNA substrate supplemented with Tdp1 (25 nM), Tpp1 (25 nM), Apn1 (50 nM), or 
Apn2 (50 nM) or in combination as indicated for 10 minutes at 30 ˚C. The results were analyzed 
on a 7 M urea-17% polyacrylamide gel. 
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Future aims and directions 
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 Exonuclease 5  
 Exonuclease 5 was first discovered in S. cerevisiae by Peter Burgers, over twenty-five 
years ago, as a unknown gene product that cleaved ssDNA leaving a di-nucleotide as a major 
product (Burgers, Bauer et al. 1988). There were no other investigations into what gene encoded 
EXO5, and no biochemical studies had been carried out. Chapter II presented here identified 
EXO5 to be encoded by the gene DEM1 (Defects in Morphology) in S. cerevisiae (Burgers, Stith 
et al. 2010). Deletion of DEM1 led to defects in the morphology of the mitochondria, and caused 
respiratory loss in the cells (Entian, Schuster et al. 1999; Dimmer, Fritz et al. 2002). DEM1 
homologs were identified in other species. The work presented in this dissertation describes our 
work to elucidate the biochemical activity of this protein family and its role in DNA metabolism. 
All of the Exo5 homologs tested are bi-directional single-strand DNA specific exonucleases. The 
S. cerevisiae homolog is essential for mitochondrial genome maintenance, but does not play an 
apparent role in the nucleus. This strong mitochondrial localization seems to be restricted to the 
Saccharomycetales order. The human homolog is a nuclear and cytoplasmic protein that is 
important for nuclear genome maintenance. The S. pombe homolog is important for both nuclear 
and mitochondrial genome maintenance in a redundant role with Rad2 (FEN1). There are many 
questions that still need to be answered, both about the biochemical activity of these proteins and 
their role in DNA metabolism.    
Specific questions that need to be addressed 
S. pombe 
The studies in S. pombe are still in progress and we are preparing a manuscript for publication. 
There are several questions that need attention that I will address here. First, the protein-protein 
interactions found from the co-immunoprecipiation of spExo5. There are several interactions that 
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 we have not characterized including with two 14-3-3 proteins, Rad24 and Rad25, as well as an 
interaction with the RuvB like proteins Rvb1 and Rvb2. The importance of these interactions still 
needs to be investigated. We also set out to further investigate the spExo5 RPA and PCNA 
interactions by two-hybrid analysis. The results have been unclear. It is possible that the 
introduction of the N-terminal Gal4 domains is occluding the interaction surfaces. We plan to 
change the tag to the C-terminus to test this possibility. It is also possible that the interaction is 
mediated by some post-translation modification that does not occur when these proteins are 
expressed in S. cerevisiae. Our two-hybrid analysis has yielded one interesting possible 
interaction between spExo5 and the covalent modification Sumo. This result is only preliminary 
and more work will be needed to further investigate this possible interaction. spExo5 has several 
possible Sumo interaction motifs, but we still need to carry out more experiments to test this 
hypothesis.  
Future Directions 
 The first area of discussion is of future investigation into the biochemical activities of 
Exo5 family members. One aspect that needs to be further examined is the sliding activity of the 
human and S. pombe homologs. The kinetics of sliding seems to be greater than the kinetics of 
cleavage. We have begun a collaboration with the lab of Tim Lohman to use single molecule 
approach to investigate the sliding of the human homolog of Exo5 similar to his lab studies of E. 
coli SSB sliding along ssDNA (Zhou, Kozlov et al. 2011). It is still not known what function the 
sliding activity has in vivo, or if it is regulated in cells by either post-translation modifications or 
protein-protein interactions. Another aspect of human homolog is to determine why the activity 
is approximately 100-fold lower than the S. pombe or S. cerevisiae homologs. It is possible that 
there are post-translational modification(s) that are required to activate the human protein in vivo 
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 that are not present in our purified protein, or again it is possible there are protein interactions 
that activate the nuclease activity.  
 One interesting aspect of the Exo5 family of proteins is the presence of a 4Fe-4S iron-
sulfur cluster complex. The presence of the iron-sulfur complex is important for the nuclease 
activity of these proteins. Use of iron-sulfur complexes as structural motifs in proteins is an 
ancient mechanism for stabilizing protein structures, but recently a hypothesis has been put 
forward that some iron-sulfur clusters are redox active and this redox activity is important for the 
protein function in vivo(Nunez, Holmquist et al. 2001). There is a growing list of DNA 
metabolism proteins that contain iron-sulfur clusters including the replicative polymerases, many 
helicases, and helicase-nuclease (Wu and Brosh 2012). It will be interesting to investigate if the 
4Fe-4S complex of the Exo5 family is redox active and if the biochemical properties of the 
enzyme changes in different redox states. These are some of the questions that should be 
addressed as to the biochemical function of the Exo5 family nucleases.  
 There are also many questions about the in vivo function of the Exo5 family of proteins. 
First, in S. cerevisiae how Exo5 functions in the mitochondria is still not known. One caveat to 
trying to understand the role of Exo5 in mitochondrial genome maintenance is that very little is 
known in general about mitochondrial replication and repair in S. cerevisiae.  
 The studies in S. pombe are still in progress and we are preparing a manuscript for 
publication. There are several questions that need attention that I will address here. First, the 
protein-protein interactions found from the co-immunoprecipiation of spExo5. There are several 
interactions that we have not characterized including with two 14-3-3 proteins, Rad24 and 
Rad25, as well as an interaction with the RuvB like proteins Rvb1 and Rvb2. The importance of 
these interactions still needs to be investigated. We also set out to further investigate the spExo5 
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 RPA and PCNA interactions by two-hybrid analysis. The results have been unclear. It is possible 
that the introduction of the N-terminal Gal4 domain is occludes the interaction surfaces. We plan 
to change the tag to the C-terminus to test this possibility. It is also possible that the interaction is 
mediated by some post-translation modification that does not occur when these proteins are 
expressed in S. cerevisiae. Our two-hybrid analysis has yielded one interesting possible 
interaction between spExo5 and the covalent modification Sumo. This result is only preliminary 
and more work will be needed to further investigate this possible interaction. spExo5 has several 
possible Sumo interaction motifs, but we still need to carry out more experiments to test this 
hypothesis.  
 The function of Exo5 in S. pombe seems to have a dual function in both mitochondrial 
and nuclear genome maintenance; although, in S. pombe Exo5 is not essential and we have 
shown that there is functional redundancy with Rad2. There also seems to be a difference in the 
phenotype of the loss of Exo5 on the mitochondrial DNA. In S. cerevisiae exo5∆ leads to large 
deletions of parts of the mitochondrial genome, whereas in S. pombe exo5∆ rad2∆ leads to 
depletion of the mitochondrial genome without gross deletion(s) and expansion of the DNA. It is 
possible that the replication mechanisms are different between these two species, and that may 
explain the difference in phenotype of exo5∆, but very little work has been carried out to 
describe the mitochondrial replication mechanism in yeast. It will be important to determine if 
the mitochondrial or nuclear functions of Exo5 and Rad2 are responsible for the synergistic 
sensitivity to DNA damaging agents. Our data now seem to indicate that both the nuclear and 
mitochondrial functions are important in that neither the nuclear nor the mitochondrial isoform 
complemented the exo5∆rad2∆ hypersensitivity to either MMS or cis-platin. To further test the 
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 requirement of both functions I will co-express both isoforms in an exo5∆rad2∆ strain to see if 
co-expression allows for complementation.  
 The nuclear function of Exo5 in S. pombe is also still an area that will need to be a focus 
of future work. It will be important to continue to expand the epistasis analysis of the exo5∆ with 
other known DNA repair proteins. We have evidence that spExo5 epistatic with the Fan1-Fml1 
pathway, but we still have not tested the possibility that Exo5 is important for the Pli1 pathway 
of ICL repair. I am currently making the Pli1 deletion strains. Finally, the overexpression of S. 
pombe Exo5 leads to checkpoint activation and cell death. We hypothesize the interaction of 
Exo5 with RPA is important for this phenotype. It will be of interest to determine how RPA 
influences Exo5 activity in vitro, and to understand why the Exo5-RPA interaction causes 
checkpoint activation.  
 Many aspects of how the human homolog works in vivo still to be determined. Initially, it 
will be interesting to investigate if the human protein also has a mitochondrial function as is seen 
in S. pombe. We have not carefully investigated the localization of Exo5 in human cells. Also, in 
collaboration with Zhongsheng You, we have examined the recruitment of Exo5-GFP to site 
directed laser stripping (data not shown). The GFP tagged protein localization was variable from 
cell to cell with some cells having nuclear Exo5 and other only cytoplasmic. After laser 
stripping, Zhongsheng You saw accumulation of Exo5-GFP at the site of cutting, but the kinetics 
was very slow with accumulation peaking at around 60 minutes after cutting. Several questions 
need to be addressed; first, is Exo5 localization cell cycle dependent or is it DNA damage 
dependent? It will be of interest to determine the mechanism of recruitment and nuclear import; 
the pathway that Exo5 is involved in human cells is still unclear.  
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  There are many areas and many questions that have yet to be explored, and these 
questions could lead to important insight into genome stability and disease. This thesis outlines 
my work on this novel exonuclease family from yeast to humans.  
 
RNase H2-initiated RER 
 The consequence of the disparity in the rNTP vs dNTP concentrations in the cell 
(rNTP~100 fold higher than dNTP) has only recently been appreciated. The high rNTP 
concentration leads to large amounts of rNMPs being incorporated into the genome by 
replicative polymerases in vitro and in vivo (Nick McElhinny, Kumar et al. 2010; Nick 
McElhinny, Watts et al. 2010; Sparks, Chon et al. 2012). RNase H2 is able to cleave at sites of 
RNA in a RNA/DNA hybrid. It has the ability to cleave both at sites of a single-ribonucleotide or 
in long stretches of ribonucleotide such as R-loops (Eder, Walder et al. 1993; Murante, 
Henricksen et al. 1998). The work presented in Chapter IIIa of this dissertation outlines the 
reconstitution of the RNase H2-initiated ribonucleotide excision repair pathway, and created a 
system to investigate the rate of rNMP incoporation by replicative polymerases using a large 
plasmid based method to decrease sequence bias. In this reconstitution we find several redundant 
steps in the repair pathway. Both Polδ and Polε are able to carry out strand displacement 
synthesis with reasonable efficiencies, and both FEN1 and Exo1 are capable of flap removal 
during strand displacement synthesis in this system. There are still questions about how this 
pathway works in vivo, and other functions it may play in genome maintenance and disease.  
Future Directions 
 One important reason for studying the RNase H2-initiated RER pathway comes from the 
finding that mutations in RNase H2 in humans causes disease Aicardi Goutières syndrome 
(Crow, Leitch et al. 2006). Aicardi Goutières is a systemic autoimmune childhood disease that is 
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 triggered by IFN (Type I interferon) activation in response to endogenous nucleic acids, usually 
from viral infection (Aicardi and Goutieres 1984; Kawai and Akira 2006). RNase H2 is essential 
for development in mice, and the patients with mutations in RNase H2 have decreased but not 
complete loss of activity (Crow, Leitch et al. 2006; Reijns, Rabe et al. 2012). Though it has not 
been investigated whether patients with these RNase H2 mutations have increased genomic 
rNMPs, it will be interesting to determine if increases in genomic rNMPs plays a role in the 
disease. Testing patient genomic DNA compared to controls sample to determine the 
approximate level of rNMPs remaining in their genomes by treatment with NaOH or RNase H2 
will be important to understand if genomic rNMPs contribute to the pathology of AGS. There 
evidence from the RNase H2 knockout mice that removal of genomic rNMP may not be the 
function of RNase H2 that is causative of the autoimmunity mediated through INF activation. 
The RNase H2-knockout mouse embryos did not have the characteristic activation of INF that is 
seen in other models of the disease in mice (Hiller, Achleitner et al. 2012; Reijns, Rabe et al. 
2012). One possible explanation is that the IFN activation phenotype occurs later in 
development, and is not seen because of the early lethality caused by deletion of RNase H2. To 
test this hypothesis it will require making mutants of RNase H2 that mimic the mutations in 
human patients rather than using a knockout. It will also be of interest to determine which 
activity of RNase H2 is responsible for preventing the activation of IFN, cleaving a single rNMP 
or at sites of multiple rNMPs. Using the knowledge gained from our study on the unlinking of 
RNase H2 activities may allow for make mouse knock-in RNase H2 mutants that have only 
single rNMP cleavage activity or only multiple rNMP cleavage activity. It may be the function of 
cleavage of multiple ribonucleotides that may mimic substrates produced during viral infection 
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 that prevents the activation of IFN in vivo. There are many aspects of RNase H2 function in 
mammalian cells that are still to be elucidated.  
 
Top1-initiated Ribonucleotide repair 
 Both human and vaccina viral Topoisomerase I homologs have endoribonuclease activity 
in vitro against RNA in RNA/DNA hybrids (Sekiguchi and Shuman 1997; Kim, Huang et al. 
2011). In S. cerevisiae RNase H2 deficient strains show a particular mutagenesis spectrum in 
which there is a significant increase in 2-5 bp deletions at sites of di-nucleotide repeats (Nick 
McElhinny, Kumar et al. 2010; Kim, Huang et al. 2011; Williams, Smith et al. 2013). 
Topoisomerase I is responsible for causing these 2-5 bp deletions in the absence of RNase H2 
(Kim, Huang et al. 2011). Also, Top1 is able to remove a small portion of ribonucleotides from 
the yeast genome in the absence of RNase H2 (Williams, Smith et al. 2013). The data we present 
in Chapter IV outlines our in vitro reconstitution of Top1 dependent removal of rNMPs from 
dsDNA. Also Chapter IV outlines the first in vitro biochemical reconstitution of Top1-mediated 
2-5 bp deletions observed in the absence of RNase H2.   
Future Directions 
 There have been many in vivo studies investigating the formation of the 2-5 bp deletions 
that are dependent on Top1 in the context of genomic rNMPs and in transcription-associated 
mutagenesis (TAM)(Cho, Kim et al. 2013). In our in vitro system when the rNMP is in the 
context of a di-nucleotide repeat sequence Top1 is able to lead to a two-nucleotide deletion. The 
deletion product is resistant to NaOH treatment supporting our hypothesis that the rNMP is 
removed by the Top1-dependent deletions, but we still need to purify and sequence the resulting 
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 oligonucleotide to gain more evidence about where the deletion occurs in our rNMP-containing 
strand.  
 The role of Top1 in repair of rNMPs seems to be a back up system that is only observed 
in the absence of RNase H2, but it is possible that at low levels Top1 may attack remaining 
genomic rNMPs in wild-type cells. Top1 attack of an rNMP forming a cyclic phosphate 
terminated nick at the rNMP blocks the ability of RNase H2 to act (data not shown). Further, 
Top1 mutagenesis may play a role in the detrimental effect of RNase H2 mutations in AGS. It 
would be interesting to investigate if AGS patients have increased deletions at sites of di-
nucleotide repeats in their genome. 
  It will also be important to investigate what pathways contribute to the repair Top1-DNA 
complexes that are not resolved by religation of the DNA. There are several proteins that have 
been implicated in repair including Tdp1, the NER endonuclease Rad1-Rad10 (XPF), and 
Mus81-mus7 endonuclease (Vance and Wilson 2001). It may be possible that these Top1-cc 
repair pathways help to prevent Top1- religation events that lead to increased mutagenesis. Work 
from this thesis outlined a mechanism for Top1-DNA repair that requires the Top1 protein to be 
partially degraded prior its  removal by Tdp1, but the mechanism for this degradation in vivo is 
not well understood. The proteins that are responsible for Top1 degradation are not known in 
yeast and need to be investigated further. Several publications implicate the proteosome in Top1-
cc degradation in mammals, but it has not been investigated in yeast (Lin, Ban et al. 2009; Lee-
Kirsch, Wolf et al. 2013). These are some of the questions that still need to be investigated.  
Summary 
 The work presented in this dissertation focuses on the role of nucleases in DNA 
metabolism. First, it describes the biochemical characterization of a novel nuclease family, 
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 Exonuclease 5. Exo5 members all contain an iron-sulfur cluster and are bi-directional ssDNA 
specific exonucleases. The S. cerevisiae homolog is essential for mitochondrial genome 
maintenance, but lacks an apparent nuclear function. The S. pombe homolog is both nuclear and 
mitochondrial, and is subsequently important for both nuclear and mitochondrial genome 
maintenance, maintaining proper mitochondrial DNA levels, and for repair of DNA damage. S. 
pombe Exo5 interacts with both PCNA and RPA in vivo. The human homolog also physically 
interacts with the human RPA complex, and is important for nuclear genome maintenance and 
genome stability.  
 The second area of this dissertation discusses our work on the incorporation of rNMPs 
into the genome by replicative polymerase and their subsequent removal by two pathways. First, 
the ribonucleotide excision repair pathway that is initiated by RNase H2 cleaves at the rNMP, 
allowing loading of PCNA by the RFC complex that allows strand displacement synthesis by 
either Polδ or Polε. The resulting ssDNA flap containing the ribonucleotide is removed by either 
FEN1 or Exo1 and the DNA is ligated by DNA ligase I. The other pathway for rNMP removal is 
dependent on Top1 and can lead to small deletions if the rNMP is in the context of a di-
nucleotide repeat sequence, If the rNMP is outside the context of a repeat sequence it must be 
repair by a pathway of Top1-DNA covalent complexes removal.   
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